data_2lzl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lzl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.769 0.318 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.85 -31.36 7.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.42 -53.76 21.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.13 -53.64 17.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.64 -53.37 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.11 -46.49 56.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -66.3 -32.74 74.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.873 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.48 68.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.95 -49.26 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.23 -36.25 79.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.435 HG22 HG21 ' B' ' 387' ' ' ILE . 8.7 mm -73.15 -34.43 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.93 -47.2 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.42 -37.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.72 -54.18 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.96 -50.44 72.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.32 -54.99 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.176 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 21.3 m -55.11 -41.1 71.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.27 -46.41 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.33 -44.4 95.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.88 0.372 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.76 -36.43 83.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.9 p -48.74 -31.56 7.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.26 -53.74 22.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.21 -53.77 16.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.441 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.4 -53.33 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.2 -46.55 56.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -66.22 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -51.45 68.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.94 -49.23 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.26 -36.26 79.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.435 HG21 HG22 ' A' ' 387' ' ' ILE . 8.7 mm -73.14 -34.57 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.75 -47.21 84.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.39 -37.68 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -69.6 -54.2 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.48 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.29 72.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.48 -55.06 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 31.7 m -55.07 -41.03 71.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.33 -46.93 59.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.0 m -59.79 -44.55 93.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.798 0.332 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.4 p -48.75 -31.9 7.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.4 -53.79 21.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.71 17.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.23 -53.01 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.117 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.3 55.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.51 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -51.29 69.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.1 -49.16 73.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.34 -36.07 79.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.435 HG21 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.11 -34.57 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.04 -47.02 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.33 -37.61 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.05 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.7 96.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.45 72.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.23 -54.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 14.2 m -55.27 -40.92 71.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.33 -45.23 63.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.6 m -61.52 -44.18 97.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.81 -35.69 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.5 p -48.93 -32.11 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.4 -53.88 20.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.79 -53.22 20.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.529 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.52 -53.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -45.98 56.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -66.94 -32.73 74.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -51.47 68.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.82 -49.08 74.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.58 -36.11 79.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.435 HG22 HG21 ' A' ' 387' ' ' ILE . 8.8 mm -73.29 -34.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.93 -47.22 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.37 -37.26 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.19 -54.1 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.78 96.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.07 -50.42 72.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.37 -54.82 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.6 m -55.3 -40.97 71.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.31 -45.58 62.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -61.21 -44.44 97.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.835 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.832 0.349 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 81.9 p -48.9 -33.52 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.3 -53.39 30.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.22 -52.73 25.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.64 -52.49 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 111.141 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.19 53.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -65.69 -32.62 74.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.391 . . . . 0.0 110.939 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.43 68.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.14 74.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -61.71 -36.17 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.433 HG22 HG22 ' B' ' 387' ' ' ILE . 8.6 mm -73.17 -34.45 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.12 -47.08 84.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.34 -37.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.1 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.5 97.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.35 73.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.33 -54.84 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 85.2 m -55.33 -41.03 71.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.27 -46.19 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.9 m -60.55 -44.54 96.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.866 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.361 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.17 -36.19 83.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.7 p -48.93 -33.4 10.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.54 -53.53 27.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.948 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.2 -52.68 26.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.88 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -47.28 53.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -65.72 -32.6 74.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.41 69.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.47 -49.16 74.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.71 -36.13 80.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.19 -34.67 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.97 -47.04 84.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.29 -37.85 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.62 -54.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.63 96.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.41 72.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.35 -55.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.1 m -55.02 -41.01 70.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.175 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.29 -46.7 60.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -60.06 -44.52 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 38.0 mmt-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.831 0.348 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.0 p -49.12 -33.29 11.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -67.43 -53.51 28.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.25 -52.74 25.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.85 -52.51 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.28 53.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -65.58 -32.6 74.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.39 68.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.42 -49.14 74.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.06 80.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.43 HG21 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.19 -34.37 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.29 -47.17 83.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.26 -37.14 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.34 -54.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.74 96.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.94 72.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 94.1 t -62.74 -54.8 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.6 m -56.36 -46.63 79.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.09 -36.0 82.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -70.81 -44.81 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.835 0.35 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.11 -36.75 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.3 p -49.28 -33.03 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.94 -53.27 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.39 -52.78 24.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.24 -52.61 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 111.154 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.71 -47.08 53.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.459 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -66.03 -32.57 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.41 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.61 -49.16 74.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.66 -36.08 79.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 387' ' ' ILE . 8.6 mm -73.08 -34.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.176 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.06 -47.13 84.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 42.2 t -75.36 -37.37 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.18 -54.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.39 97.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.6 72.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.69 -54.58 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 19.9 m -55.85 -41.08 73.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.1 -42.35 69.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.32 -43.7 93.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 24.1 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.4 p -48.99 -32.09 8.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.12 -54.01 21.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.37 19.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.23 -53.15 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.125 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.54 55.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -66.3 -32.68 74.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.41 69.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.01 -49.07 73.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.5 -36.12 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.43 HG23 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.07 -34.52 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.01 84.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.33 -37.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.07 -54.07 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.53 97.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.55 72.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.96 -54.71 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 87.0 m -55.54 -41.02 72.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.5 mt -71.18 -43.79 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.84 -44.0 97.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.79 -35.52 80.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.9 p -48.89 -32.29 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.2 -53.92 21.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.99 -53.32 19.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.19 -53.02 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -46.49 55.93 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.44 -32.56 74.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.41 -51.47 68.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.52 -49.2 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.64 -35.97 79.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 387' ' ' ILE . 8.4 mm -73.31 -34.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.26 -47.23 83.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.0 t -75.22 -37.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.35 -54.1 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.22 96.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.77 72.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.58 -54.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.9 mt -64.32 -34.7 78.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -72.27 -44.57 62.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 90.9 p -49.48 -31.88 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -68.44 -53.88 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.83 -53.27 20.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.3 t -65.48 -53.14 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.23 55.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -66.71 -32.71 74.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.898 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -51.5 68.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.4 -49.35 74.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 387' ' ' ILE . 8.8 mm -73.17 -35.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.2 -47.15 85.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.26 -39.25 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.133 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -68.05 -54.11 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.04 96.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.27 73.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.91 -55.13 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.099 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 5.8 m -55.4 -41.16 72.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.21 -44.5 65.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.03 -43.87 97.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.9 0.381 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.52 -37.07 85.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 96.5 p -49.34 -32.04 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -68.41 -53.89 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.86 -53.23 20.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -53.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.04 -46.11 56.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -66.77 -32.6 74.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.374 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.41 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.33 -49.21 74.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.82 -36.14 80.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 387' ' ' ILE . 8.6 mm -73.17 -34.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.87 -47.48 83.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.1 t -75.03 -37.84 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.5 -53.96 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.31 90.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.81 72.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.16 -54.45 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.4 m -57.92 -48.5 79.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -38.34 90.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.6 m -68.87 -44.66 72.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.813 0.339 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.1 p -49.1 -33.03 10.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.91 -53.33 27.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.41 -52.87 24.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.4 -52.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.129 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.72 -47.1 53.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -66.06 -32.55 74.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.35 . . . . 0.0 110.843 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.5 68.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.32 -49.14 75.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.95 -36.08 80.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.432 HG22 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.12 -34.76 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.99 -47.02 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.25 -38.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.5 t -69.43 -54.23 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.0 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -51.01 71.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.63 -54.82 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -56.13 -41.03 74.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.27 -35.85 71.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.71 -41.53 71.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.29 -36.33 83.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.4 p -49.12 -33.04 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.851 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.95 -53.67 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.47 -52.98 23.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.443 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.3 -52.69 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.88 54.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -65.96 -32.56 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -51.46 68.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.89 -49.29 75.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -62.03 -36.04 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 387' ' ' ILE . 8.2 mm -73.05 -34.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -63.0 -47.25 83.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.6 t -75.03 -38.07 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.55 -53.99 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.19 92.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.03 71.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.59 -54.65 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 28.5 m -57.34 -46.83 82.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.3 -34.76 78.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.12 -44.77 62.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.806 0.336 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.3 p -48.5 -31.97 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.29 -53.62 23.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.96 -53.67 17.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.45 -53.21 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.139 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.23 55.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -66.7 -32.64 74.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.35 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.83 -49.2 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.47 -36.09 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 387' ' ' ILE . 8.6 mm -73.32 -34.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -47.11 84.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.6 t -75.38 -37.66 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -69.79 -54.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.23 97.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.84 71.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.39 -54.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 60.4 m -55.59 -40.78 72.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.5 mt -71.41 -40.58 70.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.0 m -64.73 -54.19 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.37 -35.73 80.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 80.2 p -48.62 -31.79 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.35 -53.61 22.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.97 -53.67 17.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.44 -53.25 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -46.06 56.13 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -66.75 -32.73 74.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.395 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.34 69.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.82 -49.32 73.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.28 -36.31 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 387' ' ' ILE . 8.8 mm -73.12 -34.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.02 -47.13 84.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.0 t -75.46 -37.3 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.0 t -70.12 -54.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.13 98.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.28 -50.87 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.15 -54.57 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 87.1 m -56.1 -40.72 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.199 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.43 -36.7 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -70.05 -41.98 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.854 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.8 p -48.85 -33.22 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.53 -53.84 25.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.24 -52.93 24.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.66 -51.65 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.9 52.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -65.18 -32.58 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.56 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.09 -49.3 75.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.82 -35.96 79.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.427 HG22 HG21 ' B' ' 387' ' ' ILE . 8.6 mm -73.28 -34.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.96 -46.89 85.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.34 -38.22 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.44 -54.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.14 97.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.97 -50.46 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.0 -55.06 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 61.5 m -55.31 -40.92 71.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.27 -44.45 65.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.2 m -62.14 -43.68 98.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.853 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.68 -34.36 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.2 p -48.75 -33.38 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.54 -53.79 25.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.21 -52.88 24.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.53 -51.7 67.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.75 52.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -65.24 -32.64 74.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 110.892 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.69 67.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.81 -49.24 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.01 -35.94 80.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 387' ' ' ILE . 8.5 mm -73.32 -34.74 44.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -62.99 -46.91 85.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.29 -38.27 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.33 -54.06 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.12 98.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.48 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.99 -55.19 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.4 m -55.11 -40.95 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.34 -45.06 63.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -61.48 -43.68 98.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.86 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 76.0 p -48.97 -32.2 8.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -68.24 -53.84 21.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.78 -53.31 20.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.14 -53.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -46.43 55.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -66.49 -32.67 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -51.46 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.62 -49.18 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.57 -36.21 79.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.434 HG22 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.12 -34.33 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.18 -47.39 82.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.14 -37.45 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.98 -54.12 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.89 95.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.94 72.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.27 -54.73 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 65.8 m -56.71 -46.95 80.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.92 -35.73 81.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -71.12 -45.14 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.849 0.357 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.5 mt -62.56 -35.41 79.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 87.8 p -48.91 -32.3 8.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.34 -53.93 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.27 20.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.3 -53.09 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.32 55.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.46 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.39 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.71 -49.26 73.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.46 -36.11 79.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.434 HG23 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.21 -34.53 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.92 -47.12 84.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.936 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.39 -37.78 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.63 -54.1 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.57 98.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.7 72.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.13 -54.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.9 m -56.28 -40.99 75.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.19 -39.28 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.2 m -67.45 -42.81 82.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.893 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.869 0.366 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 59.1 p -48.88 -33.38 10.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -66.93 -53.3 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.59 -52.64 24.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.42 -53.1 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.99 50.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.07 -32.82 74.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.14 -51.44 69.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.56 -49.03 75.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.66 -36.16 80.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.441 HG23 HG21 ' B' ' 387' ' ' ILE . 8.5 mm -73.02 -34.43 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.16 -47.14 83.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.22 -37.52 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.01 -54.09 20.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.99 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.48 72.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.34 -54.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.167 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 25.6 m -55.21 -40.96 71.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.4 mt -71.31 -46.0 61.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.69 -44.38 96.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.83 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.19 -35.66 81.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 90.7 p -48.97 -33.48 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.91 -53.24 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.52 -52.77 24.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.34 -53.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.65 52.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.445 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -65.49 -32.74 74.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -51.39 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.71 -48.97 74.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.67 -36.13 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.441 HG21 HG23 ' A' ' 387' ' ' ILE . 8.7 mm -73.05 -34.3 45.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.22 -47.26 83.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.22 -37.43 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.97 -54.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.89 96.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.34 72.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.39 -54.92 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 23.5 m -55.2 -40.9 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.42 -46.12 60.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.62 -44.47 96.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.803 0.335 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.9 p -48.85 -33.48 10.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.46 -53.41 29.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.16 -52.71 25.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.56 -52.18 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.75 -47.72 52.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -65.25 -32.59 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -51.47 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.21 -49.27 74.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.03 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.428 HG23 HG21 ' B' ' 387' ' ' ILE . 8.5 mm -73.16 -34.73 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.92 -47.09 84.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.27 -38.23 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.28 -54.18 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.0 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.94 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.57 -54.82 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -56.19 -41.07 74.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.32 -36.36 71.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.22 -41.56 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.87 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.32 -35.5 81.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -48.81 -33.47 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.48 -53.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.24 -52.85 24.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.51 -52.14 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.189 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.76 -47.63 52.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.33 -32.53 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -51.51 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -49.23 75.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.09 80.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.428 HG21 HG23 ' A' ' 387' ' ' ILE . 8.4 mm -73.2 -34.63 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.94 -47.36 83.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.98 -38.1 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.45 -54.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.03 92.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.05 71.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.6 -54.74 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.5 m -57.17 -46.78 82.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -34.56 78.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -72.21 -45.09 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.863 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.8 mt . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 77.5 p -48.94 -33.28 10.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -67.64 -53.46 27.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.38 -52.83 24.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.09 -52.45 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.15 53.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -65.86 -32.49 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.841 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.5 68.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.31 -49.22 74.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.07 80.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.429 HG23 HG23 ' B' ' 387' ' ' ILE . 8.4 mm -73.16 -34.48 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.12 -47.24 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.16 -37.49 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.15 -54.03 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.31 96.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.63 72.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.69 -55.03 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 94.4 m -55.73 -46.24 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.09 -36.06 82.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.83 -44.69 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.867 0.365 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.06 -36.37 84.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -49.01 -33.18 10.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -67.82 -53.37 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.44 -53.02 23.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.28 -52.61 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.97 54.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -65.98 -32.6 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.48 68.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.58 -49.05 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.8 -36.03 79.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.429 HG23 HG23 ' A' ' 387' ' ' ILE . 8.3 mm -73.09 -34.71 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.06 -46.99 84.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.27 -37.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -70.03 -54.13 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.73 96.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.43 72.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.22 -54.89 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 87.7 m -55.32 -40.96 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.4 mt -71.26 -45.84 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.93 -44.75 96.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 18.8 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 99.8 p -48.6 -32.25 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.99 -53.75 23.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.92 -53.1 20.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.92 -53.07 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.94 -46.74 55.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -66.11 -32.6 74.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -51.39 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.78 -49.12 74.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.1 79.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.43 HG23 HG21 ' B' ' 387' ' ' ILE . 8.5 mm -73.16 -34.7 45.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.93 -47.05 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.31 -37.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.137 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.67 -54.23 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.159 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.64 96.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.45 72.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.14 -54.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 50.3 m -55.7 -40.49 72.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.32 -37.97 71.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.4 m -68.93 -41.83 77.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.58 -33.61 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.6 p -48.6 -32.22 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.09 -53.84 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.27 20.01 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.01 -53.02 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.65 55.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.38 68.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.79 -49.09 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.05 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.43 HG21 HG23 ' A' ' 387' ' ' ILE . 8.5 mm -73.21 -34.42 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.14 -47.07 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 42.6 t -75.39 -37.29 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.23 -54.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.58 97.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.5 72.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 93.3 t -64.81 -54.51 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 89.3 m -55.95 -40.72 73.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.33 -40.3 70.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -66.49 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.88 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.81 -32.42 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -68.23 -53.94 21.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.935 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.36 19.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.95 -52.94 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.93 -46.85 55.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.543 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.08 -32.63 74.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.46 68.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.76 -49.07 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.54 -36.08 79.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.435 HG22 HG22 ' B' ' 387' ' ' ILE . 8.6 mm -73.18 -34.42 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.24 -47.2 83.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.12 -37.46 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.04 -53.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.19 93.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.1 71.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.19 -54.7 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 16.9 m -57.43 -48.42 79.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.53 -37.23 85.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.6 m -70.08 -44.32 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.849 0.357 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.78 -35.02 79.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.4 p -48.78 -32.57 8.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -68.04 -53.77 23.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.76 -53.19 21.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.503 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -53.04 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.381 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.85 -46.63 54.75 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -66.12 -32.79 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.45 68.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.61 -49.07 74.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.64 -36.3 80.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.435 HG22 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.05 -34.54 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.05 -47.19 84.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.24 -37.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -69.88 -54.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.84 97.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.88 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.87 -54.46 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 60.3 m -56.38 -40.8 75.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.31 -34.4 70.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.2 m -72.53 -41.54 65.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.849 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -49.12 -31.97 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.35 -53.78 21.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.929 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.97 -53.36 19.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.486 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.6 t -65.56 -53.35 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.112 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.15 -46.0 56.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.509 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -66.85 -32.67 74.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.55 68.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.52 -49.22 74.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.47 -36.29 80.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.437 HG21 HG21 ' B' ' 387' ' ' ILE . 8.7 mm -73.2 -34.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.46 -47.27 84.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.34 -38.06 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.3 -54.39 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.52 97.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.089 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.44 72.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.59 -55.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.7 m -55.72 -40.49 72.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.14 -34.02 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.51 -39.39 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.816 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.31 -36.89 85.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.73 -31.75 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -68.33 -53.77 21.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.06 -53.67 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.31 -53.21 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.41 56.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.39 -32.71 74.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -51.51 68.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.75 -49.13 74.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.2 79.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.437 HG21 HG21 ' A' ' 387' ' ' ILE . 8.5 mm -73.15 -34.52 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.87 -47.51 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.05 -37.64 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.71 -54.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.41 90.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.18 71.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.95 -54.42 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.3 m -57.82 -47.14 83.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.155 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.33 -34.42 78.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.7 m -72.38 -45.53 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.866 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 24.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.0 p -49.15 -32.87 10.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.93 -53.56 25.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.05 22.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.33 -52.84 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -46.87 54.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.0 -32.48 73.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.915 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -51.4 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.15 74.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.72 -36.23 80.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.43 HG21 HG23 ' B' ' 387' ' ' ILE . 8.4 mm -73.15 -34.35 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.48 82.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.95 -37.57 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.89 -54.07 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.92 92.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.07 71.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.24 -54.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.1 m -57.55 -47.63 81.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.7 -35.41 80.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.34 -45.13 63.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.896 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.88 0.371 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 24.2 mt -65.07 -36.64 84.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -49.03 -32.91 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -68.01 -53.64 24.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.9 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.53 -53.04 22.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -64.37 -52.74 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -46.82 54.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -66.13 -32.55 74.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.51 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.44 -49.12 74.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.8 -36.14 80.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 387' ' ' ILE . 8.6 mm -73.21 -34.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.23 -47.36 82.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.07 -37.45 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.97 -54.1 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.83 91.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.08 71.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.66 -54.41 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 47.0 m -58.13 -47.7 82.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -63.67 -34.97 79.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.11 -45.11 61.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.85 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.7 p -49.19 -33.37 12.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.52 -53.38 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.46 -52.99 23.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -63.67 -52.86 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.66 -47.37 52.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.53 -32.62 74.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -51.49 68.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.54 -49.0 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.79 -36.3 80.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.434 HG21 HG23 ' B' ' 387' ' ' ILE . 8.6 mm -73.13 -34.69 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.84 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.38 -37.85 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.55 -54.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.074 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.16 70.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.94 -54.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.9 m -56.4 -41.13 75.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.3 -33.8 70.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.88 -55.98 6.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.6 mt -65.11 -36.58 84.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 93.5 p -48.96 -33.29 10.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.65 -53.29 29.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.46 -52.9 23.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.48 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.87 -52.9 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.25 53.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -65.54 -32.63 74.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.45 68.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.6 -49.07 74.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.16 80.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 387' ' ' ILE . 8.7 mm -73.3 -34.68 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.79 -47.07 85.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.38 -38.08 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.3 -54.17 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.31 98.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.21 -50.5 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.44 -54.92 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.5 m -55.75 -40.89 73.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.3 -42.26 68.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -63.33 -54.18 41.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 -179.889 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 20.7 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 86.4 p -48.38 -33.8 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -66.96 -53.81 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.9 -52.72 27.08 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.72 -51.37 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.54 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.44 -32.61 74.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.54 68.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.33 -49.22 74.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.68 -36.08 79.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.428 HG23 HG21 ' B' ' 387' ' ' ILE . 8.4 mm -73.24 -34.31 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.25 -47.1 83.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.34 -37.43 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.07 -54.12 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.23 97.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.58 72.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.66 -54.52 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.1 m -55.92 -41.01 73.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.16 -41.31 70.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.44 -43.38 90.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.6 mt -65.54 -33.56 76.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 84.0 p -48.4 -33.9 9.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -66.88 -53.74 29.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.79 -52.67 27.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.59 -51.36 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 111.126 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.83 -48.3 51.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -64.54 -32.6 74.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -51.64 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.2 -49.16 75.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.78 -36.11 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.428 HG21 HG23 ' A' ' 387' ' ' ILE . 8.5 mm -73.25 -34.26 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.29 -47.05 83.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.37 -37.36 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.18 -54.06 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.7 96.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.51 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.98 -54.72 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 91.4 m -55.54 -40.89 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.25 -44.08 66.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.74 -43.89 97.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.878 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -33.54 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.11 -53.93 26.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.06 -52.91 25.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.89 -51.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.125 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -48.52 51.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -64.46 -32.58 74.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.6 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.11 -49.27 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.77 -36.06 79.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.431 HG22 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.24 -34.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.13 -47.35 83.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.0 -37.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.54 -53.96 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.9 91.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.18 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.43 -54.94 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.5 m -57.02 -47.14 81.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -63.96 -35.3 80.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -71.36 -45.18 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.892 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.86 -33.23 75.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 70.5 p -48.58 -33.46 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.26 -54.03 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.05 -52.82 25.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.05 -51.33 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.35 51.23 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.75 -32.56 74.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.5 68.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.25 -49.16 75.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.92 -35.96 79.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 387' ' ' ILE . 8.5 mm -73.34 -34.59 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.99 -47.07 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.24 -38.18 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.4 -54.24 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.9 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.73 72.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.65 -54.66 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 22.8 m -56.36 -41.15 75.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.19 -36.47 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.08 -41.8 73.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.832 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.861 0.362 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.4 p -48.64 -31.7 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.43 -53.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.07 -53.63 17.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.46 -53.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.26 55.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.498 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -66.65 -32.7 74.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.49 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.55 -49.27 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.56 -36.16 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.435 HG21 HG21 ' B' ' 387' ' ' ILE . 8.6 mm -73.15 -34.53 45.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.91 -47.53 82.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.3 t -75.01 -37.77 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.62 -54.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.61 91.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.2 71.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.19 -54.52 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 84.8 m -57.59 -47.31 82.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.96 -34.9 79.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.96 -44.95 62.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.861 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.4 mt -57.48 -35.39 70.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 95.5 p -48.74 -31.67 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -68.48 -53.61 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.93 -53.68 18.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.514 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.51 -53.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.12 56.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -66.81 -32.65 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.62 -49.11 74.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.66 -36.17 80.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.435 HG21 HG21 ' A' ' 387' ' ' ILE . 8.5 mm -73.11 -34.63 45.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.15 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.9 -47.44 83.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.97 -37.91 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.52 -54.1 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.72 91.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.23 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.99 -54.66 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 24.4 m -57.55 -47.33 82.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.16 -45.19 61.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.836 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 20.0 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.845 0.355 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 95.7 p -48.59 -31.81 7.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.42 -53.72 21.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.902 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.96 -53.59 18.28 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.45 -53.13 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.04 56.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -66.76 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.43 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.833 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.82 -49.11 74.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.08 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.434 HG23 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.11 -34.63 45.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.96 -47.11 84.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.28 -37.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.09 -54.24 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.39 96.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.69 72.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.63 -54.43 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.5 m -56.05 -40.82 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.26 -40.55 70.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.8 m -66.13 -43.32 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.871 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.53 -35.32 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.6 -31.86 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.37 -53.68 22.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.99 -53.7 17.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.27 -53.14 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.32 55.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.53 -32.66 74.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.52 68.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.59 -49.19 74.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.62 -35.99 79.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.434 HG23 HG23 ' A' ' 387' ' ' ILE . 8.5 mm -73.25 -34.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.87 -47.24 84.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.24 -37.52 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.99 -54.11 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.65 96.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.32 -54.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 36.8 m -56.13 -45.97 79.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.65 -34.55 78.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.39 -44.72 62.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.887 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.785 0.326 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.0 p -48.45 -31.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -68.44 -53.63 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.74 -53.72 18.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.23 -52.83 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -45.83 56.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -67.02 -32.64 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 110.911 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.48 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.66 -49.29 73.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.39 -36.01 79.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.431 HG21 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.22 -34.52 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.07 -47.07 84.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.5 t -75.33 -37.34 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.17 -54.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.05 -45.05 94.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.43 -50.39 71.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.09 -55.01 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 85.6 m -54.73 -40.15 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.3 mt -71.06 -34.09 70.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -73.55 -39.16 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.88 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.827 0.346 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.11 -34.06 72.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.3 p -48.67 -32.19 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -68.24 -53.79 22.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.81 -53.39 19.87 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.452 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.36 -53.08 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.95 56.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.9 -32.74 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.45 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.68 -49.13 74.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.53 -36.14 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.431 HG23 HG21 ' A' ' 387' ' ' ILE . 8.5 mm -73.17 -34.44 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.11 -46.99 84.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.5 -37.27 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.103 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -70.28 -54.15 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.28 93.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.33 71.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.34 -55.03 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 61.4 m -54.63 -39.92 68.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.26 -34.64 70.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.7 m -73.31 -38.24 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.835 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.87 0.367 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 92.1 p -48.6 -33.87 10.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.849 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -66.93 -53.47 31.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -67.87 -52.6 27.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -62.85 -51.39 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.849 0.357 . . . . 0.0 111.12 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.4 51.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.51 -32.63 74.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.67 67.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.1 -49.31 74.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.11 79.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.433 HG22 HG21 ' B' ' 387' ' ' ILE . 8.6 mm -73.31 -34.59 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.88 -47.16 84.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 46.1 t -75.3 -38.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.34 -54.22 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.04 97.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.66 72.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.077 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.03 -54.74 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 42.2 m -56.16 -41.01 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.21 -38.97 72.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.59 -42.41 82.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 -179.876 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.35 -34.36 78.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -48.57 -33.81 10.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.0 -53.48 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -67.87 -52.65 27.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.89 -51.62 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -48.2 51.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.73 -32.47 74.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.57 68.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.13 -49.21 75.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.74 -36.38 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.433 HG21 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.08 -34.42 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.97 -47.48 83.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.03 -37.84 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.61 -53.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.72 91.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.2 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.25 -54.66 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 39.3 m -57.4 -47.1 82.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.26 -35.77 81.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.87 -45.09 65.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.851 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 94.3 p -48.78 -33.68 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.28 -53.53 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.04 -52.82 25.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.18 -51.83 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.35 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.96 51.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -64.88 -32.65 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.4 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.75 -49.28 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.34 -36.3 79.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 387' ' ' ILE . . . . . 0.43 HG23 HG22 ' B' ' 387' ' ' ILE . 9.1 mm -73.33 -34.35 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.81 -47.29 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.43 -37.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.35 -53.93 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.27 98.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.34 -48.33 79.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.6 -55.09 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.6 m -55.71 -41.12 73.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.4 -51.74 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.886 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.887 0.375 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.34 -35.2 80.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.4 p -48.6 -33.68 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.36 -53.56 28.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.01 -52.96 25.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.22 -51.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.83 52.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.02 -32.63 74.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.46 68.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.7 -49.34 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.23 -36.45 79.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 387' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 387' ' ' ILE . 9.0 mm -73.2 -34.18 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.07 -47.3 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.38 -37.32 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.03 -54.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.58 97.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.45 72.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.11 -54.93 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 61.7 m -55.33 -40.99 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.33 -44.18 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -62.42 -43.63 98.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.572 0.701 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -27.77 26.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.17 149.04 46.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -155.75 169.25 24.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -87.97 165.93 14.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -164.23 158.72 19.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.61 142.45 51.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.82 150.74 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.54 114.01 5.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.52 165.17 31.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.78 121.92 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -155.34 164.56 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 56.86 35.04 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -58.12 -88.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.8 m -109.35 10.43 25.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 90.1 t -89.4 -65.4 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.087 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -68.43 -28.67 67.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.44 -29.55 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.079 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.2 -28.21 63.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.35 -25.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.849 0.357 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.48 -36.46 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.85 -31.36 7.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.42 -53.76 21.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.13 -53.64 17.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.64 -53.37 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.11 -46.49 56.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -66.3 -32.74 74.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.873 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.48 68.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.95 -49.26 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.23 -36.25 79.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.435 HG22 HG21 ' B' ' 387' ' ' ILE . 8.7 mm -73.15 -34.43 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.93 -47.2 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.1 t -75.42 -37.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.72 -54.18 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.96 -50.44 72.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.32 -54.99 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.176 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 21.3 m -55.11 -41.1 71.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.27 -46.41 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.33 -44.4 95.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -66.97 -23.15 65.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.6 tt -52.54 -67.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 160.89 48.02 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.668 2.245 . . . . 0.0 112.374 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -98.72 136.45 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.82 131.18 35.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -57.1 112.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.37 127.7 54.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -65.2 160.7 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 158.26 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -133.33 131.76 40.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -102.5 151.92 21.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -101.57 120.13 39.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -145.16 129.43 17.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 53.06 30.78 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -103.16 -70.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.7 p -98.0 3.41 49.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 90.7 t -90.06 -65.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -68.21 -28.89 67.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.24 -30.22 16.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.42 -28.26 61.86 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.5 -25.33 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.0 mt -65.76 -36.43 83.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.9 p -48.74 -31.56 7.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.26 -53.74 22.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.21 -53.77 16.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.441 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.4 -53.33 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.2 -46.55 56.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -66.22 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -51.45 68.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.94 -49.23 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.26 -36.26 79.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.435 HG21 HG22 ' A' ' 387' ' ' ILE . 8.7 mm -73.14 -34.57 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.75 -47.21 84.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.3 t -75.39 -37.68 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -69.6 -54.2 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.48 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.29 72.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.48 -55.06 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 31.7 m -55.07 -41.03 71.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.33 -46.93 59.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.0 m -59.79 -44.55 93.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -66.74 -22.95 66.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 15.6 tp -78.47 -28.18 46.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.657 0.741 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 131.51 21.34 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -81.66 131.8 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -107.48 116.86 32.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -126.43 161.51 27.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.05 118.77 34.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.854 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.83 174.67 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 107.25 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -168.32 170.24 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.31 127.7 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.06 -62.08 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -141.54 113.15 7.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -173.19 151.42 2.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 161.55 -82.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 24.6 p -104.64 3.47 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 0.0 110.85 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.01 -65.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -68.55 -27.19 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.31 13.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.82 -28.03 65.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.54 -25.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.099 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 25.5 mt -63.31 -36.41 83.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.4 p -48.75 -31.9 7.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.4 -53.79 21.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.71 17.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.23 -53.01 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.117 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.3 55.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.51 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -51.29 69.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.1 -49.16 73.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.34 -36.07 79.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.435 HG21 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.11 -34.57 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.04 -47.02 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.33 -37.61 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.05 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.7 96.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.45 72.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.23 -54.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 14.2 m -55.27 -40.92 71.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.33 -45.23 63.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.6 m -61.52 -44.18 97.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.89 -22.31 65.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.84 -67.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.613 0.72 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 179.7 3.52 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.67 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -79.06 134.99 36.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -151.49 148.86 28.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -101.14 124.98 47.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 7.2 tp -147.19 132.85 18.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.06 135.29 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.93 165.73 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.51 171.66 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 61.66 31.43 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -83.03 162.55 21.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 52.2 50.86 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -134.95 -51.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 16.9 m -103.17 2.53 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.968 0.413 . . . . 0.0 110.885 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.14 -65.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -69.32 -31.15 69.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.954 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -55.29 -25.86 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.67 70.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.77 -25.29 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.9 mt -65.81 -35.69 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.5 p -48.93 -32.11 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.4 -53.88 20.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.79 -53.22 20.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.529 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.52 -53.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -45.98 56.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -66.94 -32.73 74.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -51.47 68.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.82 -49.08 74.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.58 -36.11 79.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.435 HG22 HG21 ' A' ' 387' ' ' ILE . 8.8 mm -73.29 -34.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.93 -47.22 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.37 -37.26 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.19 -54.1 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.78 96.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.07 -50.42 72.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 94.9 t -65.37 -54.82 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.6 m -55.3 -40.97 71.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.31 -45.58 62.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -61.21 -44.44 97.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -66.72 -23.09 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 11.5 tp -77.04 -33.38 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.592 0.711 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 167.9 23.09 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.386 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -164.87 154.76 13.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -163.42 168.42 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -126.07 154.75 42.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.74 177.99 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 47.1 mt -149.74 157.83 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.43 151.81 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.01 125.85 53.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -169.38 173.54 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.98 122.12 44.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -161.47 178.49 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -65.18 92.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.045 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -143.54 -66.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.512 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.12 1.1 42.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.27 -65.01 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.32 -30.54 70.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.9 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.069 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.01 -25.44 70.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.47 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.02 -36.16 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 81.9 p -48.9 -33.52 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.3 -53.39 30.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.22 -52.73 25.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -63.64 -52.49 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 111.141 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.19 53.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -65.69 -32.62 74.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.391 . . . . 0.0 110.939 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.43 68.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.14 74.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -61.71 -36.17 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.433 HG22 HG22 ' B' ' 387' ' ' ILE . 8.6 mm -73.17 -34.45 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.12 -47.08 84.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.34 -37.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.1 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.5 97.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.35 73.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.33 -54.84 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 85.2 m -55.33 -41.03 71.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.27 -46.19 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.9 m -60.55 -44.54 96.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -66.99 -22.96 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.5 tt -52.06 -45.52 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.65 0.738 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -27.14 27.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.693 2.262 . . . . 0.0 112.385 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -111.63 170.81 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.42 159.27 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.24 131.35 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -107.13 130.38 54.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.8 127.36 32.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.18 136.35 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -90.24 -60.42 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -127.11 123.69 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -145.83 123.77 12.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -172.62 160.61 4.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.864 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -52.55 102.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.101 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -153.72 -69.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 17.7 p -101.68 2.25 38.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 30.5 t -89.92 -65.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.2 -30.72 70.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.67 -22.7 67.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.113 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.21 -25.39 71.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.478 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.21 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 111.15 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.5 mt -65.17 -36.19 83.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.7 p -48.93 -33.4 10.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.54 -53.53 27.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.948 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.2 -52.68 26.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.88 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -47.28 53.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -65.72 -32.6 74.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.41 69.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.47 -49.16 74.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.71 -36.13 80.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.433 HG22 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.19 -34.67 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.97 -47.04 84.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.4 t -75.29 -37.85 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.62 -54.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.63 96.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.41 72.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.35 -55.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.1 m -55.02 -41.01 70.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.175 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.29 -46.7 60.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -60.06 -44.52 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 38.0 mmt-85 -66.88 -23.03 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.98 -34.85 50.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.58 0.705 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 176.05 7.27 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.683 2.255 . . . . 0.0 112.36 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.16 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -138.26 128.75 26.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -137.99 155.54 48.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.67 171.54 14.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 2.1 tt -167.65 152.5 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 31.4 m -131.46 133.78 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -167.63 168.91 12.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -65.45 126.34 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -149.56 -179.24 6.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.86 175.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.37 56.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.091 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -87.74 -82.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.6 p -84.82 3.06 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 43.0 t -87.68 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.71 -30.8 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.81 -24.19 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.58 69.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.32 -23.29 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.08 -36.65 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.0 p -49.12 -33.29 11.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -67.43 -53.51 28.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.25 -52.74 25.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.85 -52.51 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.28 53.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -65.58 -32.6 74.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.864 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.39 68.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.42 -49.14 74.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.06 80.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.43 HG21 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.19 -34.37 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.29 -47.17 83.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.26 -37.14 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.34 -54.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.74 96.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.94 72.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 94.1 t -62.74 -54.8 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.096 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.6 m -56.36 -46.63 79.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.09 -36.0 82.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -70.81 -44.81 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -86.22 5.46 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.68 -38.7 28.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.23 0.062 0 CA-C-O 121.598 0.713 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.53 17.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -71.03 162.67 29.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.28 146.84 24.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.05 107.75 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -148.3 151.68 35.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 8.3 tt -68.55 114.28 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.8 138.86 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -95.12 123.66 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.55 134.13 14.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -121.26 139.23 53.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -61.05 -57.52 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -56.81 103.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -164.29 -71.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 26.2 p -105.41 3.74 29.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 40.0 t -90.13 -65.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.53 -31.16 70.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.43 -23.29 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.79 -24.88 70.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.46 -22.45 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.106 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.11 -36.75 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.3 p -49.28 -33.03 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.94 -53.27 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.39 -52.78 24.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.24 -52.61 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 111.154 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.71 -47.08 53.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.459 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -66.03 -32.57 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.41 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.61 -49.16 74.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.66 -36.08 79.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 387' ' ' ILE . 8.6 mm -73.08 -34.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.176 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.06 -47.13 84.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 42.2 t -75.36 -37.37 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.18 -54.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.39 97.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.6 72.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 94.5 t -64.69 -54.58 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 19.9 m -55.85 -41.08 73.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.1 -42.35 69.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.32 -43.7 93.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -66.81 -23.1 66.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 19.9 tp -73.96 -25.43 59.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 19.8 mmt-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.588 0.709 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 178.32 4.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.353 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -114.32 177.96 4.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.85 176.7 4.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.939 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -77.25 178.0 7.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.72 153.94 23.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.6 tp -142.59 136.37 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.7 142.17 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.144 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -58.09 125.03 21.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -156.85 165.68 35.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -124.82 98.26 5.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -143.1 147.92 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 57.91 65.23 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -77.32 -87.43 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -107.18 10.12 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 93.8 t -89.64 -65.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.34 -27.45 66.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.02 -30.06 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.71 -28.21 62.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.512 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.44 -25.91 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.352 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 24.1 mt -65.77 -35.38 80.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.4 p -48.99 -32.09 8.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.12 -54.01 21.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.37 19.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.23 -53.15 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.125 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.54 55.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -66.3 -32.68 74.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 110.912 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.41 69.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.01 -49.07 73.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.5 -36.12 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.43 HG23 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.07 -34.52 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.01 84.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.33 -37.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.07 -54.07 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.53 97.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.55 72.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.96 -54.71 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 87.0 m -55.54 -41.02 72.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.5 mt -71.18 -43.79 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.84 -44.0 97.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -66.76 -21.7 66.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.65 -49.85 61.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.622 0.725 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -28.68 25.14 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.4 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.03 141.55 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.041 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -134.61 141.55 46.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.76 108.94 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -115.0 136.52 53.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 6.6 mp -114.91 158.81 21.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 11.0 p -156.94 133.84 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.46 170.82 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -101.89 98.74 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.5 136.88 37.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -152.62 115.94 4.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -101.89 37.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -87.0 -76.79 1.26 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.494 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 19.0 m -96.59 3.49 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.09 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.54 -30.95 69.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -53.24 -28.36 26.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.42 -28.73 65.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.543 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.84 -26.67 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.79 -35.52 80.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.9 p -48.89 -32.29 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.2 -53.92 21.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.99 -53.32 19.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.19 -53.02 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -46.49 55.93 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.44 -32.56 74.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.41 -51.47 68.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.52 -49.2 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.64 -35.97 79.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 387' ' ' ILE . 8.4 mm -73.31 -34.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.26 -47.23 83.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.0 t -75.22 -37.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.35 -54.1 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.22 96.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.77 72.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.58 -54.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.9 mt -64.32 -34.7 78.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -72.27 -44.57 62.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.49 7.29 30.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.29 -33.65 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.61 0.719 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 153.2 69.23 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.77 156.97 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.81 164.61 15.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -151.13 157.09 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -115.43 155.39 27.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.29 142.77 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 40.9 t -144.34 145.72 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -72.95 138.07 45.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.88 176.35 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -83.69 105.54 14.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -163.07 173.91 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.75 40.63 7.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -84.29 -81.18 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -110.18 7.21 23.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 46.4 t -90.0 -65.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.21 -31.91 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -53.52 -30.58 42.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.13 58.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.3 -26.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.353 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.55 -37.27 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 90.9 p -49.48 -31.88 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -68.44 -53.88 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.83 -53.27 20.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.3 t -65.48 -53.14 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.23 55.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -66.71 -32.71 74.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.898 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -51.5 68.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.4 -49.35 74.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 387' ' ' ILE . 8.8 mm -73.17 -35.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.2 -47.15 85.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.26 -39.25 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.133 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -68.05 -54.11 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.04 96.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.27 73.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.91 -55.13 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.099 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 5.8 m -55.4 -41.16 72.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.21 -44.5 65.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.03 -43.87 97.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.62 -22.54 66.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.2 tp -84.76 -71.18 0.53 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.589 0.709 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -15.54 36.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.669 2.246 . . . . 0.0 112.31 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . 63.85 35.33 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -112.27 160.72 17.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.66 144.06 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -149.34 144.41 26.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.03 136.91 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.54 120.38 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.124 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -52.07 109.08 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.28 168.68 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.74 171.98 7.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -136.29 171.9 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.62 35.59 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -76.76 -82.32 0.54 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 8.9 m -107.86 5.94 26.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.93 -65.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.171 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -67.72 -31.73 71.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.88 57.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -57.68 -28.22 59.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.42 -27.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.137 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.52 -37.07 85.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 96.5 p -49.34 -32.04 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -68.41 -53.89 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.86 -53.23 20.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -53.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.04 -46.11 56.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -66.77 -32.6 74.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.374 . . . . 0.0 110.843 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.41 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.33 -49.21 74.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.82 -36.14 80.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 387' ' ' ILE . 8.6 mm -73.17 -34.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.87 -47.48 83.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.1 t -75.03 -37.84 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.5 -53.96 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.31 90.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.81 72.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 88.3 t -61.16 -54.45 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.4 m -57.92 -48.5 79.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -38.34 90.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.6 m -68.87 -44.66 72.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -84.84 4.0 35.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.9 tp -84.44 -40.3 17.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.625 0.726 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -175.2 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.688 2.259 . . . . 0.0 112.352 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -164.52 154.26 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -152.0 176.92 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.19 177.99 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -90.71 -67.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 83.6 mt -148.09 133.44 18.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 12.6 p -115.31 -27.58 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -77.07 170.12 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -78.7 177.75 8.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -150.05 170.51 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -68.93 -20.09 64.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -92.47 42.79 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.075 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -80.02 -84.24 0.66 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 13.0 p -85.4 1.4 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 110.895 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.1 -30.47 70.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.932 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.7 -23.62 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.086 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.83 70.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.483 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.57 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.18 -36.34 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.1 p -49.1 -33.03 10.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.91 -53.33 27.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.41 -52.87 24.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.4 -52.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.129 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.72 -47.1 53.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -66.06 -32.55 74.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.35 . . . . 0.0 110.843 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.5 68.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.32 -49.14 75.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.95 -36.08 80.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.432 HG22 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.12 -34.76 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.99 -47.02 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.25 -38.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.5 t -69.43 -54.23 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.0 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -51.01 71.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 84.3 t -63.63 -54.82 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -56.13 -41.03 74.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.27 -35.85 71.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.71 -41.53 71.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.64 -23.18 66.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.7 tp -67.09 -36.92 83.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.649 0.737 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 127.29 14.36 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.365 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -127.6 170.83 12.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.121 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.27 144.34 46.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.05 136.97 21.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -83.99 133.57 34.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.4 128.37 35.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 11.1 p -75.34 -26.76 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -81.02 -63.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -140.21 116.46 10.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.24 -26.17 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -125.99 172.52 9.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.7 104.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -154.57 -72.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.518 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 29.4 p -103.96 5.35 35.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 110.829 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.02 -65.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.98 -30.76 69.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.31 -23.9 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.89 -25.88 69.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.43 -22.92 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.29 -36.33 83.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.4 p -49.12 -33.04 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.851 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.95 -53.67 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.47 -52.98 23.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.443 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.2 t -64.3 -52.69 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.88 54.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -65.96 -32.56 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -51.46 68.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.89 -49.29 75.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -62.03 -36.04 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.432 HG22 HG22 ' A' ' 387' ' ' ILE . 8.2 mm -73.05 -34.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -63.0 -47.25 83.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.6 t -75.03 -38.07 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.55 -53.99 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.19 92.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.03 71.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.59 -54.65 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 28.5 m -57.34 -46.83 82.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.3 -34.76 78.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.12 -44.77 62.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -87.74 7.69 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.2 tp -76.96 -38.61 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.636 0.732 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 173.05 11.59 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -168.19 155.21 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -168.5 177.87 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -157.5 162.53 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -153.34 172.47 17.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 39.5 tp -156.17 137.18 13.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -156.3 151.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.13 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -76.92 132.22 38.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -170.41 168.34 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -58.43 136.11 57.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -155.36 158.95 39.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.68 103.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.053 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -96.43 -51.03 1.76 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.54 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 28.1 p -98.63 0.17 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 89.0 t -90.12 -65.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.56 -26.7 65.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.5 13.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.103 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.34 -28.63 64.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -83.05 -26.71 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.6 -35.72 78.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.3 p -48.5 -31.97 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.29 -53.62 23.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.96 -53.67 17.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.45 -53.21 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.139 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.23 55.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -66.7 -32.64 74.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.35 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.83 -49.2 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.47 -36.09 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' B' ' 387' ' ' ILE . 8.6 mm -73.32 -34.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -47.11 84.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.6 t -75.38 -37.66 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -69.79 -54.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.23 97.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.84 71.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.39 -54.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 60.4 m -55.59 -40.78 72.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.5 mt -71.41 -40.58 70.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.0 m -64.73 -54.19 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -66.87 -13.57 61.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 24.0 tp -80.04 -72.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.617 0.722 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.23 35.36 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.726 2.284 . . . . 0.0 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -97.72 113.39 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -96.58 138.75 33.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.39 137.24 58.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.45 -26.05 7.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 10.6 mt -52.02 -45.79 64.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.07 142.02 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.36 151.63 26.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -92.22 145.06 24.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.79 -31.16 5.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -131.92 149.76 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.63 -66.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 89.21 -71.37 2.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 1.9 m -133.12 17.34 4.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.832 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.94 -65.58 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.68 -27.11 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.43 -29.3 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.57 65.43 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.81 -26.21 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 21.5 mt -62.37 -35.73 80.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 80.2 p -48.62 -31.79 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.35 -53.61 22.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.97 -53.67 17.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.44 -53.25 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -46.06 56.13 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -66.75 -32.73 74.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.395 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.34 69.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.82 -49.32 73.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.28 -36.31 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.433 HG23 HG23 ' A' ' 387' ' ' ILE . 8.8 mm -73.12 -34.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.02 -47.13 84.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.0 t -75.46 -37.3 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.0 t -70.12 -54.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.13 98.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.28 -50.87 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.15 -54.57 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 87.1 m -56.1 -40.72 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.199 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.43 -36.7 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -70.05 -41.98 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -66.72 -22.68 66.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 9.6 tt -51.73 -51.35 56.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 116.76 4.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.39 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.03 32.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -167.81 158.74 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.11 179.04 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -126.49 136.68 52.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 38.1 mt -96.84 178.49 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.02 123.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.126 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -154.99 163.17 40.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -92.18 110.86 22.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -173.09 177.09 2.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -159.82 165.39 32.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -67.91 136.65 54.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -115.3 -34.77 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.7 m -118.87 -0.43 11.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 0.0 110.851 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.2 -65.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.56 -29.32 65.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.6 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.31 69.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.467 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.29 -22.63 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.117 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.68 -34.32 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.8 p -48.85 -33.22 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.53 -53.84 25.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.24 -52.93 24.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.66 -51.65 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.9 52.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -65.18 -32.58 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.56 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.09 -49.3 75.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.82 -35.96 79.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.427 HG22 HG21 ' B' ' 387' ' ' ILE . 8.6 mm -73.28 -34.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.96 -46.89 85.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.34 -38.22 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.44 -54.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.14 97.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.97 -50.46 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.0 -55.06 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 61.5 m -55.31 -40.92 71.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.27 -44.45 65.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.2 m -62.14 -43.68 98.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.64 -23.03 66.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 8.1 tp -76.63 -35.19 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.639 0.733 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 125.7 12.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.719 2.28 . . . . 0.0 112.337 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -167.12 160.82 14.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -86.2 114.97 23.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.96 162.84 31.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -119.68 178.23 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.7 tt -61.04 112.59 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 26.8 m -129.4 142.56 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -125.74 116.24 21.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -130.31 130.66 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -164.21 124.95 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -161.34 104.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -57.45 -63.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 86.23 -87.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 38.9 p -108.26 7.16 27.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.34 -65.47 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.73 -29.77 66.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.25 -22.68 63.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.95 -25.95 71.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.41 -21.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.2 mt -65.68 -34.36 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.2 p -48.75 -33.38 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.54 -53.79 25.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.21 -52.88 24.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.4 t -63.53 -51.7 67.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.75 52.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -65.24 -32.64 74.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 110.892 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.69 67.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.81 -49.24 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.01 -35.94 80.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.427 HG21 HG22 ' A' ' 387' ' ' ILE . 8.5 mm -73.32 -34.74 44.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -62.99 -46.91 85.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.29 -38.27 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.33 -54.06 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.12 98.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.48 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 85.6 t -64.99 -55.19 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.4 m -55.11 -40.95 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.34 -45.06 63.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -61.48 -43.68 98.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -66.86 -22.98 65.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 8.0 tp -77.19 -39.16 49.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.617 0.722 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.46 10.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.38 30.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -102.43 177.09 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -159.62 169.89 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -98.37 145.03 27.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -127.73 168.22 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 26.2 t -95.84 147.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.77 155.06 39.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.97 -50.52 7.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.089 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.1 172.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.95 157.73 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.64 -62.12 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 85.92 -85.0 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 m -114.16 9.91 17.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.864 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 25.4 t -90.04 -65.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.47 -30.72 68.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.82 60.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.101 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.42 69.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.448 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.5 -24.16 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.135 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.6 mt -64.73 -35.91 82.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 76.0 p -48.97 -32.2 8.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -68.24 -53.84 21.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.78 -53.31 20.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.14 -53.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -46.43 55.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -66.49 -32.67 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.853 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -51.46 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.62 -49.18 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.57 -36.21 79.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.434 HG22 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.12 -34.33 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.18 -47.39 82.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.14 -37.45 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.98 -54.12 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.89 95.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.94 72.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 99.3 t -62.27 -54.73 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 65.8 m -56.71 -46.95 80.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.92 -35.73 81.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -71.12 -45.14 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -86.24 6.16 30.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 8.2 tp -80.44 -34.29 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.648 0.737 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -44.93 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.67 2.247 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -86.03 136.86 33.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.5 145.46 25.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -146.52 141.6 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.14 168.38 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.18 139.64 53.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.9 -25.45 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.94 151.56 44.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -97.41 160.1 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -78.5 112.81 15.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -154.85 135.29 13.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.64 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -108.19 -53.44 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 8.4 m -93.27 1.88 56.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.832 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 95.5 t -90.12 -65.65 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.62 -25.42 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.01 -29.55 12.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.21 65.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.62 -26.74 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.104 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.5 mt -62.56 -35.41 79.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 87.8 p -48.91 -32.3 8.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.34 -53.93 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.27 20.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.457 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.3 -53.09 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.32 55.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.46 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.878 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.39 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.71 -49.26 73.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.46 -36.11 79.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.434 HG23 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.21 -34.53 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.92 -47.12 84.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.936 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.39 -37.78 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.63 -54.1 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.57 98.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.7 72.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 93.9 t -64.13 -54.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.9 m -56.28 -40.99 75.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.19 -39.28 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.2 m -67.45 -42.81 82.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.79 -21.64 66.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 10.1 tt -51.34 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.691 0.758 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 111.96 2.95 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.341 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -137.34 105.3 5.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.58 143.37 45.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -138.02 139.32 39.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -58.6 178.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 8.5 tp -140.34 125.11 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.74 151.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -75.86 111.21 10.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -165.23 162.32 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -92.03 106.86 18.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -157.44 179.53 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -75.47 166.81 23.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 126.78 54.75 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 p 51.62 27.93 4.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.07 -48.2 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.63 -30.36 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.87 -22.19 66.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -66.64 -23.4 72.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.36 -21.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 111.139 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.4 mt -65.1 -35.9 82.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 59.1 p -48.88 -33.38 10.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -66.93 -53.3 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.59 -52.64 24.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -63.42 -53.1 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.99 50.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.07 -32.82 74.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.14 -51.44 69.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.56 -49.03 75.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.66 -36.16 80.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.441 HG23 HG21 ' B' ' 387' ' ' ILE . 8.5 mm -73.02 -34.43 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.16 -47.14 83.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.7 t -75.22 -37.52 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.01 -54.09 20.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.99 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.48 72.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.34 -54.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.167 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 25.6 m -55.21 -40.96 71.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.4 mt -71.31 -46.0 61.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.69 -44.38 96.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.96 -23.08 65.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 14.8 tp -77.1 -27.53 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.93 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 21.7 tpt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.618 0.723 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 134.43 28.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.358 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -137.57 166.04 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -94.37 107.04 19.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -149.62 143.25 25.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -109.19 127.35 54.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 7.5 tp -142.19 108.58 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.11 133.84 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.14 146.87 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -113.4 167.53 10.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.113 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -145.09 112.68 6.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -121.66 104.73 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.56 103.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -133.29 -48.28 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -126.42 7.73 7.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.0 -65.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.26 -30.34 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.932 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.05 66.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -66.57 -21.91 71.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.36 -21.31 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 19.2 mt -65.19 -35.66 81.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 90.7 p -48.97 -33.48 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.91 -53.24 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.52 -52.77 24.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.34 -53.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.65 52.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.445 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -65.49 -32.74 74.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -51.39 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.71 -48.97 74.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.67 -36.13 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.441 HG21 HG23 ' A' ' 387' ' ' ILE . 8.7 mm -73.05 -34.3 45.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.22 -47.26 83.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 42.7 t -75.22 -37.43 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.97 -54.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.89 96.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.34 72.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 97.4 t -65.39 -54.92 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 23.5 m -55.2 -40.9 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.7 mt -71.42 -46.12 60.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.62 -44.47 96.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.99 -23.08 65.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 1.5 tt -51.86 -42.36 62.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.576 0.703 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 78.79 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.72 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.07 174.78 5.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.47 144.04 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.51 130.25 56.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.38 164.24 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.972 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.3 m -151.53 145.99 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -100.09 128.06 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -115.46 175.59 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.26 105.14 6.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -154.78 157.69 38.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.1 25.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -64.94 -17.67 63.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -122.95 -3.45 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.26 -65.05 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.183 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.3 -30.56 71.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.32 66.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.082 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.57 -25.32 70.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.47 -22.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.6 mt -65.26 -35.39 80.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.9 p -48.85 -33.48 10.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.46 -53.41 29.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.16 -52.71 25.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.496 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -63.56 -52.18 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.133 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.75 -47.72 52.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -65.25 -32.59 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -51.47 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.21 -49.27 74.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.03 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.428 HG23 HG21 ' B' ' 387' ' ' ILE . 8.5 mm -73.16 -34.73 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.92 -47.09 84.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.27 -38.23 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.28 -54.18 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.0 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.94 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.57 -54.82 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -56.19 -41.07 74.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.32 -36.36 71.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.22 -41.56 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.66 -23.11 66.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 7.6 tp -67.87 -35.51 78.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.621 0.724 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.94 112.61 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -69.06 122.71 19.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.58 117.09 12.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.65 169.13 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.83 106.9 18.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.53 138.31 42.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.13 133.03 54.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -120.1 141.71 49.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -136.19 107.18 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.33 -42.22 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -165.33 166.39 18.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 139.89 -90.53 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 29.4 p -106.39 0.23 24.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.377 . . . . 0.0 110.823 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 -65.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.71 -30.16 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.9 -23.66 66.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.12 -25.49 69.62 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.35 -22.78 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.32 -35.5 81.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -48.81 -33.47 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.48 -53.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.24 -52.85 24.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.51 -52.14 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.189 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.76 -47.63 52.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.33 -32.53 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -51.51 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -49.23 75.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.09 80.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.428 HG21 HG23 ' A' ' 387' ' ' ILE . 8.4 mm -73.2 -34.63 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.94 -47.36 83.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.2 t -74.98 -38.1 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.143 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.45 -54.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.03 92.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.05 71.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.6 -54.74 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.5 m -57.17 -46.78 82.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -34.56 78.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -72.21 -45.09 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -87.3 7.4 28.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.8 tp -76.59 -34.97 58.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 171.54 14.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.692 2.261 . . . . 0.0 112.323 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.85 160.71 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.85 174.58 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -100.58 162.9 12.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.7 158.73 18.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.5 pp -158.46 162.76 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.05 145.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -102.4 -37.72 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -54.65 166.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.57 113.06 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -164.6 161.79 21.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -66.21 -179.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 127.4 -100.74 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.5 p -97.99 3.83 49.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 110.889 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 24.7 t -90.03 -65.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.83 -31.02 68.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.73 66.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.53 -25.05 69.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.437 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.25 -22.85 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.8 mt -65.02 -36.67 85.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 77.5 p -48.94 -33.28 10.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -67.64 -53.46 27.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.38 -52.83 24.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.09 -52.45 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.107 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.15 53.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -65.86 -32.49 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.841 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.5 68.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.31 -49.22 74.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.07 80.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.429 HG23 HG23 ' B' ' 387' ' ' ILE . 8.4 mm -73.16 -34.48 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.12 -47.24 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 48.5 t -75.16 -37.49 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.15 -54.03 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.31 96.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.63 72.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.69 -55.03 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 94.4 m -55.73 -46.24 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -64.09 -36.06 82.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.83 -44.69 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -86.41 5.82 33.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.83 -35.97 32.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.604 0.716 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 136.09 32.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.738 2.292 . . . . 0.0 112.299 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 105.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.058 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -131.92 137.52 48.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -138.78 120.08 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -146.95 104.67 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 8.1 tp -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 29.0 m -68.36 142.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.29 111.97 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -138.04 106.15 5.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -81.9 -49.55 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 52.5 38.69 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -106.08 27.09 8.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.23 66.95 1.76 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.25 28.75 4.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 84.5 t -88.22 -46.79 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.24 -30.68 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.57 66.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.21 -25.8 71.26 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.24 -22.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.06 -36.37 84.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -49.01 -33.18 10.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -67.82 -53.37 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.44 -53.02 23.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.28 -52.61 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.97 54.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -65.98 -32.6 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.48 68.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.58 -49.05 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.8 -36.03 79.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.429 HG23 HG23 ' A' ' 387' ' ' ILE . 8.3 mm -73.09 -34.71 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.06 -46.99 84.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.27 -37.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -70.03 -54.13 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.73 96.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.43 72.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.22 -54.89 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 87.7 m -55.32 -40.96 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.4 mt -71.26 -45.84 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.93 -44.75 96.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -66.88 -22.99 65.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.04 -60.34 3.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.58 0.705 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 113.85 3.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.47 133.76 42.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.095 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -140.04 176.45 8.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -142.28 144.3 33.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -151.83 163.17 39.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.15 149.1 52.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.06 149.96 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.94 126.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -170.71 171.0 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 171.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -172.65 168.6 5.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -52.17 -76.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.116 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 89.95 -88.68 1.48 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 37.4 p -108.78 11.88 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 0.0 110.792 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.18 -65.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.97 -24.94 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.25 -28.76 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.2 -28.56 66.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.0 -27.19 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.125 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.84 -33.83 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 99.8 p -48.6 -32.25 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.99 -53.75 23.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.92 -53.1 20.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.513 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.92 -53.07 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.94 -46.74 55.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -66.11 -32.6 74.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -51.39 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.78 -49.12 74.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.1 79.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.43 HG23 HG21 ' B' ' 387' ' ' ILE . 8.5 mm -73.16 -34.7 45.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.93 -47.05 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.31 -37.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.137 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.67 -54.23 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.159 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.64 96.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.45 72.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.3 t -65.14 -54.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 50.3 m -55.7 -40.49 72.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.32 -37.97 71.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.4 m -68.93 -41.83 77.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -67.07 -22.99 65.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 10.3 tt -51.68 -52.61 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.96 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.615 0.721 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.37 16.77 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.728 2.285 . . . . 0.0 112.315 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . 59.94 37.21 21.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.02 147.48 41.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -136.85 143.11 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -118.41 135.67 54.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 tt -123.79 144.18 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 60.4 t -124.54 130.52 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -71.06 146.32 49.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.2 136.05 29.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.33 146.82 23.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -106.74 112.02 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -124.38 8.33 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -120.89 -20.7 3.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 4.2 m -108.2 -4.42 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.2 -65.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.8 -24.4 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -50.88 -29.31 11.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.68 -28.75 65.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -83.19 -27.44 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.2 mt -59.58 -33.61 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.6 p -48.6 -32.22 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.09 -53.84 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.27 20.01 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.01 -53.02 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.65 55.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.38 68.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.79 -49.09 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.05 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.43 HG21 HG23 ' A' ' 387' ' ' ILE . 8.5 mm -73.21 -34.42 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.14 -47.07 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 42.6 t -75.39 -37.29 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.23 -54.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.58 97.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.5 72.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 93.3 t -64.81 -54.51 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 89.3 m -55.95 -40.72 73.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.33 -40.3 70.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -66.49 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.91 -22.11 65.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 37.8 tp -51.32 -32.5 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.647 0.737 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 170.08 17.39 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.313 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -107.26 178.55 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -132.91 107.8 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -90.61 150.73 21.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -127.48 130.22 48.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -148.46 144.81 27.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.9 m -151.32 174.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.28 -25.98 46.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 63.55 48.03 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.58 113.79 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 58.3 29.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -115.27 32.06 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -131.33 -43.85 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.46 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.9 p -88.0 0.18 56.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.853 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 95.4 t -90.22 -65.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -68.23 -25.07 65.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -50.68 -30.71 14.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.42 -28.3 61.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.61 -26.39 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.091 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 23.0 mt -63.73 -34.46 77.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.81 -32.42 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -68.23 -53.94 21.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.935 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.91 -53.36 19.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.95 -52.94 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.93 -46.85 55.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.543 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -66.08 -32.63 74.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.46 68.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.76 -49.07 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.54 -36.08 79.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.435 HG22 HG22 ' B' ' 387' ' ' ILE . 8.6 mm -73.18 -34.42 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.24 -47.2 83.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.12 -37.46 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.04 -53.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.19 93.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.1 71.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.19 -54.7 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 16.9 m -57.43 -48.42 79.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.4 mt -62.53 -37.23 85.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.6 m -70.08 -44.32 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.73 3.79 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 4.4 tp -71.09 -39.44 72.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.563 0.697 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 78.76 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -134.48 160.58 37.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -84.02 148.65 26.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -149.67 169.38 21.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.89 124.63 7.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 5.3 tp -93.61 151.02 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.95 126.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -113.46 27.84 9.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -79.48 -27.47 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.08 -58.17 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 51.72 51.51 16.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 54.09 57.67 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -99.79 -82.29 1.66 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.7 m -86.99 2.67 48.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.878 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 67.1 t -90.0 -65.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.48 -30.93 69.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -54.53 -28.29 44.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.29 -28.45 64.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.85 -24.56 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.1 mt -65.78 -35.02 79.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.4 p -48.78 -32.57 8.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -68.04 -53.77 23.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.76 -53.19 21.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.503 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -53.04 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.381 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.85 -46.63 54.75 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -66.12 -32.79 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.45 68.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.61 -49.07 74.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.64 -36.3 80.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.435 HG22 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.05 -34.54 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.05 -47.19 84.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.4 t -75.24 -37.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -69.88 -54.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.84 97.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.88 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.87 -54.46 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 60.3 m -56.38 -40.8 75.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.31 -34.4 70.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.2 m -72.53 -41.54 65.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -66.95 -23.06 65.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 15.5 tp -61.95 -36.47 81.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.602 0.715 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.91 7.63 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.341 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -78.13 151.55 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -135.53 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -167.57 157.1 10.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -146.85 163.58 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.26 168.88 18.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 29.1 t -137.87 139.72 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.16 153.18 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -103.99 30.71 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -80.87 -53.18 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 171.64 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 52.53 52.2 14.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -82.23 -86.31 0.74 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 19.8 p -102.49 5.94 39.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.93 -65.24 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -69.06 -31.29 69.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.965 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.71 -26.57 57.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.087 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.29 68.47 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.529 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.64 -24.46 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.3 mt -65.63 -36.64 84.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -49.12 -31.97 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.35 -53.78 21.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.929 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.97 -53.36 19.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.486 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.6 t -65.56 -53.35 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.112 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.15 -46.0 56.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.509 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -66.85 -32.67 74.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.906 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.55 68.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.52 -49.22 74.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.47 -36.29 80.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.437 HG21 HG21 ' B' ' 387' ' ' ILE . 8.7 mm -73.2 -34.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.46 -47.27 84.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 45.9 t -75.34 -38.06 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.3 -54.39 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.52 97.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.089 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.44 72.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 89.2 t -64.59 -55.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.7 m -55.72 -40.49 72.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.14 -34.02 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.51 -39.39 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -66.69 -23.47 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.69 -13.67 16.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.862 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.644 0.735 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 148.77 65.92 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.71 23.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -107.27 178.07 4.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -110.17 128.88 55.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -60.52 -64.32 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 31.2 mt -102.39 175.69 5.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 33.4 m -91.39 -25.89 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -147.32 139.42 24.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -147.9 141.96 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -96.76 106.42 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.838 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.92 -26.48 34.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -155.99 105.95 2.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -167.96 -73.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.5 p -99.29 3.23 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 98.3 t -90.08 -65.32 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.46 -27.97 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.37 -29.43 15.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.4 -28.22 64.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.46 -24.96 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.31 -36.89 85.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.73 -31.75 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -68.33 -53.77 21.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.06 -53.67 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.31 -53.21 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.41 56.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.39 -32.71 74.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -51.51 68.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.75 -49.13 74.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.2 79.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.437 HG21 HG21 ' A' ' 387' ' ' ILE . 8.5 mm -73.15 -34.52 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.87 -47.51 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.05 -37.64 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.71 -54.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.41 90.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.18 71.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.8 t -60.95 -54.42 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.3 m -57.82 -47.14 83.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.155 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.33 -34.42 78.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.7 m -72.38 -45.53 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -85.16 4.34 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.16 -36.81 58.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.648 0.737 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 130.1 18.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.381 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -101.57 148.02 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -77.92 147.35 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -120.14 171.16 8.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -127.92 150.92 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 9.9 tp -84.85 133.42 34.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.96 125.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.17 33.63 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -111.76 -48.43 3.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.075 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.01 176.04 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 61.5 40.35 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.7 58.17 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.36 -65.12 1.06 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.459 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 26.7 p -105.71 6.65 32.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.825 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.63 -65.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.08 -30.86 69.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.24 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.86 -25.54 69.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.38 -23.04 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.099 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.22 -36.58 84.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.0 p -49.15 -32.87 10.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.93 -53.56 25.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.48 -53.05 22.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.33 -52.84 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -46.87 54.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -66.0 -32.48 73.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.915 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -51.4 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.15 74.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.72 -36.23 80.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.43 HG21 HG23 ' B' ' 387' ' ' ILE . 8.4 mm -73.15 -34.35 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.48 82.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.5 t -74.95 -37.57 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.89 -54.07 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.92 92.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.07 71.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 96.4 t -61.24 -54.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.1 m -57.55 -47.63 81.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.7 -35.41 80.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.34 -45.13 63.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -86.72 6.85 29.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.0 -36.94 35.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.585 0.707 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 152.27 69.61 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.398 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -59.38 140.75 55.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -77.36 155.3 32.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.38 165.34 36.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -119.22 104.09 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 107.23 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.65 -35.94 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 52.59 47.55 24.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.01 155.29 18.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.39 150.28 24.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.46 163.71 37.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -69.17 165.32 20.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 136.34 -96.76 0.26 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.52 3.79 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.821 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 44.5 t -90.06 -65.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.103 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.0 -30.86 69.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.969 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.63 65.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.59 -25.44 68.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.488 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.26 -23.44 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 24.2 mt -65.07 -36.64 84.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -49.03 -32.91 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -68.01 -53.64 24.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.9 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.53 -53.04 22.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -64.37 -52.74 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 111.11 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -46.82 54.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -66.13 -32.55 74.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.909 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.51 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.44 -49.12 74.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.8 -36.14 80.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.43 HG23 HG21 ' A' ' 387' ' ' ILE . 8.6 mm -73.21 -34.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.23 -47.36 82.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.8 t -75.07 -37.45 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.97 -54.1 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.83 91.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.08 71.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 96.7 t -60.66 -54.41 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 47.0 m -58.13 -47.7 82.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -63.67 -34.97 79.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.11 -45.11 61.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.93 7.49 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.0 tp -78.37 -36.8 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.62 0.724 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 161.11 47.21 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -159.05 163.77 36.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.93 177.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -132.88 139.29 47.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.76 138.36 47.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.8 tt -132.95 141.03 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.53 151.67 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -138.7 147.68 43.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.72 176.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.95 115.01 8.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.1 175.23 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.84 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -171.53 -71.56 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.523 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 24.8 p -104.91 5.44 32.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.39 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 45.7 t -89.98 -65.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.54 -31.09 69.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.88 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.14 -25.2 69.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.42 -23.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.1 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.6 mt -64.81 -36.74 85.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.7 p -49.19 -33.37 12.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.52 -53.38 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.46 -52.99 23.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -63.67 -52.86 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.66 -47.37 52.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -65.53 -32.62 74.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -51.49 68.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.54 -49.0 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.79 -36.3 80.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.434 HG21 HG23 ' B' ' 387' ' ' ILE . 8.6 mm -73.13 -34.69 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.84 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 45.1 t -75.38 -37.85 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.55 -54.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.074 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.16 70.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 91.0 t -62.94 -54.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.9 m -56.4 -41.13 75.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.3 -33.8 70.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.88 -55.98 6.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -66.61 -14.0 61.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.16 -63.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.618 0.723 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 132.21 22.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.72 20.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.063 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.34 170.33 10.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.78 -49.24 69.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.66 177.22 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 46.4 mt -77.27 -46.45 23.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.9 160.9 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -164.21 156.05 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -169.72 145.79 3.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -102.2 120.0 39.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -146.86 179.72 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -104.0 34.16 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -77.39 -74.47 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 25.4 p -104.24 4.42 33.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 41.9 t -89.93 -65.23 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.99 -31.26 69.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.4 -23.78 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.27 -25.03 69.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.41 -22.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 111.145 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 22.6 mt -65.11 -36.58 84.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 93.5 p -48.96 -33.29 10.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.65 -53.29 29.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.46 -52.9 23.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.48 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.5 t -63.87 -52.9 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.25 53.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -65.54 -32.63 74.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.866 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.45 68.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.6 -49.07 74.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.16 80.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.434 HG23 HG21 ' A' ' 387' ' ' ILE . 8.7 mm -73.3 -34.68 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.79 -47.07 85.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.38 -38.08 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.3 -54.17 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.31 98.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.21 -50.5 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.44 -54.92 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.5 m -55.75 -40.89 73.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.3 -42.26 68.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -63.33 -54.18 41.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -66.71 -13.68 61.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 2.8 tt -55.8 -51.73 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.636 0.731 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 132.7 23.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.716 2.278 . . . . 0.0 112.381 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.28 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -138.5 159.3 42.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -150.37 149.58 30.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.57 172.57 12.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 12.4 mt -137.3 114.15 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 32.4 m -143.74 164.07 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -64.63 130.44 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -167.61 -177.4 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -161.28 109.95 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -147.89 111.23 4.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -159.3 87.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -127.32 -84.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.454 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -92.48 4.23 53.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 32.5 t -90.18 -65.46 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.72 -28.77 66.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.62 60.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.88 -25.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.473 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.44 -24.58 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.374 . . . . 0.0 111.158 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 20.7 mt -65.66 -33.58 76.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 86.4 p -48.38 -33.8 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -66.96 -53.81 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.9 -52.72 27.08 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.72 -51.37 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.54 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -64.44 -32.61 74.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.54 68.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.33 -49.22 74.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.68 -36.08 79.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.428 HG23 HG21 ' B' ' 387' ' ' ILE . 8.4 mm -73.24 -34.31 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.25 -47.1 83.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.7 t -75.34 -37.43 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.07 -54.12 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.23 97.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.58 72.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.66 -54.52 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.1 m -55.92 -41.01 73.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.16 -41.31 70.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.44 -43.38 90.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -67.05 -23.2 65.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.42 -30.06 64.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.663 0.744 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 129.44 17.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.325 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -102.8 114.86 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -149.8 167.36 26.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.38 113.1 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -136.77 132.54 34.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.57 146.73 28.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.25 146.92 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.82 -46.76 14.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -61.17 160.51 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.23 161.01 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -155.41 150.92 27.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -167.58 101.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.54 69.99 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.425 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.26 28.62 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 -65.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.82 -28.75 65.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.37 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.13 -25.81 64.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.42 -24.4 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.6 mt -65.54 -33.56 76.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 84.0 p -48.4 -33.9 9.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -66.88 -53.74 29.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.79 -52.67 27.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.0 t -62.59 -51.36 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 111.126 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.83 -48.3 51.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -64.54 -32.6 74.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -51.64 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.2 -49.16 75.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.78 -36.11 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.428 HG21 HG23 ' A' ' 387' ' ' ILE . 8.5 mm -73.25 -34.26 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.29 -47.05 83.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.37 -37.36 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.18 -54.06 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.7 96.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.51 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 92.9 t -64.98 -54.72 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 91.4 m -55.54 -40.89 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.25 -44.08 66.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.74 -43.89 97.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.93 -23.14 65.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 16.2 tp -75.31 -36.38 61.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.132 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.27 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.71 166.01 13.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.093 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.42 178.13 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.96 105.38 16.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -114.91 177.07 4.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.59 121.42 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.05 172.43 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -80.04 153.75 28.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -175.84 177.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.39 41.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.43 96.54 2.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -147.18 93.19 2.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.079 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -139.44 -68.71 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.1 m -109.86 2.95 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.07 -65.42 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.08 -28.89 65.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.81 -25.43 55.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.2 -26.19 67.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.34 -23.64 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.145 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.86 -33.12 75.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -33.54 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.11 -53.93 26.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.06 -52.91 25.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.89 -51.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.125 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -48.52 51.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -64.46 -32.58 74.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.6 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.11 -49.27 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.77 -36.06 79.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.431 HG22 HG22 ' B' ' 387' ' ' ILE . 8.5 mm -73.24 -34.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.13 -47.35 83.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.0 -37.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.54 -53.96 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.9 91.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.18 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 88.9 t -61.43 -54.94 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.5 m -57.02 -47.14 81.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -63.96 -35.3 80.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -71.36 -45.18 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -86.56 6.46 30.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.78 -35.01 39.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.935 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.624 0.726 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 107.51 1.88 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -165.57 162.78 19.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -68.74 146.69 52.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.85 134.9 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.87 163.41 13.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.78 129.42 37.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.93 147.07 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.23 133.21 52.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -107.39 141.15 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -60.31 -172.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -130.88 -173.88 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.44 -69.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 97.18 -65.34 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.527 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -132.07 7.45 4.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.893 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.1 -65.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.11 -28.81 65.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.82 -25.29 55.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.134 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.6 -25.72 67.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.31 -23.43 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.86 -33.23 75.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 70.5 p -48.58 -33.46 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.26 -54.03 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.403 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.05 -52.82 25.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.05 -51.33 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.35 51.23 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -64.75 -32.56 74.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.5 68.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.25 -49.16 75.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.92 -35.96 79.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.431 HG22 HG22 ' A' ' 387' ' ' ILE . 8.5 mm -73.34 -34.59 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.99 -47.07 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.24 -38.18 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.4 -54.24 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.9 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.73 72.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 86.8 t -63.65 -54.66 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.115 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 22.8 m -56.36 -41.15 75.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.19 -36.47 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.08 -41.8 73.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -66.71 -22.96 66.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.5 tp -68.08 -37.63 81.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.985 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.628 0.728 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -173.32 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -168.01 160.42 12.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.48 145.74 31.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -151.69 167.59 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 12.6 mp0 -111.14 164.99 12.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 5.4 mp -150.38 173.58 13.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.89 151.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 166.17 25.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.58 178.85 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.8 120.37 39.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -156.32 159.64 38.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 51.93 46.58 26.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.31 -39.68 5.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 16.6 p -99.3 -0.22 41.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.844 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 91.7 t -90.12 -65.43 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.06 -25.42 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.45 -28.17 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.98 -28.44 70.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.89 -27.54 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.349 . . . . 0.0 111.141 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.7 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.4 p -48.64 -31.7 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.43 -53.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -69.07 -53.63 17.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.46 -53.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.26 55.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.498 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -66.65 -32.7 74.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.49 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.55 -49.27 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.56 -36.16 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.435 HG21 HG21 ' B' ' 387' ' ' ILE . 8.6 mm -73.15 -34.53 45.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.91 -47.53 82.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 44.3 t -75.01 -37.77 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.62 -54.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.61 91.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.2 71.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 84.3 t -61.19 -54.52 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 84.8 m -57.59 -47.31 82.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.96 -34.9 79.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.96 -44.95 62.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -87.61 7.9 27.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.41 -28.44 46.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.962 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.645 0.736 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 128.25 15.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -117.84 139.63 50.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.87 107.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -136.2 116.49 13.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -152.66 140.37 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.88 122.44 34.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.14 137.68 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.152 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -131.58 133.6 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.39 114.22 4.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -115.27 114.74 25.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.87 -28.74 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -129.68 103.46 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 165.21 -35.41 0.26 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.456 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 25.4 p -103.49 1.35 32.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.22 -65.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -69.01 -25.68 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.46 -28.31 12.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.5 70.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.447 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.75 -27.44 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.4 mt -57.48 -35.39 70.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 95.5 p -48.74 -31.67 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -68.48 -53.61 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.93 -53.68 18.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.514 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.51 -53.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.12 56.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -66.81 -32.65 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.62 -49.11 74.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.66 -36.17 80.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.435 HG21 HG21 ' A' ' 387' ' ' ILE . 8.5 mm -73.11 -34.63 45.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.15 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.9 -47.44 83.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 47.6 t -74.97 -37.91 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.52 -54.1 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.72 91.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.23 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 84.7 t -60.99 -54.66 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 24.4 m -57.55 -47.33 82.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.16 -45.19 61.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -87.49 7.9 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 7.6 tp -77.64 -37.01 50.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 179.932 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 175.55 7.94 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.68 2.253 . . . . 0.0 112.372 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -152.95 169.87 21.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -99.9 179.48 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -134.69 168.92 18.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.59 167.17 31.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.87 169.45 17.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.5 151.71 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -87.56 113.36 23.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.66 137.02 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -148.47 117.71 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -115.3 -25.51 7.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -57.51 98.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.116 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.98 80.65 0.58 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.29 28.64 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.84 -65.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -68.87 -25.7 64.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.17 -28.87 12.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.43 -28.28 67.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.524 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.8 -27.72 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 20.0 mt -58.79 -35.49 72.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 95.7 p -48.59 -31.81 7.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.42 -53.72 21.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.902 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.96 -53.59 18.28 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.45 -53.13 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.04 56.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -66.76 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.43 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.833 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.82 -49.11 74.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.08 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.434 HG23 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.11 -34.63 45.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.96 -47.11 84.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 42.3 t -75.28 -37.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.09 -54.24 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.39 96.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.69 72.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.63 -54.43 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.5 m -56.05 -40.82 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.26 -40.55 70.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.8 m -66.13 -43.32 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -66.92 -23.13 65.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 18.1 tp -71.83 -26.05 62.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.948 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 166.23 28.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.252 . . . . 0.0 112.385 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -112.78 118.57 35.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -54.43 126.76 24.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -164.85 156.62 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -71.29 -67.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 31.2 mt -148.7 161.29 42.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 59.9 t -148.38 111.93 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -157.82 127.61 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -81.96 -66.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.81 153.89 50.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -175.15 155.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -52.14 102.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -169.77 -72.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.529 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 5.1 p -96.56 1.88 51.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 110.858 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.11 -65.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -68.76 -26.35 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.43 -28.77 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.19 -28.5 66.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.475 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.84 -27.55 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.377 . . . . 0.0 111.135 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 20.7 mt -59.53 -35.32 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.6 -31.86 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.37 -53.68 22.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.99 -53.7 17.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.27 -53.14 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.32 55.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -66.53 -32.66 74.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.52 68.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.59 -49.19 74.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.62 -35.99 79.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.434 HG23 HG23 ' A' ' 387' ' ' ILE . 8.5 mm -73.25 -34.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.87 -47.24 84.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 48.2 t -75.24 -37.52 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.99 -54.11 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.65 96.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.32 -54.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 36.8 m -56.13 -45.97 79.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.4 mt -64.65 -34.55 78.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.39 -44.72 62.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.18 6.91 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.66 -34.96 58.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.847 179.946 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.603 0.716 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 165.27 31.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.735 2.29 . . . . 0.0 112.365 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -157.81 168.52 26.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.38 178.15 8.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -156.31 139.64 15.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -99.73 153.01 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 10.2 mt -144.95 141.81 29.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 26.7 m -57.88 -178.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -108.43 112.64 25.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.47 107.8 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -130.09 110.73 11.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -84.66 -59.43 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.79 103.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -109.0 -54.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.2 m -115.34 13.91 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.888 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 86.2 t -90.0 -65.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.09 -24.77 64.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.36 -28.67 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.55 -28.55 67.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.95 -27.41 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.11 -34.62 72.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.0 p -48.45 -31.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -68.44 -53.63 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.74 -53.72 18.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.23 -52.83 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -45.83 56.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -67.02 -32.64 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 110.911 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.48 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.66 -49.29 73.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.39 -36.01 79.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.431 HG21 HG23 ' B' ' 387' ' ' ILE . 8.5 mm -73.22 -34.52 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.07 -47.07 84.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 43.5 t -75.33 -37.34 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.17 -54.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.05 -45.05 94.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.43 -50.39 71.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 91.2 t -66.09 -55.01 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 85.6 m -54.73 -40.15 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.3 mt -71.06 -34.09 70.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -73.55 -39.16 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.0 -23.45 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.4 -11.44 17.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 179.961 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 135.58 30.8 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.253 . . . . 0.0 112.375 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -94.4 162.12 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.083 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.31 132.24 17.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -142.89 131.63 22.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -146.4 129.32 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 pp -163.65 155.89 17.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.3 148.43 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.45 153.88 50.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.61 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.68 -65.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -155.26 115.17 3.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -121.33 12.13 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -122.68 -27.87 1.52 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.9 p -96.25 -0.66 49.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.873 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.16 -65.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.56 -24.91 64.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -50.85 -29.57 12.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.45 -28.62 65.11 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -83.14 -27.35 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.11 -34.06 72.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.3 p -48.67 -32.19 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -68.24 -53.79 22.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -68.81 -53.39 19.87 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.452 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.36 -53.08 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.95 56.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -66.9 -32.74 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.895 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.45 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.68 -49.13 74.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.53 -36.14 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.431 HG23 HG21 ' A' ' 387' ' ' ILE . 8.5 mm -73.17 -34.44 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.11 -46.99 84.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 43.6 t -75.5 -37.27 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.103 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -70.28 -54.15 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.28 93.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.33 71.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 92.0 t -66.34 -55.03 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 61.4 m -54.63 -39.92 68.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 31.1 mt -71.26 -34.64 70.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.7 m -73.31 -38.24 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -67.58 -23.37 65.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.39 -25.28 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.959 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 169.09 19.72 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.343 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -147.68 155.25 41.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.99 177.68 5.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -152.25 169.02 23.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -81.67 172.63 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 7.0 mt -112.05 174.55 5.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 19.7 m -104.4 176.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -112.45 111.51 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.19 14.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.116 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.21 102.4 7.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -147.83 153.75 39.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.09 40.86 21.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.02 -80.85 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.7 p -84.87 3.3 38.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.04 -65.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.9 -29.93 68.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -58.14 -27.67 63.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.063 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.18 -25.39 62.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.463 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.45 -25.07 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.53 -34.2 77.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.963 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 92.1 p -48.6 -33.87 10.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.849 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -66.93 -53.47 31.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . -67.87 -52.6 27.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -62.85 -51.39 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.849 0.357 . . . . 0.0 111.12 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.4 51.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -64.51 -32.63 74.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.67 67.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.1 -49.31 74.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.11 79.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.433 HG22 HG21 ' B' ' 387' ' ' ILE . 8.6 mm -73.31 -34.59 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.88 -47.16 84.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 46.1 t -75.3 -38.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.34 -54.22 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.04 97.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.66 72.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.077 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.03 -54.74 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 42.2 m -56.16 -41.01 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.21 -38.97 72.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.59 -42.41 82.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -66.53 -23.03 66.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 6.5 tp -71.38 -62.69 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 179.97 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.633 0.73 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.94 17.49 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.354 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -121.38 156.59 32.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -162.74 170.78 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.49 162.58 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -148.61 141.9 25.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 4.2 pp -159.39 166.94 30.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.9 m -152.3 126.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -146.83 141.04 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.94 157.26 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.81 179.08 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.05 98.05 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -142.76 118.07 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 157.34 -58.1 0.36 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.1 m -99.24 2.65 45.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.15 -65.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.93 -30.15 68.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.65 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.51 -24.92 62.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.36 -25.03 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.35 -34.36 78.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -48.57 -33.81 10.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.0 -53.48 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . . . . . . . . . . . -67.87 -52.65 27.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 5.9 t -62.89 -51.62 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -48.2 51.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -64.73 -32.47 74.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.57 68.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.13 -49.21 75.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.74 -36.38 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.433 HG21 HG22 ' A' ' 387' ' ' ILE . 8.6 mm -73.08 -34.42 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.97 -47.48 83.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.03 -37.84 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.61 -53.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.72 91.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.2 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 85.8 t -61.25 -54.66 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 39.3 m -57.4 -47.1 82.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.26 -35.77 81.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.87 -45.09 65.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -86.11 5.42 33.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 6.8 tp -80.26 -36.83 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.561 0.696 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 158.6 56.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.671 2.247 . . . . 0.0 112.376 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -154.4 140.21 18.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -154.55 166.15 34.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.08 172.1 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.42 172.34 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.31 170.68 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.05 176.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.18 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -125.48 175.1 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -132.72 175.62 9.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.51 176.0 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 57.25 -171.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 62.94 53.55 2.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -97.43 -75.28 1.23 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.441 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 84.8 p -90.07 2.08 55.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.02 -63.83 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.46 -29.98 68.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.63 65.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.63 -24.61 66.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.55 -23.7 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 111.112 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 377' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.39 -34.75 79.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.939 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 94.3 p -48.78 -33.68 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.28 -53.53 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.04 -52.82 25.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.18 -51.83 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.35 . . . . 0.0 111.161 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.96 51.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 383' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -64.88 -32.65 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.4 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.75 -49.28 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.34 -36.3 79.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 387' ' ' ILE . . . . . 0.43 HG23 HG22 ' B' ' 387' ' ' ILE . 9.1 mm -73.33 -34.35 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.81 -47.29 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 389' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.43 -37.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.847 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.35 -53.93 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.27 98.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.34 -48.33 79.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 393' ' ' VAL . . . . . . . . . . . . . 93.3 t -66.6 -55.09 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.6 m -55.71 -41.12 73.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.4 -51.74 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -89.22 -2.81 58.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 398' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.97 -25.37 67.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.881 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 179.97 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.549 0.69 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 115.37 4.05 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.682 2.255 . . . . 0.0 112.406 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -132.39 165.23 24.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.092 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -155.15 133.8 11.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -136.36 167.36 21.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -147.77 156.83 43.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 13.4 tp -88.63 130.24 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 39.5 t -146.28 123.68 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -122.25 137.66 54.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -126.08 110.62 13.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -149.57 116.89 6.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.39 175.98 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -52.25 107.47 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -125.39 -47.82 0.21 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 14.7 m -109.26 2.6 20.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 22.6 t -90.2 -65.38 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.03 -30.25 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.37 65.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.31 -25.6 68.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.52 -23.23 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 111.131 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.34 -35.2 80.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.4 p -48.6 -33.68 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.36 -53.56 28.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 380' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.01 -52.96 25.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.1 t -63.22 -51.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 111.119 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.83 52.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -65.02 -32.63 74.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.46 68.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.7 -49.34 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.23 -36.45 79.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 387' ' ' ILE . . . . . 0.43 HG22 HG23 ' A' ' 387' ' ' ILE . 9.0 mm -73.2 -34.18 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.07 -47.3 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 389' ' ' VAL . . . . . . . . . . . . . 44.4 t -75.38 -37.32 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.03 -54.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.58 97.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.45 72.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 393' ' ' VAL . . . . . . . . . . . . . 96.7 t -65.11 -54.93 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.122 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 61.7 m -55.33 -40.99 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.33 -44.18 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -62.42 -43.63 98.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.73 -22.92 66.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 1.7 tt -76.4 -36.27 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.769 0.318 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.85 -31.36 7.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.42 -53.76 21.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.13 -53.64 17.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.64 -53.37 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.11 -46.49 56.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.3 -32.74 74.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.48 68.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.95 -49.26 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.23 -36.25 79.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.15 -34.43 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.93 -47.2 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.1 t -75.42 -37.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.72 -54.18 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.96 -50.44 72.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.4 t -65.32 -54.99 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.176 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.498 HG21 HD21 ' B' ' 395' ' ' LEU . 21.3 m -55.11 -41.1 71.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.533 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.27 -46.41 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.33 -44.4 95.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.874 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.88 0.372 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' A' ' 377' ' ' LEU . 22.0 mt -65.76 -36.43 83.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.9 p -48.74 -31.56 7.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.26 -53.74 22.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.21 -53.77 16.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.441 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.4 -53.33 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.2 -46.55 56.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.3 t80 -66.22 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -51.45 68.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.94 -49.23 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.26 -36.26 79.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.14 -34.57 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.75 -47.21 84.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.3 t -75.39 -37.68 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -69.6 -54.2 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.48 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.29 72.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -65.48 -55.06 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.533 HG21 HD21 ' A' ' 395' ' ' LEU . 31.7 m -55.07 -41.03 71.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.498 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.33 -46.93 59.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.0 m -59.79 -44.55 93.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' B' ' 377' ' ' LEU . 25.5 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.798 0.332 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.4 p -48.75 -31.9 7.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.4 -53.79 21.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.71 17.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.23 -53.01 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.117 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.3 55.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.51 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -51.29 69.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.1 -49.16 73.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.34 -36.07 79.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.57 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.04 -47.02 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.33 -37.61 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.05 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.7 96.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.45 72.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.1 t -65.23 -54.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.499 HG21 HD21 ' B' ' 395' ' ' LEU . 14.2 m -55.27 -40.92 71.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.51 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.33 -45.23 63.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.6 m -61.52 -44.18 97.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.844 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' A' ' 377' ' ' LEU . 20.9 mt -65.81 -35.69 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.5 p -48.93 -32.11 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.4 -53.88 20.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.79 -53.22 20.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.529 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.52 -53.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -45.98 56.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.94 -32.73 74.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -51.47 68.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.82 -49.08 74.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.58 -36.11 79.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.29 -34.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.93 -47.22 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.563 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.3 t -75.37 -37.26 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.19 -54.1 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.78 96.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.07 -50.42 72.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.9 t -65.37 -54.82 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.51 HG21 HD21 ' A' ' 395' ' ' LEU . 18.6 m -55.3 -40.97 71.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.31 -45.58 62.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -61.21 -44.44 97.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.835 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' B' ' 377' ' ' LEU . 22.5 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.832 0.349 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 81.9 p -48.9 -33.52 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.3 -53.39 30.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.22 -52.73 25.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -63.64 -52.49 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.19 53.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.4 t80 -65.69 -32.62 74.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.391 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.43 68.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.14 74.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -61.71 -36.17 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.17 -34.45 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.12 -47.08 84.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.34 -37.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.1 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.5 97.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.35 73.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -65.33 -54.84 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.605 HG21 HD21 ' B' ' 395' ' ' LEU . 85.2 m -55.33 -41.03 71.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.563 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.27 -46.19 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.9 m -60.55 -44.54 96.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.866 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.361 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' A' ' 377' ' ' LEU . 22.5 mt -65.17 -36.19 83.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.7 p -48.93 -33.4 10.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.54 -53.53 27.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.948 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.2 -52.68 26.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -63.88 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -47.28 53.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.1 t80 -65.72 -32.6 74.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.41 69.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.47 -49.16 74.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.71 -36.13 80.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.19 -34.67 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.97 -47.04 84.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.4 t -75.29 -37.85 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.62 -54.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.63 96.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.41 72.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.4 t -65.35 -55.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.563 HG21 HD21 ' A' ' 395' ' ' LEU . 26.1 m -55.02 -41.01 70.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.175 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.605 HD21 HG21 ' A' ' 394' ' ' THR . 33.2 mt -71.29 -46.7 60.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -60.06 -44.52 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 38.0 mmt-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.882 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' B' ' 377' ' ' LEU . 22.9 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.831 0.348 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.0 p -49.12 -33.29 11.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -67.43 -53.51 28.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.25 -52.74 25.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.85 -52.51 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.28 53.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -65.58 -32.6 74.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.39 68.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.42 -49.14 74.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.06 80.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.19 -34.37 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.29 -47.17 83.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.26 -37.14 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.34 -54.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.74 96.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.94 72.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 389' ' ' VAL . 94.1 t -62.74 -54.8 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.096 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.45 HG21 HD21 ' B' ' 395' ' ' LEU . 26.6 m -56.36 -46.63 79.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.434 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -64.09 -36.0 82.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -70.81 -44.81 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.835 0.35 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.11 -36.75 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.3 p -49.28 -33.03 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.94 -53.27 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.39 -52.78 24.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.465 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.24 -52.61 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.71 -47.08 53.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.459 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.625 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.03 -32.57 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.41 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.61 -49.16 74.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.66 -36.08 79.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.176 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.06 -47.13 84.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.2 t -75.36 -37.37 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.18 -54.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.39 97.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.6 72.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.5 t -64.69 -54.58 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.434 HG21 HD21 ' A' ' 395' ' ' LEU . 19.9 m -55.85 -41.08 73.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.45 HD21 HG21 ' A' ' 394' ' ' THR . 32.8 mt -71.1 -42.35 69.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.32 -43.7 93.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 24.1 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.4 p -48.99 -32.09 8.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.12 -54.01 21.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.37 19.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.23 -53.15 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.125 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.54 55.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -66.3 -32.68 74.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.41 69.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.01 -49.07 73.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.5 -36.12 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.07 -34.52 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.01 84.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.33 -37.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.07 -54.07 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.53 97.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.55 72.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.8 t -64.96 -54.71 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.513 HG21 HD21 ' B' ' 395' ' ' LEU . 87.0 m -55.54 -41.02 72.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.18 -43.79 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.84 -44.0 97.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.885 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.79 -35.52 80.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.9 p -48.89 -32.29 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.2 -53.92 21.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.32 19.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.19 -53.02 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -46.49 55.93 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -66.44 -32.56 74.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.41 -51.47 68.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.52 -49.2 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.64 -35.97 79.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.31 -34.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.26 -47.23 83.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.22 -37.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.35 -54.1 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.22 96.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.77 72.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 389' ' ' VAL . 95.2 t -63.58 -54.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 86.5 m -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 394' ' ' THR . 32.9 mt -64.32 -34.7 78.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -72.27 -44.57 62.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 25.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 90.9 p -49.48 -31.88 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -68.44 -53.88 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.83 -53.27 20.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.3 t -65.48 -53.14 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.23 55.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.71 -32.71 74.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.898 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -51.5 68.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.4 -49.35 74.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.8 mm -73.17 -35.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.2 -47.15 85.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.26 -39.25 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.133 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -68.05 -54.11 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.04 96.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.27 73.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.6 t -64.91 -55.13 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 5.8 m -55.4 -41.16 72.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.21 -44.5 65.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.03 -43.87 97.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.9 0.381 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 24.6 mt -65.52 -37.07 85.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 96.5 p -49.34 -32.04 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -68.41 -53.89 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.86 -53.23 20.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -53.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.04 -46.11 56.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.77 -32.6 74.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.374 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.41 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.33 -49.21 74.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.82 -36.14 80.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.17 -34.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.87 -47.48 83.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.1 t -75.03 -37.84 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.5 -53.96 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.31 90.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.81 72.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 88.3 t -61.16 -54.45 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.4 m -57.92 -48.5 79.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -38.34 90.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.6 m -68.87 -44.66 72.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' B' ' 377' ' ' LEU . 23.8 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.813 0.339 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.1 p -49.1 -33.03 10.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.91 -53.33 27.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.41 -52.87 24.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.4 -52.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.129 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.72 -47.1 53.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.638 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.3 t80 -66.06 -32.55 74.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.35 . . . . 0.0 110.843 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.5 68.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.32 -49.14 75.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.95 -36.08 80.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.76 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.99 -47.02 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.25 -38.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.5 t -69.43 -54.23 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.0 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -51.01 71.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -63.63 -54.82 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -56.13 -41.03 74.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.27 -35.85 71.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.71 -41.53 71.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.29 -36.33 83.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.4 p -49.12 -33.04 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.851 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.95 -53.67 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.47 -52.98 23.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.443 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.2 t -64.3 -52.69 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.88 54.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -65.96 -32.56 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -51.46 68.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.89 -49.29 75.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -62.03 -36.04 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.2 mm -73.05 -34.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -63.0 -47.25 83.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.622 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.6 t -75.03 -38.07 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.55 -53.99 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.19 92.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.03 71.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.5 t -61.59 -54.65 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 28.5 m -57.34 -46.83 82.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.3 -34.76 78.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.12 -44.77 62.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.806 0.336 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.3 p -48.5 -31.97 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.29 -53.62 23.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.67 17.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.45 -53.21 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.139 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.23 55.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.7 t80 -66.7 -32.64 74.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.35 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.83 -49.2 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.47 -36.09 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.633 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.32 -34.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -47.11 84.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.6 t -75.38 -37.66 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -69.79 -54.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.23 97.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.84 71.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.4 t -64.39 -54.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.512 HG21 HD21 ' B' ' 395' ' ' LEU . 60.4 m -55.59 -40.78 72.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.41 -40.58 70.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.0 m -64.73 -54.19 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' A' ' 377' ' ' LEU . 21.5 mt -62.37 -35.73 80.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 80.2 p -48.62 -31.79 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.35 -53.61 22.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.97 -53.67 17.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.44 -53.25 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -46.06 56.13 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.75 -32.73 74.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.395 . . . . 0.0 110.894 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.34 69.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.82 -49.32 73.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.28 -36.31 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.618 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.12 -34.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.02 -47.13 84.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.58 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.46 -37.3 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.0 t -70.12 -54.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.13 98.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.28 -50.87 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.0 t -64.15 -54.57 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.501 HG21 HD21 ' A' ' 395' ' ' LEU . 87.1 m -56.1 -40.72 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.199 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.43 -36.7 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -70.05 -41.98 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.854 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.8 p -48.85 -33.22 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.53 -53.84 25.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.24 -52.93 24.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.3 t -63.66 -51.65 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.9 52.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -65.18 -32.58 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.894 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.56 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.09 -49.3 75.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.82 -35.96 79.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.28 -34.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.96 -46.89 85.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -38.22 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.44 -54.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.14 97.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.97 -50.46 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.4 t -65.0 -55.06 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.544 HG21 HD21 ' B' ' 395' ' ' LEU . 61.5 m -55.31 -40.92 71.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 33.3 mt -71.27 -44.45 65.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.2 m -62.14 -43.68 98.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.853 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.68 -34.36 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.2 p -48.75 -33.38 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.54 -53.79 25.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.21 -52.88 24.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.4 t -63.53 -51.7 67.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.75 52.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -65.24 -32.64 74.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.69 67.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.81 -49.24 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.01 -35.94 80.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.32 -34.74 44.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -62.99 -46.91 85.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.593 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.29 -38.27 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.33 -54.06 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.12 98.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.48 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.6 t -64.99 -55.19 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 40.4 m -55.11 -40.95 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.34 -45.06 63.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -61.48 -43.68 98.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.86 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' B' ' 377' ' ' LEU . 23.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 76.0 p -48.97 -32.2 8.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -68.24 -53.84 21.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.78 -53.31 20.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.14 -53.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -46.43 55.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.49 -32.67 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.853 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -51.46 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.62 -49.18 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.57 -36.21 79.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.33 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.18 -47.39 82.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.5 t -75.14 -37.45 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.98 -54.12 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.89 95.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.94 72.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -62.27 -54.73 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.417 HG21 HD21 ' B' ' 395' ' ' LEU . 65.8 m -56.71 -46.95 80.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.41 HD21 HG21 ' B' ' 394' ' ' THR . 34.2 mt -63.92 -35.73 81.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -71.12 -45.14 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.849 0.357 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' A' ' 377' ' ' LEU . 23.5 mt -62.56 -35.41 79.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 87.8 p -48.91 -32.3 8.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.34 -53.93 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.3 -53.09 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.32 55.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.46 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.878 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.39 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.71 -49.26 73.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.46 -36.11 79.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.53 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.92 -47.12 84.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.936 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.595 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.5 t -75.39 -37.78 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.63 -54.1 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.57 98.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.7 72.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.9 t -64.13 -54.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.41 HG21 HD21 ' A' ' 395' ' ' LEU . 32.9 m -56.28 -40.99 75.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.19 -39.28 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.2 m -67.45 -42.81 82.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.893 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.869 0.366 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 59.1 p -48.88 -33.38 10.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -66.93 -53.3 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.59 -52.64 24.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.42 -53.1 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.99 50.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.0 t80 -65.07 -32.82 74.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.14 -51.44 69.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.56 -49.03 75.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.66 -36.16 80.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.636 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.02 -34.43 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.16 -47.14 83.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.7 t -75.22 -37.52 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.01 -54.09 20.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.99 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.48 72.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.6 t -65.34 -54.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.558 HG21 HD21 ' B' ' 395' ' ' LEU . 25.6 m -55.21 -40.96 71.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.528 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -71.31 -46.0 61.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.69 -44.38 96.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.83 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 377' ' ' LEU . 19.2 mt -65.19 -35.66 81.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 90.7 p -48.97 -33.48 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.91 -53.24 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.52 -52.77 24.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.34 -53.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.65 52.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.445 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.1 t80 -65.49 -32.74 74.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -51.39 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.71 -48.97 74.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.67 -36.13 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.624 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.05 -34.3 45.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.22 -47.26 83.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.7 t -75.22 -37.43 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.97 -54.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.89 96.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.34 72.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 97.4 t -65.39 -54.92 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 395' ' ' LEU . 23.5 m -55.2 -40.9 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 394' ' ' THR . 32.7 mt -71.42 -46.12 60.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.62 -44.47 96.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.803 0.335 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.9 p -48.85 -33.48 10.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.46 -53.41 29.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.16 -52.71 25.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.496 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -63.56 -52.18 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.75 -47.72 52.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.2 t80 -65.25 -32.59 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -51.47 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.21 -49.27 74.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.03 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.73 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.92 -47.09 84.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.4 t -75.27 -38.23 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.28 -54.18 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.0 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.94 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.0 t -63.57 -54.82 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -56.19 -41.07 74.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.32 -36.36 71.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.22 -41.56 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.87 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' A' ' 377' ' ' LEU . 22.2 mt -65.32 -35.5 81.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -48.81 -33.47 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.48 -53.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.24 -52.85 24.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.51 -52.14 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.76 -47.63 52.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.33 -32.53 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -51.51 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -49.23 75.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.09 80.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.2 -34.63 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.94 -47.36 83.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.625 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.2 t -74.98 -38.1 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.143 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.45 -54.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.03 92.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.05 71.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.625 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.6 t -61.6 -54.74 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.5 m -57.17 -46.78 82.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -34.56 78.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -72.21 -45.09 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.863 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' B' ' 377' ' ' LEU . 22.8 mt . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 77.5 p -48.94 -33.28 10.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -67.64 -53.46 27.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.38 -52.83 24.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.09 -52.45 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.107 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.15 53.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -65.86 -32.49 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.5 68.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.31 -49.22 74.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.07 80.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.16 -34.48 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.12 -47.24 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.16 -37.49 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.15 -54.03 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.31 96.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.63 72.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.9 t -63.69 -55.03 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.59 HG21 HD21 ' B' ' 395' ' ' LEU . 94.4 m -55.73 -46.24 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.163 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.541 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -64.09 -36.06 82.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.83 -44.69 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.867 0.365 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.06 -36.37 84.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -49.01 -33.18 10.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -67.82 -53.37 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.44 -53.02 23.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.28 -52.61 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.97 54.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -65.98 -32.6 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.48 68.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.58 -49.05 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.8 -36.03 79.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.3 mm -73.09 -34.71 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.06 -46.99 84.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.27 -37.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -70.03 -54.13 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.73 96.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.43 72.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.0 t -65.22 -54.89 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.541 HG21 HD21 ' A' ' 395' ' ' LEU . 87.7 m -55.32 -40.96 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 394' ' ' THR . 32.4 mt -71.26 -45.84 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.93 -44.75 96.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' B' ' 377' ' ' LEU . 18.8 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 99.8 p -48.6 -32.25 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.99 -53.75 23.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.92 -53.1 20.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.92 -53.07 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.94 -46.74 55.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.626 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.1 t80 -66.11 -32.6 74.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -51.39 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.78 -49.12 74.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.1 79.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.7 45.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.93 -47.05 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 47.8 t -75.31 -37.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.137 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.67 -54.23 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.159 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.64 96.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.45 72.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -65.14 -54.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.592 HG21 HD21 ' B' ' 395' ' ' LEU . 50.3 m -55.7 -40.49 72.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.571 HD21 HG21 ' B' ' 394' ' ' THR . 32.1 mt -71.32 -37.97 71.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.4 m -68.93 -41.83 77.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' A' ' 377' ' ' LEU . 20.2 mt -59.58 -33.61 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.6 p -48.6 -32.22 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.09 -53.84 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.01 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.01 -53.02 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.65 55.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.38 68.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.79 -49.09 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.05 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.21 -34.42 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.14 -47.07 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.569 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.6 t -75.39 -37.29 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.23 -54.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.58 97.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.5 72.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.3 t -64.81 -54.51 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.571 HG21 HD21 ' A' ' 395' ' ' LEU . 89.3 m -55.95 -40.72 73.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 394' ' ' THR . 32.0 mt -71.33 -40.3 70.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -66.49 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.88 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' B' ' 377' ' ' LEU . 23.0 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.81 -32.42 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -68.23 -53.94 21.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.935 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.36 19.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.95 -52.94 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.93 -46.85 55.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.543 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.08 -32.63 74.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.46 68.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.76 -49.07 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.54 -36.08 79.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.18 -34.42 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.24 -47.2 83.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.5 t -75.12 -37.46 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.04 -53.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.19 93.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.1 71.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -61.19 -54.7 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 16.9 m -57.43 -48.42 79.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 394' ' ' THR . 34.4 mt -62.53 -37.23 85.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.6 m -70.08 -44.32 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.849 0.357 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 377' ' ' LEU . 22.1 mt -65.78 -35.02 79.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.4 p -48.78 -32.57 8.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -68.04 -53.77 23.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.76 -53.19 21.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.503 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -53.04 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.381 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.85 -46.63 54.75 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -66.12 -32.79 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.45 68.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.61 -49.07 74.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.64 -36.3 80.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.05 -34.54 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.05 -47.19 84.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.585 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.4 t -75.24 -37.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -69.88 -54.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.84 97.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.88 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -63.87 -54.46 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 395' ' ' LEU . 60.3 m -56.38 -40.8 75.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.31 -34.4 70.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.2 m -72.53 -41.54 65.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.849 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -49.12 -31.97 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.35 -53.78 21.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.929 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.97 -53.36 19.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.486 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.6 t -65.56 -53.35 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.112 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.15 -46.0 56.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.509 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.85 -32.67 74.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.55 68.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.52 -49.22 74.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.47 -36.29 80.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.2 -34.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.46 -47.27 84.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.9 t -75.34 -38.06 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.3 -54.39 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.52 97.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.089 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.44 72.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.2 t -64.59 -55.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.7 m -55.72 -40.49 72.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.14 -34.02 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.51 -39.39 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.816 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' A' ' 377' ' ' LEU . 25.0 mt -65.31 -36.89 85.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.73 -31.75 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -68.33 -53.77 21.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.06 -53.67 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.31 -53.21 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.41 56.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.39 -32.71 74.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -51.51 68.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.75 -49.13 74.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.2 79.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.15 -34.52 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.87 -47.51 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.632 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.05 -37.64 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.71 -54.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.41 90.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.18 71.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.632 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -60.95 -54.42 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.3 m -57.82 -47.14 83.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.155 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.33 -34.42 78.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.7 m -72.38 -45.53 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.866 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' B' ' 377' ' ' LEU . 24.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.0 p -49.15 -32.87 10.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.93 -53.56 25.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.48 -53.05 22.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.33 -52.84 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -46.87 54.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.6 t80 -66.0 -32.48 73.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -51.4 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.15 74.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.72 -36.23 80.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.15 -34.35 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.48 82.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -74.95 -37.57 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.89 -54.07 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.92 92.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.07 71.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.4 t -61.24 -54.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.1 m -57.55 -47.63 81.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.7 -35.41 80.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.34 -45.13 63.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.896 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.88 0.371 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' A' ' 377' ' ' LEU . 24.2 mt -65.07 -36.64 84.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -49.03 -32.91 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -68.01 -53.64 24.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.9 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.53 -53.04 22.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.4 t -64.37 -52.74 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 111.11 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -46.82 54.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.13 -32.55 74.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.51 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.44 -49.12 74.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.8 -36.14 80.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.23 -47.36 82.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.619 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.8 t -75.07 -37.45 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.97 -54.1 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.83 91.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.08 71.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.619 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -60.66 -54.41 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 47.0 m -58.13 -47.7 82.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -63.67 -34.97 79.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.11 -45.11 61.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.85 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.7 p -49.19 -33.37 12.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.52 -53.38 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.46 -52.99 23.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.7 t -63.67 -52.86 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.66 -47.37 52.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -65.53 -32.62 74.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -51.49 68.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.54 -49.0 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.79 -36.3 80.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.13 -34.69 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.84 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.1 t -75.38 -37.85 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.55 -54.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.074 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.16 70.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.0 t -62.94 -54.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.9 m -56.4 -41.13 75.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.3 -33.8 70.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.88 -55.98 6.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' A' ' 377' ' ' LEU . 22.6 mt -65.11 -36.58 84.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 93.5 p -48.96 -33.29 10.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.65 -53.29 29.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.46 -52.9 23.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.48 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.87 -52.9 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.25 53.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -65.54 -32.63 74.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.45 68.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.6 -49.07 74.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.16 80.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.3 -34.68 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.79 -47.07 85.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.4 t -75.38 -38.08 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.3 -54.17 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.31 98.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.21 -50.5 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.599 HG23 ' O ' ' B' ' 389' ' ' VAL . 87.5 t -64.44 -54.92 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.5 m -55.75 -40.89 73.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.3 -42.26 68.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -63.33 -54.18 41.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 -179.889 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' B' ' 377' ' ' LEU . 20.7 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 86.4 p -48.38 -33.8 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -66.96 -53.81 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.9 -52.72 27.08 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -62.72 -51.37 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.54 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.3 t80 -64.44 -32.61 74.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.54 68.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.33 -49.22 74.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.68 -36.08 79.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.24 -34.31 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.25 -47.1 83.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -37.43 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.07 -54.12 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.23 97.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.58 72.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.66 -54.52 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.578 HG21 HD21 ' B' ' 395' ' ' LEU . 26.1 m -55.92 -41.01 73.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.6 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.16 -41.31 70.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.44 -43.38 90.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 377' ' ' LEU . 20.6 mt -65.54 -33.56 76.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 84.0 p -48.4 -33.9 9.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -66.88 -53.74 29.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.79 -52.67 27.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.0 t -62.59 -51.36 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 111.126 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.83 -48.3 51.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -64.54 -32.6 74.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -51.64 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.2 -49.16 75.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.78 -36.11 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.26 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.29 -47.05 83.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.37 -37.36 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.18 -54.06 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.7 96.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.51 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.9 t -64.98 -54.72 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.6 HG21 HD21 ' A' ' 395' ' ' LEU . 91.4 m -55.54 -40.89 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.25 -44.08 66.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.74 -43.89 97.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.878 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -33.54 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.11 -53.93 26.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.06 -52.91 25.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.7 t -62.89 -51.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.125 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -48.52 51.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -64.46 -32.58 74.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.6 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.11 -49.27 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.77 -36.06 79.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.24 -34.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.13 -47.35 83.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.9 t -75.0 -37.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.54 -53.96 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.9 91.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.18 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 389' ' ' VAL . 88.9 t -61.43 -54.94 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.5 m -57.02 -47.14 81.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -63.96 -35.3 80.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -71.36 -45.18 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.892 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' A' ' 377' ' ' LEU . 21.0 mt -65.86 -33.23 75.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 70.5 p -48.58 -33.46 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.26 -54.03 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.05 -52.82 25.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.05 -51.33 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.35 51.23 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -64.75 -32.56 74.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.5 68.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.25 -49.16 75.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.92 -35.96 79.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.34 -34.59 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.99 -47.07 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.5 t -75.24 -38.18 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.4 -54.24 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.9 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.73 72.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -63.65 -54.66 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 22.8 m -56.36 -41.15 75.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.19 -36.47 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.08 -41.8 73.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.832 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.669 HD23 HD23 ' B' ' 377' ' ' LEU . 19.7 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.861 0.362 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.4 p -48.64 -31.7 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.43 -53.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.07 -53.63 17.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.46 -53.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.26 55.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.498 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.0 t80 -66.65 -32.7 74.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.49 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.55 -49.27 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.56 -36.16 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.15 -34.53 45.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.91 -47.53 82.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.3 t -75.01 -37.77 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.62 -54.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.61 91.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.2 71.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -61.19 -54.52 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 84.8 m -57.59 -47.31 82.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.96 -34.9 79.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.96 -44.95 62.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.861 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 377' ' ' LEU . 20.4 mt -57.48 -35.39 70.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 95.5 p -48.74 -31.67 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -68.48 -53.61 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.93 -53.68 18.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.514 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.51 -53.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.12 56.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.81 -32.65 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.62 -49.11 74.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.66 -36.17 80.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.15 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.9 -47.44 83.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 47.6 t -74.97 -37.91 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.52 -54.1 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.72 91.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.23 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 84.7 t -60.99 -54.66 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 24.4 m -57.55 -47.33 82.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.16 -45.19 61.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.836 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' B' ' 377' ' ' LEU . 20.0 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.845 0.355 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 95.7 p -48.59 -31.81 7.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.42 -53.72 21.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.902 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.59 18.28 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.45 -53.13 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.04 56.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -66.76 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.43 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.833 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.82 -49.11 74.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.08 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.96 -47.11 84.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.28 -37.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.09 -54.24 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.39 96.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.69 72.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.63 -54.43 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.437 HG21 HD21 ' B' ' 395' ' ' LEU . 29.5 m -56.05 -40.82 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -71.26 -40.55 70.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.8 m -66.13 -43.32 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.871 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 377' ' ' LEU . 20.7 mt -59.53 -35.32 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.6 -31.86 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.37 -53.68 22.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.7 17.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.27 -53.14 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.32 55.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.8 t80 -66.53 -32.66 74.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.52 68.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.59 -49.19 74.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.62 -35.99 79.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.87 -47.24 84.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.24 -37.52 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.99 -54.11 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.65 96.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 389' ' ' VAL . 99.4 t -63.32 -54.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 395' ' ' LEU . 36.8 m -56.13 -45.97 79.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.437 HD21 HG21 ' A' ' 394' ' ' THR . 33.4 mt -64.65 -34.55 78.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.39 -44.72 62.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.887 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' B' ' 377' ' ' LEU . 19.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.785 0.326 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.0 p -48.45 -31.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -68.44 -53.63 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.74 -53.72 18.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.23 -52.83 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -45.83 56.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -67.02 -32.64 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.48 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.66 -49.29 73.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.39 -36.01 79.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.22 -34.52 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.07 -47.07 84.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -75.33 -37.34 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.17 -54.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.05 -45.05 94.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.43 -50.39 71.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.2 t -66.09 -55.01 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.632 HG21 HD21 ' B' ' 395' ' ' LEU . 85.6 m -54.73 -40.15 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.591 HD21 HG21 ' B' ' 394' ' ' THR . 31.3 mt -71.06 -34.09 70.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -73.55 -39.16 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.88 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.827 0.346 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' A' ' 377' ' ' LEU . 19.7 mt -60.11 -34.06 72.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.3 p -48.67 -32.19 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -68.24 -53.79 22.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.81 -53.39 19.87 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.452 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.36 -53.08 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.95 56.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -66.9 -32.74 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.895 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.45 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.68 -49.13 74.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.53 -36.14 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.615 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.17 -34.44 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.11 -46.99 84.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.5 -37.27 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.103 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -70.28 -54.15 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.28 93.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.33 71.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.0 t -66.34 -55.03 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.591 HG21 HD21 ' A' ' 395' ' ' LEU . 61.4 m -54.63 -39.92 68.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.632 HD21 HG21 ' A' ' 394' ' ' THR . 31.1 mt -71.26 -34.64 70.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.7 m -73.31 -38.24 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.835 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.87 0.367 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 92.1 p -48.6 -33.87 10.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.849 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -66.93 -53.47 31.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.87 -52.6 27.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -62.85 -51.39 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.849 0.357 . . . . 0.0 111.12 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.4 51.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -64.51 -32.63 74.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 0.0 110.853 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.67 67.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.1 -49.31 74.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.11 79.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.31 -34.59 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.88 -47.16 84.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.1 t -75.3 -38.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.34 -54.22 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.04 97.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.66 72.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.077 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 389' ' ' VAL . 86.8 t -64.03 -54.74 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 42.2 m -56.16 -41.01 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.21 -38.97 72.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.59 -42.41 82.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 -179.876 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 377' ' ' LEU . 19.9 mt -65.35 -34.36 78.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -48.57 -33.81 10.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.0 -53.48 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.87 -52.65 27.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.474 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -62.89 -51.62 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -48.2 51.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.0 t80 -64.73 -32.47 74.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.57 68.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.13 -49.21 75.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.74 -36.38 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.42 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.97 -47.48 83.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.03 -37.84 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.61 -53.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.72 91.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.2 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.8 t -61.25 -54.66 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 39.3 m -57.4 -47.1 82.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.26 -35.77 81.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.87 -45.09 65.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.851 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' B' ' 377' ' ' LEU . 22.2 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 94.3 p -48.78 -33.68 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.28 -53.53 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.04 -52.82 25.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -63.18 -51.83 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.35 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.96 51.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -64.88 -32.65 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.4 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.75 -49.28 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.34 -36.3 79.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 9.1 mm -73.33 -34.35 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.81 -47.29 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 389' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.5 t -75.43 -37.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.35 -53.93 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.27 98.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.34 -48.33 79.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 393' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 389' ' ' VAL . 93.3 t -66.6 -55.09 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 394' ' ' THR . . . . . 0.566 HG21 HD21 ' B' ' 395' ' ' LEU . 35.6 m -55.71 -41.12 73.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 395' ' ' LEU . . . . . 0.577 HD21 HG21 ' B' ' 394' ' ' THR . 35.5 mt -71.4 -51.74 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.886 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.887 0.375 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' A' ' 377' ' ' LEU . 21.9 mt -65.34 -35.2 80.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.4 p -48.6 -33.68 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.36 -53.56 28.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.01 -52.96 25.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 381' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -63.22 -51.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.83 52.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.02 -32.63 74.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.46 68.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.7 -49.34 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.23 -36.45 79.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 9.0 mm -73.2 -34.18 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.07 -47.3 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 389' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.4 t -75.38 -37.32 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.03 -54.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.58 97.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.45 72.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 393' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -65.11 -54.93 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 394' ' ' THR . . . . . 0.577 HG21 HD21 ' A' ' 395' ' ' LEU . 61.7 m -55.33 -40.99 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 395' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.33 -44.18 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -62.42 -43.63 98.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.572 0.701 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -27.77 26.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.17 149.04 46.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -155.75 169.25 24.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -87.97 165.93 14.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -164.23 158.72 19.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.61 142.45 51.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.82 150.74 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.54 114.01 5.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.723 ' HB3' ' CD ' ' B' ' 368' ' ' GLU . . . -160.52 165.17 31.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.78 121.92 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -155.34 164.56 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 56.86 35.04 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -58.12 -88.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.8 m -109.35 10.43 25.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 90.1 t -89.4 -65.4 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.087 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.6 t80 -68.43 -28.67 67.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.44 -29.55 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.079 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.2 -28.21 63.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.35 -25.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.849 0.357 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt -65.48 -36.46 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.85 -31.36 7.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.42 -53.76 21.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.13 -53.64 17.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.64 -53.37 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.11 -46.49 56.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.3 -32.74 74.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.48 68.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.95 -49.26 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.23 -36.25 79.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.15 -34.43 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.93 -47.2 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.1 t -75.42 -37.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.72 -54.18 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.96 -50.44 72.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.4 t -65.32 -54.99 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.176 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.498 HG21 HD21 ' B' ' 395' ' ' LEU . 21.3 m -55.11 -41.1 71.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.533 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.27 -46.41 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.33 -44.4 95.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -66.97 -23.15 65.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.678 ' HG ' HD13 ' B' ' 398' ' ' LEU . 7.6 tt -52.54 -67.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 160.89 48.02 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.668 2.245 . . . . 0.0 112.374 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -98.72 136.45 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.82 131.18 35.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -57.1 112.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.37 127.7 54.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -65.2 160.7 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 158.26 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -133.33 131.76 40.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -102.5 151.92 21.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -101.57 120.13 39.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLU . . . . . 0.723 ' CD ' ' HB3' ' A' ' 366' ' ' ALA . 6.6 tp10 -145.16 129.43 17.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 53.06 30.78 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -103.16 -70.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.7 p -98.0 3.41 49.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 90.7 t -90.06 -65.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.492 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.7 t80 -68.21 -28.89 67.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.484 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.24 -30.22 16.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.42 -28.26 61.86 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.5 -25.33 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' A' ' 377' ' ' LEU . 22.0 mt -65.76 -36.43 83.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.9 p -48.74 -31.56 7.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.26 -53.74 22.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.21 -53.77 16.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.441 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.4 -53.33 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.2 -46.55 56.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.3 t80 -66.22 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -51.45 68.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.94 -49.23 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.26 -36.26 79.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.14 -34.57 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.75 -47.21 84.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.3 t -75.39 -37.68 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -69.6 -54.2 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.48 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.29 72.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -65.48 -55.06 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.533 HG21 HD21 ' A' ' 395' ' ' LEU . 31.7 m -55.07 -41.03 71.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.498 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.33 -46.93 59.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.0 m -59.79 -44.55 93.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -66.74 -22.95 66.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.678 HD13 ' HG ' ' A' ' 398' ' ' LEU . 15.6 tp -78.47 -28.18 46.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.657 0.741 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 131.51 21.34 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -81.66 131.8 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -107.48 116.86 32.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -126.43 161.51 27.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.05 118.77 34.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.854 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.83 174.67 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 107.25 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -168.32 170.24 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.31 127.7 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.06 -62.08 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -141.54 113.15 7.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -173.19 151.42 2.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 161.55 -82.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 24.6 p -104.64 3.47 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 0.0 110.85 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.01 -65.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.62 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.1 t80 -68.55 -27.19 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.31 13.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.82 -28.03 65.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 373' ' ' TYR . 4.8 mt -82.54 -25.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.099 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' B' ' 377' ' ' LEU . 25.5 mt -63.31 -36.41 83.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.4 p -48.75 -31.9 7.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.4 -53.79 21.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.71 17.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.23 -53.01 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.117 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.3 55.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.51 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -51.29 69.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.1 -49.16 73.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.34 -36.07 79.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.57 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.04 -47.02 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.33 -37.61 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.05 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.7 96.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.45 72.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.1 t -65.23 -54.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.499 HG21 HD21 ' B' ' 395' ' ' LEU . 14.2 m -55.27 -40.92 71.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.51 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.33 -45.23 63.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.6 m -61.52 -44.18 97.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.89 -22.31 65.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.631 ' HG ' HD13 ' B' ' 398' ' ' LEU . 8.1 tt -51.84 -67.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.613 0.72 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 179.7 3.52 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.67 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -79.06 134.99 36.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -151.49 148.86 28.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -101.14 124.98 47.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 7.2 tp -147.19 132.85 18.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.06 135.29 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.93 165.73 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.51 171.66 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 61.66 31.43 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -83.03 162.55 21.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 52.2 50.86 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -134.95 -51.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 16.9 m -103.17 2.53 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.968 0.413 . . . . 0.0 110.885 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.14 -65.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.583 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -69.32 -31.15 69.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.954 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -55.29 -25.86 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.67 70.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.77 -25.29 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' A' ' 377' ' ' LEU . 20.9 mt -65.81 -35.69 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.5 p -48.93 -32.11 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.4 -53.88 20.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.79 -53.22 20.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.529 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.52 -53.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -45.98 56.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.94 -32.73 74.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -51.47 68.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.82 -49.08 74.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.58 -36.11 79.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.29 -34.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.93 -47.22 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.563 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.3 t -75.37 -37.26 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.19 -54.1 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.78 96.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.07 -50.42 72.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.9 t -65.37 -54.82 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.51 HG21 HD21 ' A' ' 395' ' ' LEU . 18.6 m -55.3 -40.97 71.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.31 -45.58 62.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -61.21 -44.44 97.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -66.72 -23.09 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.631 HD13 ' HG ' ' A' ' 398' ' ' LEU . 11.5 tp -77.04 -33.38 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.592 0.711 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 167.9 23.09 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.386 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -164.87 154.76 13.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -163.42 168.42 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -126.07 154.75 42.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.74 177.99 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 47.1 mt -149.74 157.83 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.43 151.81 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.01 125.85 53.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -169.38 173.54 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.98 122.12 44.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -161.47 178.49 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' B' ' 369' ' ' ALA . . . -65.18 92.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.045 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -143.54 -66.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.512 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.12 1.1 42.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.27 -65.01 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.32 -30.54 70.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.9 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.069 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.01 -25.44 70.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.47 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' B' ' 377' ' ' LEU . 22.5 mt -65.02 -36.16 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 81.9 p -48.9 -33.52 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.3 -53.39 30.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.22 -52.73 25.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -63.64 -52.49 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.19 53.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.4 t80 -65.69 -32.62 74.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.391 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.43 68.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.14 74.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -61.71 -36.17 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.17 -34.45 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.12 -47.08 84.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.34 -37.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.1 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.5 97.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.35 73.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -65.33 -54.84 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.605 HG21 HD21 ' B' ' 395' ' ' LEU . 85.2 m -55.33 -41.03 71.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.563 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.27 -46.19 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.9 m -60.55 -44.54 96.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -66.99 -22.96 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.638 ' CD2' HD13 ' B' ' 398' ' ' LEU . 1.5 tt -52.06 -45.52 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.65 0.738 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -27.14 27.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.693 2.262 . . . . 0.0 112.385 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -111.63 170.81 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.42 159.27 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.24 131.35 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -107.13 130.38 54.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' LEU . . . . . 0.53 HD13 ' N ' ' B' ' 364' ' ' VAL . 0.4 OUTLIER -74.8 127.36 32.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.898 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 364' ' ' VAL . . . . . 0.53 ' N ' HD13 ' B' ' 363' ' ' LEU . 15.9 m -137.18 136.35 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -90.24 -60.42 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -127.11 123.69 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -145.83 123.77 12.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -172.62 160.61 4.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.864 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 369' ' ' ALA . . . -52.55 102.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.101 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -153.72 -69.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 17.7 p -101.68 2.25 38.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 30.5 t -89.92 -65.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.2 -30.72 70.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.67 -22.7 67.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.113 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.21 -25.39 71.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.478 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.21 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 111.15 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' A' ' 377' ' ' LEU . 22.5 mt -65.17 -36.19 83.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.7 p -48.93 -33.4 10.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.54 -53.53 27.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.948 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.2 -52.68 26.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -63.88 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -47.28 53.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.1 t80 -65.72 -32.6 74.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.41 69.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.47 -49.16 74.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.71 -36.13 80.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.19 -34.67 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.97 -47.04 84.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.4 t -75.29 -37.85 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.62 -54.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.63 96.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.41 72.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.4 t -65.35 -55.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.563 HG21 HD21 ' A' ' 395' ' ' LEU . 26.1 m -55.02 -41.01 70.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.175 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.605 HD21 HG21 ' A' ' 394' ' ' THR . 33.2 mt -71.29 -46.7 60.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -60.06 -44.52 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 38.0 mmt-85 -66.88 -23.03 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.638 HD13 ' CD2' ' A' ' 398' ' ' LEU . 15.9 tp -77.98 -34.85 50.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.58 0.705 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 176.05 7.27 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.683 2.255 . . . . 0.0 112.36 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.16 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -138.26 128.75 26.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -137.99 155.54 48.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.67 171.54 14.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 364' ' ' VAL . 2.1 tt -167.65 152.5 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 363' ' ' LEU . 31.4 m -131.46 133.78 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -167.63 168.91 12.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -65.45 126.34 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -149.56 -179.24 6.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.86 175.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.37 56.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.091 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -87.74 -82.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.6 p -84.82 3.06 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 43.0 t -87.68 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.71 -30.8 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.81 -24.19 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.58 69.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.32 -23.29 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' B' ' 377' ' ' LEU . 22.9 mt -65.08 -36.65 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.0 p -49.12 -33.29 11.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -67.43 -53.51 28.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.25 -52.74 25.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.85 -52.51 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.28 53.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -65.58 -32.6 74.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.39 68.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.42 -49.14 74.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.06 80.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.19 -34.37 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.29 -47.17 83.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.26 -37.14 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.34 -54.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.74 96.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.94 72.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 389' ' ' VAL . 94.1 t -62.74 -54.8 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.096 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.45 HG21 HD21 ' B' ' 395' ' ' LEU . 26.6 m -56.36 -46.63 79.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.434 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -64.09 -36.0 82.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -70.81 -44.81 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -86.22 5.46 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.764 ' HG ' HD13 ' B' ' 398' ' ' LEU . 1.1 tt -80.68 -38.7 28.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.23 0.062 0 CA-C-O 121.598 0.713 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.53 17.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -71.03 162.67 29.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.28 146.84 24.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.05 107.75 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -148.3 151.68 35.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 8.3 tt -68.55 114.28 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.8 138.86 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -95.12 123.66 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.55 134.13 14.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -121.26 139.23 53.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -61.05 -57.52 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -56.81 103.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -164.29 -71.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 26.2 p -105.41 3.74 29.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 40.0 t -90.13 -65.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.53 -31.16 70.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.43 -23.29 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.79 -24.88 70.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.46 -22.45 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.106 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.11 -36.75 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.3 p -49.28 -33.03 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.94 -53.27 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.39 -52.78 24.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.465 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.24 -52.61 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.71 -47.08 53.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.459 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.625 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.03 -32.57 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.41 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.61 -49.16 74.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.66 -36.08 79.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.176 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.06 -47.13 84.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.2 t -75.36 -37.37 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.18 -54.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.39 97.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.6 72.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.5 t -64.69 -54.58 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.434 HG21 HD21 ' A' ' 395' ' ' LEU . 19.9 m -55.85 -41.08 73.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.45 HD21 HG21 ' A' ' 394' ' ' THR . 32.8 mt -71.1 -42.35 69.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.32 -43.7 93.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -66.81 -23.1 66.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.764 HD13 ' HG ' ' A' ' 398' ' ' LEU . 19.9 tp -73.96 -25.43 59.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 19.8 mmt-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.588 0.709 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 178.32 4.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.353 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -114.32 177.96 4.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.85 176.7 4.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.939 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -77.25 178.0 7.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.72 153.94 23.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.6 tp -142.59 136.37 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.7 142.17 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.144 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -58.09 125.03 21.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 367' ' ' ASP . . . -156.85 165.68 35.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -124.82 98.26 5.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -143.1 147.92 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 57.91 65.23 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -77.32 -87.43 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -107.18 10.12 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 93.8 t -89.64 -65.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.0 t80 -68.34 -27.45 66.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.02 -30.06 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.71 -28.21 62.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.512 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 373' ' ' TYR . 4.8 mt -82.44 -25.91 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.352 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 24.1 mt -65.77 -35.38 80.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.4 p -48.99 -32.09 8.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.12 -54.01 21.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.37 19.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.23 -53.15 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.125 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.54 55.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -66.3 -32.68 74.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.41 69.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.01 -49.07 73.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.5 -36.12 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.07 -34.52 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.01 84.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.33 -37.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.07 -54.07 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.53 97.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.55 72.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.8 t -64.96 -54.71 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.513 HG21 HD21 ' B' ' 395' ' ' LEU . 87.0 m -55.54 -41.02 72.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.18 -43.79 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.84 -44.0 97.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -66.76 -21.7 66.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 398' ' ' LEU . 3.2 tt -51.65 -49.85 61.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.622 0.725 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -28.68 25.14 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.4 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.03 141.55 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.041 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -134.61 141.55 46.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.76 108.94 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -115.0 136.52 53.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 6.6 mp -114.91 158.81 21.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 11.0 p -156.94 133.84 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.46 170.82 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -101.89 98.74 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 367' ' ' ASP . . . . . 0.427 ' HA ' ' HB1' ' A' ' 366' ' ' ALA . 1.5 m-20 -78.5 136.88 37.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -152.62 115.94 4.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -101.89 37.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -87.0 -76.79 1.26 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.494 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 19.0 m -96.59 3.49 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.09 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -68.54 -30.95 69.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -53.24 -28.36 26.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.42 -28.73 65.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.543 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 376' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' B' ' 373' ' ' TYR . 4.8 mt -82.84 -26.67 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.79 -35.52 80.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.9 p -48.89 -32.29 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.2 -53.92 21.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.32 19.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.19 -53.02 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -46.49 55.93 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -66.44 -32.56 74.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.41 -51.47 68.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.52 -49.2 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.64 -35.97 79.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.31 -34.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.26 -47.23 83.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.22 -37.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.35 -54.1 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.22 96.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.77 72.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 389' ' ' VAL . 95.2 t -63.58 -54.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 86.5 m -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 394' ' ' THR . 32.9 mt -64.32 -34.7 78.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -72.27 -44.57 62.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.49 7.29 30.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.29 -33.65 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.61 0.719 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 153.2 69.23 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.77 156.97 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.81 164.61 15.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -151.13 157.09 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -115.43 155.39 27.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.29 142.77 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 40.9 t -144.34 145.72 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -72.95 138.07 45.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.48 ' HB3' ' CD ' ' B' ' 368' ' ' GLU . . . -162.88 176.35 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -83.69 105.54 14.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -163.07 173.91 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.75 40.63 7.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -84.29 -81.18 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -110.18 7.21 23.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 46.4 t -90.0 -65.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.555 ' CE2' HD11 ' B' ' 377' ' ' LEU . 2.4 t80 -67.21 -31.91 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -53.52 -30.58 42.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.13 58.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.3 -26.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.353 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 25.1 mt -65.55 -37.27 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 90.9 p -49.48 -31.88 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -68.44 -53.88 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.83 -53.27 20.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.3 t -65.48 -53.14 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.23 55.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.71 -32.71 74.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.898 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -51.5 68.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.4 -49.35 74.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.8 mm -73.17 -35.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.2 -47.15 85.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.26 -39.25 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.133 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -68.05 -54.11 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.04 96.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.27 73.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.6 t -64.91 -55.13 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 5.8 m -55.4 -41.16 72.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.21 -44.5 65.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.03 -43.87 97.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.62 -22.54 66.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.878 HD22 HD13 ' B' ' 398' ' ' LEU . 7.2 tp -84.76 -71.18 0.53 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.589 0.709 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -15.54 36.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.669 2.246 . . . . 0.0 112.31 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . 63.85 35.33 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -112.27 160.72 17.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.66 144.06 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -149.34 144.41 26.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.03 136.91 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.54 120.38 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.124 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -52.07 109.08 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.28 168.68 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.74 171.98 7.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 368' ' ' GLU . . . . . 0.48 ' CD ' ' HB3' ' A' ' 366' ' ' ALA . 19.4 mp0 -136.29 171.9 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.62 35.59 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -76.76 -82.32 0.54 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 8.9 m -107.86 5.94 26.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.93 -65.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.171 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' A' ' 377' ' ' LEU . 3.1 t80 -67.72 -31.73 71.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.88 57.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -57.68 -28.22 59.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.42 -27.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.137 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 24.6 mt -65.52 -37.07 85.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 96.5 p -49.34 -32.04 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -68.41 -53.89 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.86 -53.23 20.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -53.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.04 -46.11 56.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.77 -32.6 74.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.374 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.41 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.33 -49.21 74.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.82 -36.14 80.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.17 -34.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.87 -47.48 83.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.1 t -75.03 -37.84 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.5 -53.96 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.31 90.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.81 72.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 88.3 t -61.16 -54.45 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.4 m -57.92 -48.5 79.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -38.34 90.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.6 m -68.87 -44.66 72.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -84.84 4.0 35.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.878 HD13 HD22 ' A' ' 398' ' ' LEU . 7.9 tp -84.44 -40.3 17.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.625 0.726 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -175.2 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.688 2.259 . . . . 0.0 112.352 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -164.52 154.26 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -152.0 176.92 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.19 177.99 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -90.71 -67.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 83.6 mt -148.09 133.44 18.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 12.6 p -115.31 -27.58 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -77.07 170.12 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -78.7 177.75 8.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -150.05 170.51 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -68.93 -20.09 64.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' B' ' 369' ' ' ALA . . . -92.47 42.79 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.075 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -80.02 -84.24 0.66 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 13.0 p -85.4 1.4 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 110.895 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.421 ' HB2' ' HB1' ' A' ' 369' ' ' ALA . 2.2 t80 -67.1 -30.47 70.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.932 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.7 -23.62 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.086 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.83 70.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.483 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.57 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' B' ' 377' ' ' LEU . 23.8 mt -65.18 -36.34 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.1 p -49.1 -33.03 10.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.91 -53.33 27.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.41 -52.87 24.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.4 -52.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.129 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.72 -47.1 53.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.638 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.3 t80 -66.06 -32.55 74.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.35 . . . . 0.0 110.843 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.5 68.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.32 -49.14 75.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.95 -36.08 80.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.76 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.99 -47.02 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.25 -38.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.5 t -69.43 -54.23 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.0 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -51.01 71.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -63.63 -54.82 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -56.13 -41.03 74.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.27 -35.85 71.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.71 -41.53 71.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.64 -23.18 66.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.744 HD13 ' CD1' ' B' ' 398' ' ' LEU . 7.7 tp -67.09 -36.92 83.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.649 0.737 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 127.29 14.36 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.365 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -127.6 170.83 12.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.121 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.27 144.34 46.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.05 136.97 21.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -83.99 133.57 34.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.4 128.37 35.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 11.1 p -75.34 -26.76 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -81.02 -63.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -140.21 116.46 10.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.24 -26.17 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -125.99 172.52 9.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.593 ' CB ' ' HB3' ' A' ' 369' ' ' ALA . . . -51.7 104.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -154.57 -72.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.518 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 29.4 p -103.96 5.35 35.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 110.829 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.02 -65.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.98 -30.76 69.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.31 -23.9 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.89 -25.88 69.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.43 -22.92 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.29 -36.33 83.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.4 p -49.12 -33.04 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.851 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.95 -53.67 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.47 -52.98 23.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.443 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.2 t -64.3 -52.69 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.88 54.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -65.96 -32.56 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -51.46 68.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.89 -49.29 75.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -62.03 -36.04 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.2 mm -73.05 -34.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -63.0 -47.25 83.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.622 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.6 t -75.03 -38.07 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.55 -53.99 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.19 92.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.03 71.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.5 t -61.59 -54.65 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 28.5 m -57.34 -46.83 82.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.3 -34.76 78.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.12 -44.77 62.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -87.74 7.69 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.744 ' CD1' HD13 ' A' ' 398' ' ' LEU . 7.2 tp -76.96 -38.61 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.636 0.732 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 173.05 11.59 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -168.19 155.21 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -168.5 177.87 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -157.5 162.53 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -153.34 172.47 17.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 39.5 tp -156.17 137.18 13.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -156.3 151.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.13 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -76.92 132.22 38.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -170.41 168.34 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -58.43 136.11 57.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -155.36 158.95 39.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.678 ' HB1' ' HB ' ' A' ' 372' ' ' VAL . . . -51.68 103.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.053 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 374' ' ' ALA . . . -96.43 -51.03 1.76 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.54 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 28.1 p -98.63 0.17 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.678 ' HB ' ' HB1' ' A' ' 369' ' ' ALA . 89.0 t -90.12 -65.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.617 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.3 t80 -68.56 -26.7 65.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.956 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.13 -29.5 13.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.103 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.34 -28.63 64.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -83.05 -26.71 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt -61.6 -35.72 78.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.3 p -48.5 -31.97 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.29 -53.62 23.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.67 17.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.45 -53.21 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.139 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.23 55.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.7 t80 -66.7 -32.64 74.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.35 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.83 -49.2 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.47 -36.09 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.633 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.32 -34.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -47.11 84.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.6 t -75.38 -37.66 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -69.79 -54.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.23 97.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.84 71.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.4 t -64.39 -54.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.512 HG21 HD21 ' B' ' 395' ' ' LEU . 60.4 m -55.59 -40.78 72.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.41 -40.58 70.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.0 m -64.73 -54.19 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -66.87 -13.57 61.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.755 HD13 HD12 ' B' ' 398' ' ' LEU . 24.0 tp -80.04 -72.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.617 0.722 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.23 35.36 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.726 2.284 . . . . 0.0 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -97.72 113.39 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -96.58 138.75 33.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.39 137.24 58.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.45 -26.05 7.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 10.6 mt -52.02 -45.79 64.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.07 142.02 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.36 151.63 26.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -92.22 145.06 24.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.79 -31.16 5.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -131.92 149.76 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.63 -66.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 89.21 -71.37 2.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 1.9 m -133.12 17.34 4.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.832 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.94 -65.58 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.604 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -68.68 -27.11 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.588 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.43 -29.3 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.081 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.57 65.43 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.81 -26.21 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' A' ' 377' ' ' LEU . 21.5 mt -62.37 -35.73 80.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 80.2 p -48.62 -31.79 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.35 -53.61 22.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.97 -53.67 17.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.44 -53.25 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -46.06 56.13 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.75 -32.73 74.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.395 . . . . 0.0 110.894 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.34 69.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.82 -49.32 73.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.28 -36.31 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.618 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.12 -34.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.02 -47.13 84.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.58 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.46 -37.3 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.0 t -70.12 -54.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.13 98.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.28 -50.87 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.0 t -64.15 -54.57 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.501 HG21 HD21 ' A' ' 395' ' ' LEU . 87.1 m -56.1 -40.72 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.199 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.43 -36.7 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -70.05 -41.98 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -66.72 -22.68 66.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.755 HD12 HD13 ' A' ' 398' ' ' LEU . 9.6 tt -51.73 -51.35 56.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.912 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 116.76 4.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.39 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.03 32.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -167.81 158.74 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.11 179.04 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' B' ' 366' ' ' ALA . 2.8 pm0 -126.49 136.68 52.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.467 ' HB2' HG21 ' B' ' 364' ' ' VAL . 38.1 mt -96.84 178.49 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 364' ' ' VAL . 19.1 m -87.02 123.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.126 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -154.99 163.17 40.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -92.18 110.86 22.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -173.09 177.09 2.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 369' ' ' ALA . 6.9 pt-20 -159.82 165.39 32.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 372' ' ' VAL . . . -67.91 136.65 54.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -115.3 -34.77 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.7 m -118.87 -0.43 11.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 0.0 110.851 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 369' ' ' ALA . 21.3 t -90.2 -65.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.56 -29.32 65.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.6 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.31 69.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.467 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.29 -22.63 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.117 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt -65.68 -34.32 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.8 p -48.85 -33.22 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.53 -53.84 25.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.24 -52.93 24.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.3 t -63.66 -51.65 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.9 52.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -65.18 -32.58 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.894 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.56 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.09 -49.3 75.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.82 -35.96 79.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.28 -34.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.96 -46.89 85.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -38.22 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.44 -54.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.14 97.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.97 -50.46 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.4 t -65.0 -55.06 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.544 HG21 HD21 ' B' ' 395' ' ' LEU . 61.5 m -55.31 -40.92 71.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 33.3 mt -71.27 -44.45 65.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.2 m -62.14 -43.68 98.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.64 -23.03 66.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 1.098 HD13 HD13 ' B' ' 398' ' ' LEU . 8.1 tp -76.63 -35.19 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.639 0.733 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 125.7 12.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.719 2.28 . . . . 0.0 112.337 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -167.12 160.82 14.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -86.2 114.97 23.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.96 162.84 31.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -119.68 178.23 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.7 tt -61.04 112.59 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 364' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 363' ' ' LEU . 26.8 m -129.4 142.56 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -125.74 116.24 21.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 366' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 362' ' ' GLU . . . -130.31 130.66 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -164.21 124.95 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -161.34 104.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.599 ' HB1' ' H ' ' B' ' 373' ' ' TYR . . . -57.45 -63.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 86.23 -87.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 38.9 p -108.26 7.16 27.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 372' ' ' VAL . . . . . 0.439 ' HB ' ' HB1' ' B' ' 369' ' ' ALA . 21.7 t -89.34 -65.47 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.599 ' H ' ' HB1' ' B' ' 369' ' ' ALA . 2.0 t80 -70.73 -29.77 66.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.25 -22.68 63.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.95 -25.95 71.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.41 -21.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.68 -34.36 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.2 p -48.75 -33.38 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.54 -53.79 25.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.21 -52.88 24.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.4 t -63.53 -51.7 67.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.75 52.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -65.24 -32.64 74.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.69 67.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.81 -49.24 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.01 -35.94 80.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.32 -34.74 44.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -62.99 -46.91 85.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.593 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.29 -38.27 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.33 -54.06 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.12 98.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.48 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.6 t -64.99 -55.19 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 40.4 m -55.11 -40.95 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.34 -45.06 63.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -61.48 -43.68 98.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -66.86 -22.98 65.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 1.098 HD13 HD13 ' A' ' 398' ' ' LEU . 8.0 tp -77.19 -39.16 49.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.617 0.722 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.46 10.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.38 30.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -102.43 177.09 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -159.62 169.89 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLU . . . . . 0.61 ' O ' HD22 ' A' ' 363' ' ' LEU . 71.7 mm-40 -98.37 145.03 27.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 362' ' ' GLU . 4.3 mm? -127.73 168.22 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 26.2 t -95.84 147.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.77 155.06 39.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.97 -50.52 7.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.089 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.1 172.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.95 157.73 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.567 ' HB1' ' H ' ' A' ' 373' ' ' TYR . . . -51.64 -62.12 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 85.92 -85.0 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 m -114.16 9.91 17.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.864 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' A' ' 369' ' ' ALA . 25.4 t -90.04 -65.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.567 ' H ' ' HB1' ' A' ' 369' ' ' ALA . 2.2 t80 -69.47 -30.72 68.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -57.58 -25.82 60.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.101 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.42 69.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.448 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.5 -24.16 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.135 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' B' ' 377' ' ' LEU . 23.6 mt -64.73 -35.91 82.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 76.0 p -48.97 -32.2 8.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -68.24 -53.84 21.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.78 -53.31 20.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.14 -53.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -46.43 55.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.49 -32.67 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.853 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -51.46 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.62 -49.18 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.57 -36.21 79.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.33 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.18 -47.39 82.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.5 t -75.14 -37.45 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.98 -54.12 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.89 95.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.94 72.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -62.27 -54.73 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.417 HG21 HD21 ' B' ' 395' ' ' LEU . 65.8 m -56.71 -46.95 80.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.41 HD21 HG21 ' B' ' 394' ' ' THR . 34.2 mt -63.92 -35.73 81.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -71.12 -45.14 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -86.24 6.16 30.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.754 HD13 HD12 ' B' ' 398' ' ' LEU . 8.2 tp -80.44 -34.29 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.648 0.737 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -44.93 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.67 2.247 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -86.03 136.86 33.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.5 145.46 25.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -146.52 141.6 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.14 168.38 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.18 139.64 53.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.9 -25.45 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.94 151.56 44.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -97.41 160.1 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -78.5 112.81 15.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -154.85 135.29 13.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' B' ' 372' ' ' VAL . . . -60.39 121.64 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 370' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -108.19 -53.44 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 8.4 m -93.27 1.88 56.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.832 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 372' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' B' ' 369' ' ' ALA . 95.5 t -90.12 -65.65 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.682 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.0 t80 -68.62 -25.42 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' B' ' 370' ' ' GLY . . . -51.01 -29.55 12.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.21 65.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 376' ' ' ILE . . . . . 0.548 HD12 ' CE1' ' B' ' 373' ' ' TYR . 4.8 mt -82.62 -26.74 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.104 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' A' ' 377' ' ' LEU . 23.5 mt -62.56 -35.41 79.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 87.8 p -48.91 -32.3 8.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.34 -53.93 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.3 -53.09 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.32 55.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.46 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.878 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.39 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.71 -49.26 73.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.46 -36.11 79.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.53 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.92 -47.12 84.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.936 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.595 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.5 t -75.39 -37.78 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.63 -54.1 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.57 98.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.7 72.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.9 t -64.13 -54.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.41 HG21 HD21 ' A' ' 395' ' ' LEU . 32.9 m -56.28 -40.99 75.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.19 -39.28 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.2 m -67.45 -42.81 82.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.79 -21.64 66.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.754 HD12 HD13 ' A' ' 398' ' ' LEU . 10.1 tt -51.34 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.691 0.758 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 111.96 2.95 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.341 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -137.34 105.3 5.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.58 143.37 45.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -138.02 139.32 39.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -58.6 178.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 8.5 tp -140.34 125.11 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.74 151.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -75.86 111.21 10.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -165.23 162.32 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -92.03 106.86 18.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -157.44 179.53 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -75.47 166.81 23.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 126.78 54.75 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 p 51.62 27.93 4.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.07 -48.2 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.63 -30.36 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -62.87 -22.19 66.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -66.64 -23.4 72.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.36 -21.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 111.139 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt -65.1 -35.9 82.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 59.1 p -48.88 -33.38 10.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -66.93 -53.3 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.59 -52.64 24.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.42 -53.1 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.99 50.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.0 t80 -65.07 -32.82 74.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.14 -51.44 69.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.56 -49.03 75.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.66 -36.16 80.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.636 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.02 -34.43 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.16 -47.14 83.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.7 t -75.22 -37.52 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.01 -54.09 20.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.99 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.48 72.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.6 t -65.34 -54.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.558 HG21 HD21 ' B' ' 395' ' ' LEU . 25.6 m -55.21 -40.96 71.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.528 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -71.31 -46.0 61.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.69 -44.38 96.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.96 -23.08 65.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' B' ' 398' ' ' LEU . 14.8 tp -77.1 -27.53 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 21.7 tpt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.618 0.723 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 134.43 28.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.358 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -137.57 166.04 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -94.37 107.04 19.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -149.62 143.25 25.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -109.19 127.35 54.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 7.5 tp -142.19 108.58 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.11 133.84 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.14 146.87 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -113.4 167.53 10.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.113 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -145.09 112.68 6.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -121.66 104.73 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.56 103.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -133.29 -48.28 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -126.42 7.73 7.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.0 -65.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.26 -30.34 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.932 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.05 66.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -66.57 -21.91 71.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.36 -21.31 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 377' ' ' LEU . 19.2 mt -65.19 -35.66 81.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 90.7 p -48.97 -33.48 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.91 -53.24 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.52 -52.77 24.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.34 -53.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.65 52.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.445 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.1 t80 -65.49 -32.74 74.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -51.39 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.71 -48.97 74.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.67 -36.13 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.624 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.05 -34.3 45.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.22 -47.26 83.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.7 t -75.22 -37.43 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.97 -54.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.89 96.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.34 72.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 97.4 t -65.39 -54.92 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 395' ' ' LEU . 23.5 m -55.2 -40.9 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 394' ' ' THR . 32.7 mt -71.42 -46.12 60.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.62 -44.47 96.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.99 -23.08 65.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 398' ' ' LEU . 1.5 tt -51.86 -42.36 62.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.576 0.703 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 78.79 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.72 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.07 174.78 5.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.47 144.04 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.51 130.25 56.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.38 164.24 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.972 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.3 m -151.53 145.99 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -100.09 128.06 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -115.46 175.59 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.26 105.14 6.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLU . . . . . 0.715 ' O ' HG23 ' A' ' 372' ' ' VAL . 16.1 tt0 -154.78 157.69 38.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.1 25.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -64.94 -17.67 63.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -122.95 -3.45 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 368' ' ' GLU . 93.6 t -90.26 -65.05 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.3 -30.56 71.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.32 66.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.082 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.57 -25.32 70.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.47 -22.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt -65.26 -35.39 80.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.9 p -48.85 -33.48 10.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.46 -53.41 29.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.16 -52.71 25.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.496 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -63.56 -52.18 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.75 -47.72 52.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.2 t80 -65.25 -32.59 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -51.47 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.21 -49.27 74.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.03 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.73 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.92 -47.09 84.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.4 t -75.27 -38.23 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.28 -54.18 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.0 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.94 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.0 t -63.57 -54.82 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -56.19 -41.07 74.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.32 -36.36 71.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.22 -41.56 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.66 -23.11 66.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.735 HD13 ' CD1' ' B' ' 398' ' ' LEU . 7.6 tp -67.87 -35.51 78.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.621 0.724 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.94 112.61 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -69.06 122.71 19.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.58 117.09 12.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.65 169.13 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.83 106.9 18.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.53 138.31 42.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.13 133.03 54.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -120.1 141.71 49.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -136.19 107.18 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.33 -42.22 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -165.33 166.39 18.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 139.89 -90.53 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 29.4 p -106.39 0.23 24.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.377 . . . . 0.0 110.823 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 -65.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.71 -30.16 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.9 -23.66 66.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.12 -25.49 69.62 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.35 -22.78 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' A' ' 377' ' ' LEU . 22.2 mt -65.32 -35.5 81.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -48.81 -33.47 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.48 -53.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.24 -52.85 24.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.51 -52.14 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.76 -47.63 52.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.33 -32.53 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -51.51 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -49.23 75.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.09 80.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.2 -34.63 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.94 -47.36 83.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.625 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.2 t -74.98 -38.1 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.143 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.45 -54.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.03 92.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.05 71.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.625 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.6 t -61.6 -54.74 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.5 m -57.17 -46.78 82.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -34.56 78.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -72.21 -45.09 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -87.3 7.4 28.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.735 ' CD1' HD13 ' A' ' 398' ' ' LEU . 7.8 tp -76.59 -34.97 58.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 171.54 14.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.692 2.261 . . . . 0.0 112.323 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.85 160.71 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.85 174.58 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -100.58 162.9 12.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.7 158.73 18.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.5 pp -158.46 162.76 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.05 145.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -102.4 -37.72 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -54.65 166.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.57 113.06 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -164.6 161.79 21.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -66.21 -179.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 127.4 -100.74 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.5 p -97.99 3.83 49.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 110.889 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 24.7 t -90.03 -65.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.83 -31.02 68.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.73 66.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.53 -25.05 69.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.437 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.25 -22.85 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' B' ' 377' ' ' LEU . 22.8 mt -65.02 -36.67 85.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 77.5 p -48.94 -33.28 10.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -67.64 -53.46 27.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.38 -52.83 24.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.09 -52.45 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.107 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.15 53.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -65.86 -32.49 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.5 68.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.31 -49.22 74.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.07 80.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.16 -34.48 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.12 -47.24 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.16 -37.49 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.15 -54.03 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.31 96.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.63 72.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.9 t -63.69 -55.03 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.59 HG21 HD21 ' B' ' 395' ' ' LEU . 94.4 m -55.73 -46.24 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.163 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.541 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -64.09 -36.06 82.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.83 -44.69 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -86.41 5.82 33.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.953 HD12 HD12 ' B' ' 398' ' ' LEU . 1.1 tt -80.83 -35.97 32.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.604 0.716 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 136.09 32.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.738 2.292 . . . . 0.0 112.299 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 105.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.058 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -131.92 137.52 48.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -138.78 120.08 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -146.95 104.67 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 8.1 tp -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 29.0 m -68.36 142.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.29 111.97 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -138.04 106.15 5.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -81.9 -49.55 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 52.5 38.69 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -106.08 27.09 8.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.23 66.95 1.76 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.25 28.75 4.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 84.5 t -88.22 -46.79 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.24 -30.68 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.57 66.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.21 -25.8 71.26 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.24 -22.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.06 -36.37 84.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -49.01 -33.18 10.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -67.82 -53.37 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.44 -53.02 23.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.28 -52.61 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.97 54.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -65.98 -32.6 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.48 68.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.58 -49.05 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.8 -36.03 79.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.3 mm -73.09 -34.71 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.06 -46.99 84.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.27 -37.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -70.03 -54.13 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.73 96.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.43 72.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.0 t -65.22 -54.89 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.541 HG21 HD21 ' A' ' 395' ' ' LEU . 87.7 m -55.32 -40.96 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 394' ' ' THR . 32.4 mt -71.26 -45.84 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.93 -44.75 96.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -66.88 -22.99 65.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.953 HD12 HD12 ' A' ' 398' ' ' LEU . 7.0 tt -52.04 -60.34 3.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.58 0.705 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 113.85 3.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.47 133.76 42.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.095 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -140.04 176.45 8.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -142.28 144.3 33.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -151.83 163.17 39.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.15 149.1 52.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.06 149.96 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.94 126.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -170.71 171.0 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 171.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -172.65 168.6 5.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.4 ' H ' ' HB1' ' B' ' 369' ' ' ALA . . . -52.17 -76.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 89.95 -88.68 1.48 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 37.4 p -108.78 11.88 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 0.0 110.792 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.18 -65.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.663 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.0 t80 -68.97 -24.94 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.25 -28.76 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.2 -28.56 66.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.532 HD12 ' CE1' ' A' ' 373' ' ' TYR . 5.1 mt -83.0 -27.19 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.125 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' B' ' 377' ' ' LEU . 18.8 mt -59.84 -33.83 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 99.8 p -48.6 -32.25 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.99 -53.75 23.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.92 -53.1 20.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.92 -53.07 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.94 -46.74 55.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.626 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.1 t80 -66.11 -32.6 74.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -51.39 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.78 -49.12 74.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.1 79.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.7 45.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.93 -47.05 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 47.8 t -75.31 -37.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.137 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.67 -54.23 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.159 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.64 96.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.45 72.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -65.14 -54.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.592 HG21 HD21 ' B' ' 395' ' ' LEU . 50.3 m -55.7 -40.49 72.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.571 HD21 HG21 ' B' ' 394' ' ' THR . 32.1 mt -71.32 -37.97 71.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.4 m -68.93 -41.83 77.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -67.07 -22.99 65.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.493 HD12 HD13 ' B' ' 398' ' ' LEU . 10.3 tt -51.68 -52.61 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.615 0.721 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.37 16.77 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.728 2.285 . . . . 0.0 112.315 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . 59.94 37.21 21.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.02 147.48 41.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -136.85 143.11 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -118.41 135.67 54.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 363' ' ' LEU . . . . . 0.64 HD23 ' N ' ' B' ' 364' ' ' VAL . 3.3 tt -123.79 144.18 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 364' ' ' VAL . . . . . 0.64 ' N ' HD23 ' B' ' 363' ' ' LEU . 60.4 t -124.54 130.52 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -71.06 146.32 49.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.2 136.05 29.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.33 146.82 23.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -106.74 112.02 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.4 ' HB1' ' H ' ' A' ' 369' ' ' ALA . . . -124.38 8.33 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 370' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -120.89 -20.7 3.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 4.2 m -108.2 -4.42 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.2 -65.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.653 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.0 t80 -68.8 -24.4 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -50.88 -29.31 11.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.68 -28.75 65.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 376' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' B' ' 373' ' ' TYR . 5.1 mt -83.19 -27.44 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' A' ' 377' ' ' LEU . 20.2 mt -59.58 -33.61 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.6 p -48.6 -32.22 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.09 -53.84 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.01 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.01 -53.02 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.65 55.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.38 68.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.79 -49.09 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.05 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.21 -34.42 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.14 -47.07 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.569 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.6 t -75.39 -37.29 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.23 -54.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.58 97.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.5 72.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.3 t -64.81 -54.51 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.571 HG21 HD21 ' A' ' 395' ' ' LEU . 89.3 m -55.95 -40.72 73.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 394' ' ' THR . 32.0 mt -71.33 -40.3 70.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -66.49 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.91 -22.11 65.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 398' ' ' LEU . 37.8 tp -51.32 -32.5 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.647 0.737 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 170.08 17.39 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.313 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -107.26 178.55 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -132.91 107.8 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -90.61 150.73 21.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -127.48 130.22 48.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -148.46 144.81 27.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.9 m -151.32 174.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.28 -25.98 46.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 63.55 48.03 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.58 113.79 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 58.3 29.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -115.27 32.06 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 374' ' ' ALA . . . -131.33 -43.85 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.46 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.9 p -88.0 0.18 56.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.853 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 95.4 t -90.22 -65.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.681 ' CE1' HD11 ' B' ' 377' ' ' LEU . 1.9 t80 -68.23 -25.07 65.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 370' ' ' GLY . . . -50.68 -30.71 14.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.42 -28.3 61.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 373' ' ' TYR . 5.1 mt -82.61 -26.39 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.091 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' B' ' 377' ' ' LEU . 23.0 mt -63.73 -34.46 77.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.81 -32.42 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -68.23 -53.94 21.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.935 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.36 19.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.95 -52.94 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.93 -46.85 55.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.543 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.08 -32.63 74.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.46 68.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.76 -49.07 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.54 -36.08 79.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.18 -34.42 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.24 -47.2 83.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.5 t -75.12 -37.46 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.04 -53.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.19 93.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.1 71.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -61.19 -54.7 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 16.9 m -57.43 -48.42 79.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 394' ' ' THR . 34.4 mt -62.53 -37.23 85.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.6 m -70.08 -44.32 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.73 3.79 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.762 HD12 HD13 ' B' ' 398' ' ' LEU . 4.4 tp -71.09 -39.44 72.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.563 0.697 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 78.76 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -134.48 160.58 37.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -84.02 148.65 26.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -149.67 169.38 21.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.89 124.63 7.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 5.3 tp -93.61 151.02 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 364' ' ' VAL . . . . . 0.599 HG22 ' H ' ' B' ' 366' ' ' ALA . 7.2 p -149.95 126.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -113.46 27.84 9.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 366' ' ' ALA . . . . . 0.599 ' H ' HG22 ' B' ' 364' ' ' VAL . . . -79.48 -27.47 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.08 -58.17 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 51.72 51.51 16.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 54.09 57.67 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -99.79 -82.29 1.66 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.7 m -86.99 2.67 48.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.878 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 67.1 t -90.0 -65.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.529 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -68.48 -30.93 69.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.503 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -54.53 -28.29 44.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.29 -28.45 64.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.85 -24.56 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 377' ' ' LEU . 22.1 mt -65.78 -35.02 79.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.4 p -48.78 -32.57 8.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -68.04 -53.77 23.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.76 -53.19 21.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.503 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -53.04 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.381 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.85 -46.63 54.75 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -66.12 -32.79 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.45 68.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.61 -49.07 74.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.64 -36.3 80.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.05 -34.54 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.05 -47.19 84.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.585 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.4 t -75.24 -37.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -69.88 -54.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.84 97.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.88 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -63.87 -54.46 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 395' ' ' LEU . 60.3 m -56.38 -40.8 75.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.31 -34.4 70.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.2 m -72.53 -41.54 65.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -66.95 -23.06 65.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.762 HD13 HD12 ' A' ' 398' ' ' LEU . 15.5 tp -61.95 -36.47 81.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.914 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.602 0.715 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.91 7.63 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.341 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -78.13 151.55 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -135.53 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -167.57 157.1 10.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -146.85 163.58 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.26 168.88 18.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.866 HG21 HG21 ' B' ' 372' ' ' VAL . 29.1 t -137.87 139.72 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.16 153.18 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -103.99 30.71 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -80.87 -53.18 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 171.64 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 52.53 52.2 14.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -82.23 -86.31 0.74 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 19.8 p -102.49 5.94 39.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.93 -65.24 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' B' ' 377' ' ' LEU . 2.4 t80 -69.06 -31.29 69.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -56.71 -26.57 57.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.29 68.47 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.529 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.64 -24.46 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt -65.63 -36.64 84.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -49.12 -31.97 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.35 -53.78 21.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.929 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.97 -53.36 19.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.486 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.6 t -65.56 -53.35 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.112 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.15 -46.0 56.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.509 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.85 -32.67 74.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.55 68.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.52 -49.22 74.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.47 -36.29 80.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.2 -34.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.46 -47.27 84.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.9 t -75.34 -38.06 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.3 -54.39 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.52 97.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.089 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.44 72.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.2 t -64.59 -55.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.7 m -55.72 -40.49 72.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.14 -34.02 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.51 -39.39 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -66.69 -23.47 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.975 HD22 HD12 ' B' ' 398' ' ' LEU . 1.0 OUTLIER -103.69 -13.67 16.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.862 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 357' ' ' LEU . . . . . 0.411 HD23 ' HD2' ' B' ' 358' ' ' PRO . 1.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.644 0.735 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 358' ' ' PRO . . . . . 0.411 ' HD2' HD23 ' B' ' 357' ' ' LEU . 54.0 Cg_endo -69.74 148.77 65.92 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.71 23.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -107.27 178.07 4.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -110.17 128.88 55.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -60.52 -64.32 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 31.2 mt -102.39 175.69 5.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 33.4 m -91.39 -25.89 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -147.32 139.42 24.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -147.9 141.96 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -96.76 106.42 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.838 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.92 -26.48 34.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -155.99 105.95 2.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -167.96 -73.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.5 p -99.29 3.23 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 372' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 364' ' ' VAL . 98.3 t -90.08 -65.32 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.575 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -68.46 -27.97 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.424 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.37 -29.43 15.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.4 -28.22 64.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.46 -24.96 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' A' ' 377' ' ' LEU . 25.0 mt -65.31 -36.89 85.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.73 -31.75 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -68.33 -53.77 21.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.06 -53.67 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.31 -53.21 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.41 56.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.39 -32.71 74.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -51.51 68.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.75 -49.13 74.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.2 79.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.15 -34.52 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.87 -47.51 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.632 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.05 -37.64 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.71 -54.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.41 90.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.18 71.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.632 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -60.95 -54.42 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.3 m -57.82 -47.14 83.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.155 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.33 -34.42 78.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.7 m -72.38 -45.53 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -85.16 4.34 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.975 HD12 HD22 ' A' ' 398' ' ' LEU . 1.2 tt -76.16 -36.81 58.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.648 0.737 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 130.1 18.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.381 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -101.57 148.02 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -77.92 147.35 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -120.14 171.16 8.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -127.92 150.92 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 9.9 tp -84.85 133.42 34.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.567 HG22 ' H ' ' A' ' 366' ' ' ALA . 7.5 p -152.96 125.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.17 33.63 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.567 ' H ' HG22 ' A' ' 364' ' ' VAL . . . -111.76 -48.43 3.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.075 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.01 176.04 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 61.5 40.35 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.7 58.17 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.36 -65.12 1.06 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.459 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 26.7 p -105.71 6.65 32.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.825 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.63 -65.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.407 ' CE2' HD11 ' B' ' 377' ' ' LEU . 2.2 t80 -69.08 -30.86 69.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.24 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.86 -25.54 69.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.38 -23.04 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.099 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' B' ' 377' ' ' LEU . 24.9 mt -65.22 -36.58 84.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.0 p -49.15 -32.87 10.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.93 -53.56 25.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.48 -53.05 22.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.33 -52.84 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -46.87 54.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.6 t80 -66.0 -32.48 73.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -51.4 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.15 74.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.72 -36.23 80.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.15 -34.35 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.48 82.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -74.95 -37.57 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.89 -54.07 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.92 92.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.07 71.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.4 t -61.24 -54.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.1 m -57.55 -47.63 81.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.7 -35.41 80.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.34 -45.13 63.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -86.72 6.85 29.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.732 HD12 HD13 ' B' ' 398' ' ' LEU . 0.9 OUTLIER -80.0 -36.94 35.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.585 0.707 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 152.27 69.61 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.398 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -59.38 140.75 55.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -77.36 155.3 32.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.38 165.34 36.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -119.22 104.09 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 107.23 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.65 -35.94 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 52.59 47.55 24.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.01 155.29 18.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.39 150.28 24.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.46 163.71 37.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -69.17 165.32 20.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 136.34 -96.76 0.26 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.52 3.79 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.821 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 44.5 t -90.06 -65.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.103 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -69.0 -30.86 69.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.969 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.63 65.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.59 -25.44 68.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.488 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.26 -23.44 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' A' ' 377' ' ' LEU . 24.2 mt -65.07 -36.64 84.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -49.03 -32.91 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -68.01 -53.64 24.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.9 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.53 -53.04 22.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.4 t -64.37 -52.74 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 111.11 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -46.82 54.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.13 -32.55 74.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.51 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.44 -49.12 74.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.8 -36.14 80.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.23 -47.36 82.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.619 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.8 t -75.07 -37.45 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.97 -54.1 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.83 91.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.08 71.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.619 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -60.66 -54.41 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 47.0 m -58.13 -47.7 82.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -63.67 -34.97 79.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.11 -45.11 61.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.93 7.49 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.732 HD13 HD12 ' A' ' 398' ' ' LEU . 7.0 tp -78.37 -36.8 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.62 0.724 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 161.11 47.21 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -159.05 163.77 36.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.93 177.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -132.88 139.29 47.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.76 138.36 47.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 364' ' ' VAL . 1.8 tt -132.95 141.03 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' VAL . . . . . 0.485 ' N ' HD23 ' A' ' 363' ' ' LEU . 10.8 p -115.53 151.67 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -138.7 147.68 43.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.72 176.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.95 115.01 8.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.1 175.23 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.84 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -171.53 -71.56 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.523 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 24.8 p -104.91 5.44 32.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.39 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 45.7 t -89.98 -65.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.54 -31.09 69.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.88 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.14 -25.2 69.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.42 -23.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.1 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt -64.81 -36.74 85.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.7 p -49.19 -33.37 12.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.52 -53.38 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.46 -52.99 23.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.7 t -63.67 -52.86 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.66 -47.37 52.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -65.53 -32.62 74.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -51.49 68.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.54 -49.0 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.79 -36.3 80.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.13 -34.69 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.84 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.1 t -75.38 -37.85 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.55 -54.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.074 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.16 70.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.0 t -62.94 -54.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.9 m -56.4 -41.13 75.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.3 -33.8 70.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.88 -55.98 6.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -66.61 -14.0 61.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' B' ' 398' ' ' LEU . 5.1 tp -67.16 -63.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 357' ' ' LEU . . . . . 0.461 HD23 ' HD2' ' B' ' 358' ' ' PRO . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.618 0.723 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 358' ' ' PRO . . . . . 0.461 ' HD2' HD23 ' B' ' 357' ' ' LEU . 53.9 Cg_endo -69.69 132.21 22.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.72 20.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.063 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.34 170.33 10.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.78 -49.24 69.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.66 177.22 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 46.4 mt -77.27 -46.45 23.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.9 160.9 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -164.21 156.05 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -169.72 145.79 3.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -102.2 120.0 39.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -146.86 179.72 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -104.0 34.16 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -77.39 -74.47 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 25.4 p -104.24 4.42 33.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 41.9 t -89.93 -65.23 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.99 -31.26 69.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.4 -23.78 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.27 -25.03 69.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.41 -22.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 111.145 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' A' ' 377' ' ' LEU . 22.6 mt -65.11 -36.58 84.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 93.5 p -48.96 -33.29 10.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.65 -53.29 29.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.46 -52.9 23.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.48 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.87 -52.9 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.25 53.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -65.54 -32.63 74.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.45 68.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.6 -49.07 74.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.16 80.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.3 -34.68 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.79 -47.07 85.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.4 t -75.38 -38.08 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.3 -54.17 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.31 98.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.21 -50.5 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.599 HG23 ' O ' ' B' ' 389' ' ' VAL . 87.5 t -64.44 -54.92 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.5 m -55.75 -40.89 73.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.3 -42.26 68.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -63.33 -54.18 41.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -66.71 -13.68 61.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.564 ' CD2' HD13 ' A' ' 398' ' ' LEU . 2.8 tt -55.8 -51.73 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.636 0.731 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 132.7 23.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.716 2.278 . . . . 0.0 112.381 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.28 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -138.5 159.3 42.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -150.37 149.58 30.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.57 172.57 12.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 12.4 mt -137.3 114.15 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 32.4 m -143.74 164.07 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -64.63 130.44 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -167.61 -177.4 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -161.28 109.95 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -147.89 111.23 4.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -159.3 87.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -127.32 -84.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.454 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -92.48 4.23 53.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 32.5 t -90.18 -65.46 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.72 -28.77 66.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -57.14 -26.62 60.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.88 -25.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.473 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.44 -24.58 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.374 . . . . 0.0 111.158 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' B' ' 377' ' ' LEU . 20.7 mt -65.66 -33.58 76.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 86.4 p -48.38 -33.8 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -66.96 -53.81 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.9 -52.72 27.08 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -62.72 -51.37 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.54 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.3 t80 -64.44 -32.61 74.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.54 68.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.33 -49.22 74.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.68 -36.08 79.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.24 -34.31 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.25 -47.1 83.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -37.43 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.07 -54.12 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.23 97.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.58 72.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.66 -54.52 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.578 HG21 HD21 ' B' ' 395' ' ' LEU . 26.1 m -55.92 -41.01 73.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.6 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.16 -41.31 70.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.44 -43.38 90.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -67.05 -23.2 65.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.872 HD12 HD13 ' B' ' 398' ' ' LEU . 1.6 tt -72.42 -30.06 64.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.663 0.744 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 129.44 17.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.325 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -102.8 114.86 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -149.8 167.36 26.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.38 113.1 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -136.77 132.54 34.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.57 146.73 28.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.25 146.92 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.82 -46.76 14.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -61.17 160.51 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.23 161.01 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -155.41 150.92 27.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -167.58 101.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.54 69.99 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.425 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.26 28.62 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 -65.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.82 -28.75 65.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.37 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.13 -25.81 64.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.42 -24.4 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 377' ' ' LEU . 20.6 mt -65.54 -33.56 76.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 84.0 p -48.4 -33.9 9.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -66.88 -53.74 29.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.79 -52.67 27.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.0 t -62.59 -51.36 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 111.126 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.83 -48.3 51.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -64.54 -32.6 74.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -51.64 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.2 -49.16 75.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.78 -36.11 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.26 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.29 -47.05 83.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.37 -37.36 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.18 -54.06 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.7 96.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.51 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.9 t -64.98 -54.72 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.6 HG21 HD21 ' A' ' 395' ' ' LEU . 91.4 m -55.54 -40.89 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.25 -44.08 66.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.74 -43.89 97.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.93 -23.14 65.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.872 HD13 HD12 ' A' ' 398' ' ' LEU . 16.2 tp -75.31 -36.38 61.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.132 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.27 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.71 166.01 13.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.093 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.42 178.13 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.96 105.38 16.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -114.91 177.07 4.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.59 121.42 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.05 172.43 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -80.04 153.75 28.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ALA . . . . . 0.666 ' HB3' ' N ' ' B' ' 367' ' ' ASP . . . -175.84 177.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.39 41.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.43 96.54 2.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -147.18 93.19 2.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.079 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -139.44 -68.71 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.1 m -109.86 2.95 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.07 -65.42 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.402 ' CE1' HD12 ' A' ' 376' ' ' ILE . 1.9 t80 -70.08 -28.89 65.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.81 -25.43 55.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.2 -26.19 67.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.402 HD12 ' CE1' ' A' ' 373' ' ' TYR . 5.1 mt -82.34 -23.64 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt -65.86 -33.12 75.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -33.54 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.11 -53.93 26.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.06 -52.91 25.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.7 t -62.89 -51.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.125 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -48.52 51.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -64.46 -32.58 74.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.6 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.11 -49.27 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.77 -36.06 79.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.24 -34.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.13 -47.35 83.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.9 t -75.0 -37.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.54 -53.96 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.9 91.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.18 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 389' ' ' VAL . 88.9 t -61.43 -54.94 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.5 m -57.02 -47.14 81.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -63.96 -35.3 80.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -71.36 -45.18 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -86.56 6.46 30.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.702 ' CD1' HD13 ' B' ' 398' ' ' LEU . 13.7 tp -79.78 -35.01 39.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.935 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.624 0.726 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 107.51 1.88 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -165.57 162.78 19.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -68.74 146.69 52.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.85 134.9 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.87 163.41 13.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 363' ' ' LEU . . . . . 0.417 ' O ' HD12 ' B' ' 363' ' ' LEU . 3.2 pp -75.78 129.42 37.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.93 147.07 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.23 133.21 52.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -107.39 141.15 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 367' ' ' ASP . . . . . 0.666 ' N ' ' HB3' ' A' ' 366' ' ' ALA . 2.9 t0 -60.31 -172.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -130.88 -173.88 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' B' ' 372' ' ' VAL . . . -51.44 -69.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 97.18 -65.34 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.527 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -132.07 7.45 4.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.893 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 372' ' ' VAL . . . . . 0.428 ' HB ' ' HB1' ' B' ' 369' ' ' ALA . 21.5 t -90.1 -65.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.425 ' CE1' HD12 ' B' ' 376' ' ' ILE . 1.9 t80 -70.11 -28.81 65.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.82 -25.29 55.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.134 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.6 -25.72 67.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 376' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' B' ' 373' ' ' TYR . 5.0 mt -82.31 -23.43 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' A' ' 377' ' ' LEU . 21.0 mt -65.86 -33.23 75.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 70.5 p -48.58 -33.46 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.26 -54.03 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.05 -52.82 25.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.05 -51.33 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.35 51.23 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -64.75 -32.56 74.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.5 68.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.25 -49.16 75.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.92 -35.96 79.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.34 -34.59 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.99 -47.07 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.5 t -75.24 -38.18 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.4 -54.24 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.9 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.73 72.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -63.65 -54.66 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 22.8 m -56.36 -41.15 75.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.19 -36.47 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.08 -41.8 73.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -66.71 -22.96 66.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 398' ' ' LEU . 7.5 tp -68.08 -37.63 81.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.985 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.628 0.728 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -173.32 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -168.01 160.42 12.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.48 145.74 31.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -151.69 167.59 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 362' ' ' GLU . . . . . 0.549 ' C ' HD12 ' A' ' 363' ' ' LEU . 12.6 mp0 -111.14 164.99 12.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 362' ' ' GLU . 5.4 mp -150.38 173.58 13.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.89 151.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 166.17 25.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.58 178.85 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.8 120.37 39.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -156.32 159.64 38.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 51.93 46.58 26.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 374' ' ' ALA . . . -93.31 -39.68 5.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 16.6 p -99.3 -0.22 41.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.844 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 91.7 t -90.12 -65.43 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.56 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.2 t80 -69.06 -25.42 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.45 -28.17 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.98 -28.44 70.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.89 -27.54 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.349 . . . . 0.0 111.141 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 374' ' ' ALA . 19.7 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.4 p -48.64 -31.7 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.43 -53.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.07 -53.63 17.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.46 -53.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.26 55.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.498 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.0 t80 -66.65 -32.7 74.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.49 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.55 -49.27 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.56 -36.16 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.15 -34.53 45.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.91 -47.53 82.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.3 t -75.01 -37.77 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.62 -54.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.61 91.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.2 71.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -61.19 -54.52 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 84.8 m -57.59 -47.31 82.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.96 -34.9 79.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.96 -44.95 62.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -87.61 7.9 27.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.76 HD12 HD13 ' B' ' 398' ' ' LEU . 0.8 OUTLIER -78.41 -28.44 46.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.962 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.645 0.736 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 128.25 15.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -117.84 139.63 50.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.87 107.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -136.2 116.49 13.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -152.66 140.37 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.88 122.44 34.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.14 137.68 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.152 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -131.58 133.6 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.39 114.22 4.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -115.27 114.74 25.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.87 -28.74 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -129.68 103.46 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . 165.21 -35.41 0.26 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.456 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 25.4 p -103.49 1.35 32.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.22 -65.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.564 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.1 t80 -69.01 -25.68 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.46 -28.31 12.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.5 70.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.447 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.75 -27.44 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 377' ' ' LEU . 20.4 mt -57.48 -35.39 70.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 95.5 p -48.74 -31.67 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -68.48 -53.61 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.93 -53.68 18.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.514 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.51 -53.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.12 56.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.81 -32.65 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.62 -49.11 74.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.66 -36.17 80.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.15 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.9 -47.44 83.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 47.6 t -74.97 -37.91 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.52 -54.1 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.72 91.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.23 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 84.7 t -60.99 -54.66 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 24.4 m -57.55 -47.33 82.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.16 -45.19 61.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -87.49 7.9 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.76 HD13 HD12 ' A' ' 398' ' ' LEU . 7.6 tp -77.64 -37.01 50.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 179.932 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 175.55 7.94 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.68 2.253 . . . . 0.0 112.372 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -152.95 169.87 21.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -99.9 179.48 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -134.69 168.92 18.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.59 167.17 31.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.87 169.45 17.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.5 151.71 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -87.56 113.36 23.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.66 137.02 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -148.47 117.71 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -115.3 -25.51 7.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -57.51 98.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.116 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.98 80.65 0.58 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.29 28.64 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.84 -65.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.611 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.4 t80 -68.87 -25.7 64.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.17 -28.87 12.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.43 -28.28 67.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.524 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.8 -27.72 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' B' ' 377' ' ' LEU . 20.0 mt -58.79 -35.49 72.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 95.7 p -48.59 -31.81 7.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.42 -53.72 21.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.902 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.59 18.28 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.45 -53.13 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.04 56.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -66.76 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.43 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.833 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.82 -49.11 74.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.08 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.96 -47.11 84.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.28 -37.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.09 -54.24 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.39 96.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.69 72.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.63 -54.43 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.437 HG21 HD21 ' B' ' 395' ' ' LEU . 29.5 m -56.05 -40.82 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -71.26 -40.55 70.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.8 m -66.13 -43.32 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -66.92 -23.13 65.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.817 HD13 ' HG ' ' B' ' 398' ' ' LEU . 18.1 tp -71.83 -26.05 62.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.948 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 166.23 28.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.252 . . . . 0.0 112.385 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -112.78 118.57 35.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -54.43 126.76 24.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -164.85 156.62 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -71.29 -67.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 31.2 mt -148.7 161.29 42.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 59.9 t -148.38 111.93 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -157.82 127.61 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -81.96 -66.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.81 153.89 50.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -175.15 155.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -52.14 102.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 370' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -169.77 -72.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.529 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 5.1 p -96.56 1.88 51.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 110.858 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.11 -65.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.634 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -68.76 -26.35 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.622 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.43 -28.77 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.19 -28.5 66.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.475 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.84 -27.55 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.377 . . . . 0.0 111.135 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 377' ' ' LEU . 20.7 mt -59.53 -35.32 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.6 -31.86 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.37 -53.68 22.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.7 17.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.27 -53.14 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.32 55.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.8 t80 -66.53 -32.66 74.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.52 68.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.59 -49.19 74.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.62 -35.99 79.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.87 -47.24 84.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.24 -37.52 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.99 -54.11 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.65 96.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 389' ' ' VAL . 99.4 t -63.32 -54.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 395' ' ' LEU . 36.8 m -56.13 -45.97 79.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.437 HD21 HG21 ' A' ' 394' ' ' THR . 33.4 mt -64.65 -34.55 78.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.39 -44.72 62.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.18 6.91 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.817 ' HG ' HD13 ' A' ' 398' ' ' LEU . 0.9 OUTLIER -76.66 -34.96 58.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.847 179.946 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.603 0.716 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 165.27 31.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.735 2.29 . . . . 0.0 112.365 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -157.81 168.52 26.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.38 178.15 8.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -156.31 139.64 15.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -99.73 153.01 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 10.2 mt -144.95 141.81 29.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 26.7 m -57.88 -178.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -108.43 112.64 25.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.47 107.8 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -130.09 110.73 11.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -84.66 -59.43 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.79 103.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -109.0 -54.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.2 m -115.34 13.91 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.888 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 86.2 t -90.0 -65.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.633 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.2 t80 -69.09 -24.77 64.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 374' ' ' ALA . . . . . 0.658 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.36 -28.67 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.55 -28.55 67.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 376' ' ' ILE . . . . . 0.478 HD12 ' CE1' ' A' ' 373' ' ' TYR . 4.9 mt -82.95 -27.41 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' B' ' 377' ' ' LEU . 19.7 mt -59.11 -34.62 72.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.0 p -48.45 -31.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -68.44 -53.63 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.74 -53.72 18.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.23 -52.83 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -45.83 56.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -67.02 -32.64 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.48 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.66 -49.29 73.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.39 -36.01 79.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.22 -34.52 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.07 -47.07 84.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -75.33 -37.34 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.17 -54.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.05 -45.05 94.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.43 -50.39 71.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.2 t -66.09 -55.01 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.632 HG21 HD21 ' B' ' 395' ' ' LEU . 85.6 m -54.73 -40.15 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.591 HD21 HG21 ' B' ' 394' ' ' THR . 31.3 mt -71.06 -34.09 70.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -73.55 -39.16 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.0 -23.45 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 398' ' ' LEU . 1.1 pp -104.4 -11.44 17.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 179.961 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 135.58 30.8 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.253 . . . . 0.0 112.375 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -94.4 162.12 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.083 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.31 132.24 17.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -142.89 131.63 22.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -146.4 129.32 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 pp -163.65 155.89 17.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.3 148.43 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.45 153.88 50.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.61 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.68 -65.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -155.26 115.17 3.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -121.33 12.13 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 370' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -122.68 -27.87 1.52 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.9 p -96.25 -0.66 49.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.873 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.16 -65.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 373' ' ' TYR . . . . . 0.644 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -68.56 -24.91 64.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 374' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -50.85 -29.57 12.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.45 -28.62 65.11 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 376' ' ' ILE . . . . . 0.47 HD12 ' CE1' ' B' ' 373' ' ' TYR . 5.0 mt -83.14 -27.35 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' A' ' 377' ' ' LEU . 19.7 mt -60.11 -34.06 72.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.3 p -48.67 -32.19 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -68.24 -53.79 22.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.81 -53.39 19.87 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.452 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.36 -53.08 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.95 56.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -66.9 -32.74 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.895 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.45 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.68 -49.13 74.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.53 -36.14 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.615 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.17 -34.44 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.11 -46.99 84.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.5 -37.27 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.103 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -70.28 -54.15 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.28 93.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.33 71.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.0 t -66.34 -55.03 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.591 HG21 HD21 ' A' ' 395' ' ' LEU . 61.4 m -54.63 -39.92 68.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.796 ' HA ' HD23 ' B' ' 398' ' ' LEU . 31.1 mt -71.26 -34.64 70.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.7 m -73.31 -38.24 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -67.58 -23.37 65.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' B' ' 395' ' ' LEU . 0.4 OUTLIER -74.39 -25.28 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.959 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 169.09 19.72 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.343 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -147.68 155.25 41.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.99 177.68 5.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -152.25 169.02 23.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -81.67 172.63 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.636 HD22 ' OE2' ' B' ' 368' ' ' GLU . 7.0 mt -112.05 174.55 5.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 19.7 m -104.4 176.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -112.45 111.51 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.19 14.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.116 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.21 102.4 7.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -147.83 153.75 39.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 373' ' ' TYR . . . 59.09 40.86 21.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.02 -80.85 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.7 p -84.87 3.3 38.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.04 -65.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.591 ' HB2' ' HB1' ' A' ' 369' ' ' ALA . 2.0 t80 -68.9 -29.93 68.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -58.14 -27.67 63.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.063 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.18 -25.39 62.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.463 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.45 -25.07 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt -65.53 -34.2 77.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.963 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 92.1 p -48.6 -33.87 10.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.849 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -66.93 -53.47 31.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.87 -52.6 27.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -62.85 -51.39 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.849 0.357 . . . . 0.0 111.12 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.4 51.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -64.51 -32.63 74.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 0.0 110.853 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.67 67.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.1 -49.31 74.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.11 79.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.31 -34.59 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.88 -47.16 84.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.1 t -75.3 -38.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.34 -54.22 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.04 97.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.66 72.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.077 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 389' ' ' VAL . 86.8 t -64.03 -54.74 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 42.2 m -56.16 -41.01 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.21 -38.97 72.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.59 -42.41 82.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -66.53 -23.03 66.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.724 HD13 ' CD1' ' B' ' 398' ' ' LEU . 6.5 tp -71.38 -62.69 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 179.97 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.633 0.73 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.94 17.49 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.354 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -121.38 156.59 32.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -162.74 170.78 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.49 162.58 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -148.61 141.9 25.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 4.2 pp -159.39 166.94 30.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.9 m -152.3 126.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -146.83 141.04 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.94 157.26 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.81 179.08 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 368' ' ' GLU . . . . . 0.636 ' OE2' HD22 ' A' ' 363' ' ' LEU . 41.4 tt0 -85.05 98.05 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -142.76 118.07 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 157.34 -58.1 0.36 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.1 m -99.24 2.65 45.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.15 -65.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.93 -30.15 68.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.65 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.51 -24.92 62.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.36 -25.03 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 377' ' ' LEU . 19.9 mt -65.35 -34.36 78.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -48.57 -33.81 10.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.0 -53.48 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.87 -52.65 27.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.474 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -62.89 -51.62 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -48.2 51.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.0 t80 -64.73 -32.47 74.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.57 68.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.13 -49.21 75.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.74 -36.38 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.42 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.97 -47.48 83.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.03 -37.84 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.61 -53.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.72 91.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.2 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.8 t -61.25 -54.66 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 39.3 m -57.4 -47.1 82.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.26 -35.77 81.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.87 -45.09 65.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -86.11 5.42 33.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.724 ' CD1' HD13 ' A' ' 398' ' ' LEU . 6.8 tp -80.26 -36.83 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.561 0.696 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 158.6 56.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.671 2.247 . . . . 0.0 112.376 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -154.4 140.21 18.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -154.55 166.15 34.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.08 172.1 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.42 172.34 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.31 170.68 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.05 176.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.18 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -125.48 175.1 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -132.72 175.62 9.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.51 176.0 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 57.25 -171.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 369' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' B' ' 369' ' ' ALA . . . 62.94 53.55 2.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -97.43 -75.28 1.23 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.441 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 84.8 p -90.07 2.08 55.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.02 -63.83 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.46 -29.98 68.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.63 65.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.63 -24.61 66.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.55 -23.7 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 111.112 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' B' ' 377' ' ' LEU . 22.2 mt -65.39 -34.75 79.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.939 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 94.3 p -48.78 -33.68 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.28 -53.53 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.04 -52.82 25.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -63.18 -51.83 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.35 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.96 51.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -64.88 -32.65 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.4 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.75 -49.28 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.34 -36.3 79.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 9.1 mm -73.33 -34.35 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.81 -47.29 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 389' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.5 t -75.43 -37.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.35 -53.93 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.27 98.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.34 -48.33 79.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 393' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 389' ' ' VAL . 93.3 t -66.6 -55.09 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 394' ' ' THR . . . . . 0.566 HG21 HD21 ' B' ' 395' ' ' LEU . 35.6 m -55.71 -41.12 73.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 395' ' ' LEU . . . . . 0.577 HD21 HG21 ' B' ' 394' ' ' THR . 35.5 mt -71.4 -51.74 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -89.22 -2.81 58.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 398' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' B' ' 398' ' ' LEU . 0.3 OUTLIER -64.97 -25.37 67.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.881 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 179.97 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.549 0.69 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 115.37 4.05 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.682 2.255 . . . . 0.0 112.406 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -132.39 165.23 24.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.092 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -155.15 133.8 11.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -136.36 167.36 21.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -147.77 156.83 43.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 13.4 tp -88.63 130.24 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 39.5 t -146.28 123.68 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -122.25 137.66 54.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -126.08 110.62 13.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -149.57 116.89 6.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.39 175.98 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 369' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' A' ' 369' ' ' ALA . . . -52.25 107.47 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -125.39 -47.82 0.21 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 14.7 m -109.26 2.6 20.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 22.6 t -90.2 -65.38 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.03 -30.25 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.37 65.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.31 -25.6 68.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.52 -23.23 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 111.131 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' A' ' 377' ' ' LEU . 21.9 mt -65.34 -35.2 80.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.4 p -48.6 -33.68 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.36 -53.56 28.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.01 -52.96 25.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 381' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -63.22 -51.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.83 52.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.02 -32.63 74.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.46 68.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.7 -49.34 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.23 -36.45 79.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 9.0 mm -73.2 -34.18 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.07 -47.3 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 389' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.4 t -75.38 -37.32 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.03 -54.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.58 97.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.45 72.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 393' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -65.11 -54.93 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 394' ' ' THR . . . . . 0.577 HG21 HD21 ' A' ' 395' ' ' LEU . 61.7 m -55.33 -40.99 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 395' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.33 -44.18 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -62.42 -43.63 98.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.73 -22.92 66.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 398' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 398' ' ' LEU . 1.7 tt -76.4 -36.27 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.769 0.318 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.85 -31.36 7.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.42 -53.76 21.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.13 -53.64 17.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.64 -53.37 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.11 -46.49 56.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.3 -32.74 74.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.48 68.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.95 -49.26 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.23 -36.25 79.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.15 -34.43 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.93 -47.2 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.1 t -75.42 -37.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.72 -54.18 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.96 -50.44 72.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.4 t -65.32 -54.99 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.176 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.498 HG21 HD21 ' B' ' 395' ' ' LEU . 21.3 m -55.11 -41.1 71.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.533 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.27 -46.41 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.33 -44.4 95.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.88 0.372 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' A' ' 377' ' ' LEU . 22.0 mt -65.76 -36.43 83.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.9 p -48.74 -31.56 7.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.26 -53.74 22.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.21 -53.77 16.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.441 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.4 -53.33 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.2 -46.55 56.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.3 t80 -66.22 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -51.45 68.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.94 -49.23 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.26 -36.26 79.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.14 -34.57 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.75 -47.21 84.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.3 t -75.39 -37.68 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -69.6 -54.2 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.48 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.29 72.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -65.48 -55.06 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.533 HG21 HD21 ' A' ' 395' ' ' LEU . 31.7 m -55.07 -41.03 71.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.498 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.33 -46.93 59.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.0 m -59.79 -44.55 93.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.863 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' B' ' 377' ' ' LEU . 25.5 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.798 0.332 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.4 p -48.75 -31.9 7.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.4 -53.79 21.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.71 17.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.23 -53.01 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.117 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.3 55.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.51 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -51.29 69.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.1 -49.16 73.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.34 -36.07 79.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.57 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.04 -47.02 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.33 -37.61 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.05 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.7 96.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.45 72.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.1 t -65.23 -54.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.499 HG21 HD21 ' B' ' 395' ' ' LEU . 14.2 m -55.27 -40.92 71.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.51 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.33 -45.23 63.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.6 m -61.52 -44.18 97.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.844 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' A' ' 377' ' ' LEU . 20.9 mt -65.81 -35.69 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.5 p -48.93 -32.11 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.4 -53.88 20.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.79 -53.22 20.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.529 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.52 -53.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -45.98 56.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.94 -32.73 74.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -51.47 68.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.82 -49.08 74.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.58 -36.11 79.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.29 -34.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.93 -47.22 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.563 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.3 t -75.37 -37.26 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.19 -54.1 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.78 96.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.07 -50.42 72.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.9 t -65.37 -54.82 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.51 HG21 HD21 ' A' ' 395' ' ' LEU . 18.6 m -55.3 -40.97 71.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.31 -45.58 62.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -61.21 -44.44 97.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.835 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' B' ' 377' ' ' LEU . 22.5 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.832 0.349 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 81.9 p -48.9 -33.52 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.3 -53.39 30.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.22 -52.73 25.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -63.64 -52.49 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.19 53.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.4 t80 -65.69 -32.62 74.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.391 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.43 68.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.14 74.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -61.71 -36.17 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.17 -34.45 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.12 -47.08 84.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.34 -37.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.1 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.5 97.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.35 73.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -65.33 -54.84 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.605 HG21 HD21 ' B' ' 395' ' ' LEU . 85.2 m -55.33 -41.03 71.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.563 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.27 -46.19 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.9 m -60.55 -44.54 96.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.866 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.361 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' A' ' 377' ' ' LEU . 22.5 mt -65.17 -36.19 83.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.7 p -48.93 -33.4 10.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.54 -53.53 27.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.948 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.2 -52.68 26.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -63.88 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -47.28 53.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.1 t80 -65.72 -32.6 74.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.41 69.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.47 -49.16 74.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.71 -36.13 80.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.19 -34.67 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.97 -47.04 84.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.4 t -75.29 -37.85 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.62 -54.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.63 96.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.41 72.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.4 t -65.35 -55.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.563 HG21 HD21 ' A' ' 395' ' ' LEU . 26.1 m -55.02 -41.01 70.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.175 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.605 HD21 HG21 ' A' ' 394' ' ' THR . 33.2 mt -71.29 -46.7 60.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -60.06 -44.52 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 38.0 mmt-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' B' ' 377' ' ' LEU . 22.9 mt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.831 0.348 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.0 p -49.12 -33.29 11.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -67.43 -53.51 28.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.25 -52.74 25.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.85 -52.51 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.28 53.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -65.58 -32.6 74.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.39 68.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.42 -49.14 74.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.06 80.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.19 -34.37 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.29 -47.17 83.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.26 -37.14 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.34 -54.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.74 96.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.94 72.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 389' ' ' VAL . 94.1 t -62.74 -54.8 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.096 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.45 HG21 HD21 ' B' ' 395' ' ' LEU . 26.6 m -56.36 -46.63 79.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.434 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -64.09 -36.0 82.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -70.81 -44.81 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.835 0.35 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.11 -36.75 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.3 p -49.28 -33.03 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.94 -53.27 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.39 -52.78 24.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.465 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.24 -52.61 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.71 -47.08 53.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.459 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.625 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.03 -32.57 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.41 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.61 -49.16 74.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.66 -36.08 79.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.176 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.06 -47.13 84.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.2 t -75.36 -37.37 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.18 -54.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.39 97.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.6 72.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.5 t -64.69 -54.58 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.434 HG21 HD21 ' A' ' 395' ' ' LEU . 19.9 m -55.85 -41.08 73.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.45 HD21 HG21 ' A' ' 394' ' ' THR . 32.8 mt -71.1 -42.35 69.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.32 -43.7 93.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.875 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 24.1 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.851 0.357 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.4 p -48.99 -32.09 8.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.12 -54.01 21.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.37 19.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.23 -53.15 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.125 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.54 55.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -66.3 -32.68 74.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.41 69.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.01 -49.07 73.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.5 -36.12 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.07 -34.52 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.01 84.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.33 -37.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.07 -54.07 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.53 97.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.55 72.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.8 t -64.96 -54.71 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.513 HG21 HD21 ' B' ' 395' ' ' LEU . 87.0 m -55.54 -41.02 72.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.18 -43.79 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.84 -44.0 97.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.885 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.79 -35.52 80.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.9 p -48.89 -32.29 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.2 -53.92 21.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.32 19.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.19 -53.02 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -46.49 55.93 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -66.44 -32.56 74.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.41 -51.47 68.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.52 -49.2 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.64 -35.97 79.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.31 -34.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.26 -47.23 83.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.22 -37.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.35 -54.1 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.22 96.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.77 72.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 389' ' ' VAL . 95.2 t -63.58 -54.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 86.5 m -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 394' ' ' THR . 32.9 mt -64.32 -34.7 78.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -72.27 -44.57 62.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.842 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 25.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.781 0.324 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 90.9 p -49.48 -31.88 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -68.44 -53.88 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.83 -53.27 20.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.3 t -65.48 -53.14 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.23 55.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.71 -32.71 74.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.898 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -51.5 68.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.4 -49.35 74.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.8 mm -73.17 -35.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.2 -47.15 85.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.26 -39.25 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.133 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -68.05 -54.11 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.04 96.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.27 73.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.6 t -64.91 -55.13 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 5.8 m -55.4 -41.16 72.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.21 -44.5 65.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.03 -43.87 97.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.9 0.381 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 24.6 mt -65.52 -37.07 85.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 96.5 p -49.34 -32.04 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -68.41 -53.89 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.86 -53.23 20.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -53.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.04 -46.11 56.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.77 -32.6 74.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.374 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.41 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.33 -49.21 74.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.82 -36.14 80.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.17 -34.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.87 -47.48 83.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.1 t -75.03 -37.84 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.5 -53.96 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.31 90.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.81 72.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 88.3 t -61.16 -54.45 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.4 m -57.92 -48.5 79.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -38.34 90.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.6 m -68.87 -44.66 72.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' B' ' 377' ' ' LEU . 23.8 mt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.813 0.339 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.1 p -49.1 -33.03 10.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.91 -53.33 27.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.41 -52.87 24.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.4 -52.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.129 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.72 -47.1 53.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.638 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.3 t80 -66.06 -32.55 74.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.35 . . . . 0.0 110.843 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.5 68.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.32 -49.14 75.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.95 -36.08 80.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.76 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.99 -47.02 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.25 -38.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.5 t -69.43 -54.23 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.0 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -51.01 71.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -63.63 -54.82 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -56.13 -41.03 74.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.27 -35.85 71.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.71 -41.53 71.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.866 0.365 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.29 -36.33 83.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.4 p -49.12 -33.04 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.851 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.95 -53.67 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.47 -52.98 23.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.443 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.2 t -64.3 -52.69 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.88 54.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -65.96 -32.56 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -51.46 68.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.89 -49.29 75.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -62.03 -36.04 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.2 mm -73.05 -34.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -63.0 -47.25 83.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.622 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.6 t -75.03 -38.07 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.55 -53.99 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.19 92.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.03 71.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.5 t -61.59 -54.65 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 28.5 m -57.34 -46.83 82.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.3 -34.76 78.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.12 -44.77 62.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.806 0.336 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.3 p -48.5 -31.97 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.29 -53.62 23.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.67 17.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.45 -53.21 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.139 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.23 55.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.7 t80 -66.7 -32.64 74.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.35 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.83 -49.2 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.47 -36.09 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.633 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.32 -34.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -47.11 84.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.6 t -75.38 -37.66 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -69.79 -54.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.23 97.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.84 71.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.4 t -64.39 -54.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.512 HG21 HD21 ' B' ' 395' ' ' LEU . 60.4 m -55.59 -40.78 72.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.41 -40.58 70.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.0 m -64.73 -54.19 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' A' ' 377' ' ' LEU . 21.5 mt -62.37 -35.73 80.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 80.2 p -48.62 -31.79 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.35 -53.61 22.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.97 -53.67 17.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.44 -53.25 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -46.06 56.13 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.75 -32.73 74.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.395 . . . . 0.0 110.894 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.34 69.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.82 -49.32 73.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.28 -36.31 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.618 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.12 -34.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.02 -47.13 84.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.58 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.46 -37.3 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.0 t -70.12 -54.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.13 98.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.28 -50.87 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.0 t -64.15 -54.57 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.501 HG21 HD21 ' A' ' 395' ' ' LEU . 87.1 m -56.1 -40.72 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.199 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.43 -36.7 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -70.05 -41.98 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.854 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.842 0.353 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.8 p -48.85 -33.22 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.53 -53.84 25.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.24 -52.93 24.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.3 t -63.66 -51.65 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.9 52.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -65.18 -32.58 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.894 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.56 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.09 -49.3 75.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.82 -35.96 79.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.28 -34.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.96 -46.89 85.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -38.22 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.44 -54.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.14 97.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.97 -50.46 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.4 t -65.0 -55.06 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.544 HG21 HD21 ' B' ' 395' ' ' LEU . 61.5 m -55.31 -40.92 71.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 33.3 mt -71.27 -44.45 65.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.2 m -62.14 -43.68 98.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.853 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.68 -34.36 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.2 p -48.75 -33.38 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.54 -53.79 25.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.21 -52.88 24.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.4 t -63.53 -51.7 67.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.75 52.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -65.24 -32.64 74.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.69 67.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.81 -49.24 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.01 -35.94 80.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.32 -34.74 44.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -62.99 -46.91 85.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.593 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.29 -38.27 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.33 -54.06 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.12 98.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.48 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.6 t -64.99 -55.19 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 40.4 m -55.11 -40.95 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.34 -45.06 63.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -61.48 -43.68 98.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.86 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' B' ' 377' ' ' LEU . 23.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.77 0.319 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 76.0 p -48.97 -32.2 8.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -68.24 -53.84 21.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.78 -53.31 20.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.14 -53.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -46.43 55.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.49 -32.67 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.853 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -51.46 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.62 -49.18 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.57 -36.21 79.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.33 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.18 -47.39 82.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.5 t -75.14 -37.45 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.98 -54.12 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.89 95.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.94 72.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -62.27 -54.73 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.417 HG21 HD21 ' B' ' 395' ' ' LEU . 65.8 m -56.71 -46.95 80.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.41 HD21 HG21 ' B' ' 394' ' ' THR . 34.2 mt -63.92 -35.73 81.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -71.12 -45.14 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.849 0.357 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' A' ' 377' ' ' LEU . 23.5 mt -62.56 -35.41 79.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 87.8 p -48.91 -32.3 8.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.34 -53.93 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.3 -53.09 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.32 55.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.46 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.878 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.39 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.71 -49.26 73.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.46 -36.11 79.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.53 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.92 -47.12 84.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.936 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.595 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.5 t -75.39 -37.78 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.63 -54.1 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.57 98.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.7 72.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.9 t -64.13 -54.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.41 HG21 HD21 ' A' ' 395' ' ' LEU . 32.9 m -56.28 -40.99 75.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.19 -39.28 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.2 m -67.45 -42.81 82.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.893 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.869 0.366 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 59.1 p -48.88 -33.38 10.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -66.93 -53.3 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.59 -52.64 24.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.42 -53.1 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.99 50.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.0 t80 -65.07 -32.82 74.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.14 -51.44 69.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.56 -49.03 75.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.66 -36.16 80.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.636 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.02 -34.43 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.16 -47.14 83.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.7 t -75.22 -37.52 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.01 -54.09 20.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.99 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.48 72.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.6 t -65.34 -54.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.558 HG21 HD21 ' B' ' 395' ' ' LEU . 25.6 m -55.21 -40.96 71.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.528 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -71.31 -46.0 61.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.69 -44.38 96.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.83 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 377' ' ' LEU . 19.2 mt -65.19 -35.66 81.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 90.7 p -48.97 -33.48 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.91 -53.24 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.52 -52.77 24.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.34 -53.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.65 52.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.445 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.1 t80 -65.49 -32.74 74.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -51.39 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.71 -48.97 74.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.67 -36.13 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.624 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.05 -34.3 45.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.22 -47.26 83.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.7 t -75.22 -37.43 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.97 -54.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.89 96.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.34 72.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 97.4 t -65.39 -54.92 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 395' ' ' LEU . 23.5 m -55.2 -40.9 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 394' ' ' THR . 32.7 mt -71.42 -46.12 60.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.62 -44.47 96.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.803 0.335 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.9 p -48.85 -33.48 10.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.46 -53.41 29.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.16 -52.71 25.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.496 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -63.56 -52.18 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.75 -47.72 52.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.2 t80 -65.25 -32.59 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -51.47 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.21 -49.27 74.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.03 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.73 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.92 -47.09 84.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.4 t -75.27 -38.23 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.28 -54.18 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.0 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.94 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.0 t -63.57 -54.82 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -56.19 -41.07 74.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.32 -36.36 71.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.22 -41.56 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.87 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' A' ' 377' ' ' LEU . 22.2 mt -65.32 -35.5 81.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -48.81 -33.47 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.48 -53.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.24 -52.85 24.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.51 -52.14 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.76 -47.63 52.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.33 -32.53 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -51.51 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -49.23 75.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.09 80.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.2 -34.63 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.94 -47.36 83.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.625 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.2 t -74.98 -38.1 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.143 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.45 -54.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.03 92.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.05 71.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.625 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.6 t -61.6 -54.74 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.5 m -57.17 -46.78 82.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -34.56 78.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -72.21 -45.09 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.863 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' B' ' 377' ' ' LEU . 22.8 mt . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.85 0.357 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 77.5 p -48.94 -33.28 10.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -67.64 -53.46 27.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.38 -52.83 24.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.09 -52.45 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.107 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.15 53.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -65.86 -32.49 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.5 68.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.31 -49.22 74.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.07 80.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.16 -34.48 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.12 -47.24 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.16 -37.49 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.15 -54.03 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.31 96.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.63 72.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.9 t -63.69 -55.03 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.59 HG21 HD21 ' B' ' 395' ' ' LEU . 94.4 m -55.73 -46.24 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.163 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.541 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -64.09 -36.06 82.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.83 -44.69 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.867 0.365 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.06 -36.37 84.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -49.01 -33.18 10.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -67.82 -53.37 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.44 -53.02 23.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.28 -52.61 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.97 54.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -65.98 -32.6 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.48 68.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.58 -49.05 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.8 -36.03 79.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.3 mm -73.09 -34.71 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.06 -46.99 84.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.27 -37.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -70.03 -54.13 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.73 96.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.43 72.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.0 t -65.22 -54.89 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.541 HG21 HD21 ' A' ' 395' ' ' LEU . 87.7 m -55.32 -40.96 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 394' ' ' THR . 32.4 mt -71.26 -45.84 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.93 -44.75 96.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' B' ' 377' ' ' LEU . 18.8 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.829 0.347 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 99.8 p -48.6 -32.25 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.99 -53.75 23.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.92 -53.1 20.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.92 -53.07 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.94 -46.74 55.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.626 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.1 t80 -66.11 -32.6 74.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -51.39 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.78 -49.12 74.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.1 79.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.7 45.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.93 -47.05 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 47.8 t -75.31 -37.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.137 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.67 -54.23 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.159 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.64 96.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.45 72.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -65.14 -54.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.592 HG21 HD21 ' B' ' 395' ' ' LEU . 50.3 m -55.7 -40.49 72.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.571 HD21 HG21 ' B' ' 394' ' ' THR . 32.1 mt -71.32 -37.97 71.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.4 m -68.93 -41.83 77.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' A' ' 377' ' ' LEU . 20.2 mt -59.58 -33.61 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.6 p -48.6 -32.22 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.09 -53.84 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.01 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.01 -53.02 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.65 55.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.38 68.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.79 -49.09 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.05 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.21 -34.42 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.14 -47.07 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.569 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.6 t -75.39 -37.29 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.23 -54.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.58 97.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.5 72.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.3 t -64.81 -54.51 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.571 HG21 HD21 ' A' ' 395' ' ' LEU . 89.3 m -55.95 -40.72 73.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 394' ' ' THR . 32.0 mt -71.33 -40.3 70.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -66.49 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.88 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' B' ' 377' ' ' LEU . 23.0 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.825 0.345 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.81 -32.42 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -68.23 -53.94 21.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.935 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.36 19.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.95 -52.94 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.93 -46.85 55.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.543 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.08 -32.63 74.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.46 68.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.76 -49.07 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.54 -36.08 79.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.18 -34.42 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.24 -47.2 83.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.5 t -75.12 -37.46 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.04 -53.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.19 93.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.1 71.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -61.19 -54.7 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 16.9 m -57.43 -48.42 79.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 394' ' ' THR . 34.4 mt -62.53 -37.23 85.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.6 m -70.08 -44.32 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.849 0.357 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 377' ' ' LEU . 22.1 mt -65.78 -35.02 79.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.4 p -48.78 -32.57 8.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -68.04 -53.77 23.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.76 -53.19 21.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.503 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -53.04 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.381 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.85 -46.63 54.75 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -66.12 -32.79 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.45 68.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.61 -49.07 74.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.64 -36.3 80.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.05 -34.54 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.05 -47.19 84.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.585 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.4 t -75.24 -37.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -69.88 -54.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.84 97.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.88 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -63.87 -54.46 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 395' ' ' LEU . 60.3 m -56.38 -40.8 75.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.31 -34.4 70.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.2 m -72.53 -41.54 65.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.849 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.844 0.354 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -49.12 -31.97 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.35 -53.78 21.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.929 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.97 -53.36 19.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.486 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.6 t -65.56 -53.35 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.112 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.15 -46.0 56.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.509 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.85 -32.67 74.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.55 68.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.52 -49.22 74.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.47 -36.29 80.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.2 -34.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.46 -47.27 84.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.9 t -75.34 -38.06 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.3 -54.39 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.52 97.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.089 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.44 72.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.2 t -64.59 -55.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.7 m -55.72 -40.49 72.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.14 -34.02 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.51 -39.39 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.816 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' A' ' 377' ' ' LEU . 25.0 mt -65.31 -36.89 85.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.73 -31.75 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -68.33 -53.77 21.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.06 -53.67 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.31 -53.21 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.41 56.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.39 -32.71 74.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -51.51 68.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.75 -49.13 74.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.2 79.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.15 -34.52 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.87 -47.51 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.632 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.05 -37.64 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.71 -54.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.41 90.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.18 71.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.632 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -60.95 -54.42 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.3 m -57.82 -47.14 83.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.155 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.33 -34.42 78.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.7 m -72.38 -45.53 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.866 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' B' ' 377' ' ' LEU . 24.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.795 0.331 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.0 p -49.15 -32.87 10.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.93 -53.56 25.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.48 -53.05 22.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.33 -52.84 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -46.87 54.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.6 t80 -66.0 -32.48 73.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -51.4 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.15 74.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.72 -36.23 80.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.15 -34.35 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.48 82.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -74.95 -37.57 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.89 -54.07 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.92 92.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.07 71.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.4 t -61.24 -54.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.1 m -57.55 -47.63 81.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.7 -35.41 80.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.34 -45.13 63.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.896 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.88 0.371 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' A' ' 377' ' ' LEU . 24.2 mt -65.07 -36.64 84.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -49.03 -32.91 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -68.01 -53.64 24.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.9 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.53 -53.04 22.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.4 t -64.37 -52.74 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 111.11 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -46.82 54.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.13 -32.55 74.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.51 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.44 -49.12 74.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.8 -36.14 80.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.23 -47.36 82.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.619 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.8 t -75.07 -37.45 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.97 -54.1 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.83 91.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.08 71.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.619 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -60.66 -54.41 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 47.0 m -58.13 -47.7 82.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -63.67 -34.97 79.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.11 -45.11 61.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.85 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.7 p -49.19 -33.37 12.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.52 -53.38 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.46 -52.99 23.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.7 t -63.67 -52.86 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.66 -47.37 52.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -65.53 -32.62 74.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -51.49 68.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.54 -49.0 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.79 -36.3 80.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.13 -34.69 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.84 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.1 t -75.38 -37.85 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.55 -54.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.074 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.16 70.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.0 t -62.94 -54.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.9 m -56.4 -41.13 75.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.3 -33.8 70.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.88 -55.98 6.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' A' ' 377' ' ' LEU . 22.6 mt -65.11 -36.58 84.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 93.5 p -48.96 -33.29 10.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.65 -53.29 29.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.46 -52.9 23.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.48 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.87 -52.9 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.25 53.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -65.54 -32.63 74.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.45 68.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.6 -49.07 74.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.16 80.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.3 -34.68 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.79 -47.07 85.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.4 t -75.38 -38.08 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.3 -54.17 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.31 98.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.21 -50.5 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.599 HG23 ' O ' ' B' ' 389' ' ' VAL . 87.5 t -64.44 -54.92 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.5 m -55.75 -40.89 73.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.3 -42.26 68.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -63.33 -54.18 41.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 -179.889 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' B' ' 377' ' ' LEU . 20.7 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.858 0.361 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 86.4 p -48.38 -33.8 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -66.96 -53.81 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.9 -52.72 27.08 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -62.72 -51.37 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.54 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.3 t80 -64.44 -32.61 74.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.54 68.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.33 -49.22 74.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.68 -36.08 79.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.24 -34.31 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.25 -47.1 83.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -37.43 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.07 -54.12 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.23 97.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.58 72.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.66 -54.52 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.578 HG21 HD21 ' B' ' 395' ' ' LEU . 26.1 m -55.92 -41.01 73.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.6 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.16 -41.31 70.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.44 -43.38 90.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.819 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 377' ' ' LEU . 20.6 mt -65.54 -33.56 76.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 84.0 p -48.4 -33.9 9.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -66.88 -53.74 29.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.79 -52.67 27.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.0 t -62.59 -51.36 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 111.126 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.83 -48.3 51.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -64.54 -32.6 74.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -51.64 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.2 -49.16 75.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.78 -36.11 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.26 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.29 -47.05 83.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.37 -37.36 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.18 -54.06 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.7 96.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.51 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.9 t -64.98 -54.72 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.6 HG21 HD21 ' A' ' 395' ' ' LEU . 91.4 m -55.54 -40.89 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.25 -44.08 66.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.74 -43.89 97.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.878 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.774 0.321 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -33.54 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.11 -53.93 26.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.06 -52.91 25.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.7 t -62.89 -51.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.125 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -48.52 51.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -64.46 -32.58 74.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.6 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.11 -49.27 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.77 -36.06 79.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.24 -34.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.13 -47.35 83.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.9 t -75.0 -37.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.54 -53.96 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.9 91.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.18 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 389' ' ' VAL . 88.9 t -61.43 -54.94 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.5 m -57.02 -47.14 81.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -63.96 -35.3 80.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -71.36 -45.18 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.892 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' A' ' 377' ' ' LEU . 21.0 mt -65.86 -33.23 75.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 70.5 p -48.58 -33.46 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.26 -54.03 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.05 -52.82 25.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.05 -51.33 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.35 51.23 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -64.75 -32.56 74.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.5 68.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.25 -49.16 75.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.92 -35.96 79.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.34 -34.59 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.99 -47.07 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.5 t -75.24 -38.18 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.4 -54.24 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.9 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.73 72.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -63.65 -54.66 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 22.8 m -56.36 -41.15 75.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.19 -36.47 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.08 -41.8 73.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.832 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.669 HD23 HD23 ' B' ' 377' ' ' LEU . 19.7 mt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.861 0.362 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.4 p -48.64 -31.7 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.43 -53.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.07 -53.63 17.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.46 -53.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.26 55.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.498 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.0 t80 -66.65 -32.7 74.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.49 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.55 -49.27 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.56 -36.16 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.15 -34.53 45.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.91 -47.53 82.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.3 t -75.01 -37.77 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.62 -54.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.61 91.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.2 71.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -61.19 -54.52 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 84.8 m -57.59 -47.31 82.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.96 -34.9 79.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.96 -44.95 62.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.861 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.891 0.377 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 377' ' ' LEU . 20.4 mt -57.48 -35.39 70.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 95.5 p -48.74 -31.67 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -68.48 -53.61 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.93 -53.68 18.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.514 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.51 -53.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.12 56.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.81 -32.65 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.62 -49.11 74.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.66 -36.17 80.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.15 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.9 -47.44 83.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 47.6 t -74.97 -37.91 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.52 -54.1 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.72 91.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.23 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 84.7 t -60.99 -54.66 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 24.4 m -57.55 -47.33 82.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.16 -45.19 61.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.836 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' B' ' 377' ' ' LEU . 20.0 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.845 0.355 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 95.7 p -48.59 -31.81 7.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.42 -53.72 21.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.902 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.59 18.28 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.45 -53.13 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.04 56.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -66.76 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.43 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.833 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.82 -49.11 74.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.08 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.96 -47.11 84.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.28 -37.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.09 -54.24 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.39 96.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.69 72.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.63 -54.43 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.437 HG21 HD21 ' B' ' 395' ' ' LEU . 29.5 m -56.05 -40.82 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -71.26 -40.55 70.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.8 m -66.13 -43.32 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.871 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.891 0.377 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 377' ' ' LEU . 20.7 mt -59.53 -35.32 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.6 -31.86 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.37 -53.68 22.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.7 17.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.27 -53.14 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.32 55.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.8 t80 -66.53 -32.66 74.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.52 68.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.59 -49.19 74.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.62 -35.99 79.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.87 -47.24 84.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.24 -37.52 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.99 -54.11 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.65 96.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 389' ' ' VAL . 99.4 t -63.32 -54.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 395' ' ' LEU . 36.8 m -56.13 -45.97 79.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.437 HD21 HG21 ' A' ' 394' ' ' THR . 33.4 mt -64.65 -34.55 78.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.39 -44.72 62.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.887 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' B' ' 377' ' ' LEU . 19.7 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.785 0.326 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.0 p -48.45 -31.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -68.44 -53.63 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.74 -53.72 18.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.23 -52.83 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -45.83 56.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -67.02 -32.64 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.48 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.66 -49.29 73.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.39 -36.01 79.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.22 -34.52 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.07 -47.07 84.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -75.33 -37.34 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.17 -54.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.05 -45.05 94.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.43 -50.39 71.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.2 t -66.09 -55.01 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.632 HG21 HD21 ' B' ' 395' ' ' LEU . 85.6 m -54.73 -40.15 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.591 HD21 HG21 ' B' ' 394' ' ' THR . 31.3 mt -71.06 -34.09 70.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -73.55 -39.16 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.88 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.827 0.346 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' A' ' 377' ' ' LEU . 19.7 mt -60.11 -34.06 72.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.3 p -48.67 -32.19 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -68.24 -53.79 22.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.81 -53.39 19.87 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.452 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.36 -53.08 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.95 56.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -66.9 -32.74 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.895 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.45 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.68 -49.13 74.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.53 -36.14 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.615 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.17 -34.44 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.11 -46.99 84.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.5 -37.27 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.103 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -70.28 -54.15 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.28 93.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.33 71.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.0 t -66.34 -55.03 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.591 HG21 HD21 ' A' ' 395' ' ' LEU . 61.4 m -54.63 -39.92 68.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.632 HD21 HG21 ' A' ' 394' ' ' THR . 31.1 mt -71.26 -34.64 70.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.7 m -73.31 -38.24 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.835 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.87 0.367 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 92.1 p -48.6 -33.87 10.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.849 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -66.93 -53.47 31.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.87 -52.6 27.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -62.85 -51.39 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.849 0.357 . . . . 0.0 111.12 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.4 51.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -64.51 -32.63 74.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 0.0 110.853 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.67 67.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.1 -49.31 74.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.11 79.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.31 -34.59 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.88 -47.16 84.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.1 t -75.3 -38.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.34 -54.22 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.04 97.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.66 72.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.077 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 389' ' ' VAL . 86.8 t -64.03 -54.74 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 42.2 m -56.16 -41.01 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.21 -38.97 72.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.59 -42.41 82.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 -179.876 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 377' ' ' LEU . 19.9 mt -65.35 -34.36 78.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -48.57 -33.81 10.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.0 -53.48 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.87 -52.65 27.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.474 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -62.89 -51.62 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -48.2 51.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.0 t80 -64.73 -32.47 74.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.57 68.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.13 -49.21 75.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.74 -36.38 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.42 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.97 -47.48 83.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.03 -37.84 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.61 -53.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.72 91.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.2 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.8 t -61.25 -54.66 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 39.3 m -57.4 -47.1 82.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.26 -35.77 81.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.87 -45.09 65.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.851 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' B' ' 377' ' ' LEU . 22.2 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.849 0.357 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 94.3 p -48.78 -33.68 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.28 -53.53 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.04 -52.82 25.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -63.18 -51.83 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.35 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.96 51.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -64.88 -32.65 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.4 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.75 -49.28 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.34 -36.3 79.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 9.1 mm -73.33 -34.35 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.81 -47.29 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 389' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.5 t -75.43 -37.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.35 -53.93 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.27 98.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.34 -48.33 79.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 393' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 389' ' ' VAL . 93.3 t -66.6 -55.09 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 394' ' ' THR . . . . . 0.566 HG21 HD21 ' B' ' 395' ' ' LEU . 35.6 m -55.71 -41.12 73.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 395' ' ' LEU . . . . . 0.577 HD21 HG21 ' B' ' 394' ' ' THR . 35.5 mt -71.4 -51.74 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.886 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.887 0.375 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' A' ' 377' ' ' LEU . 21.9 mt -65.34 -35.2 80.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.4 p -48.6 -33.68 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.36 -53.56 28.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.01 -52.96 25.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 381' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -63.22 -51.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.83 52.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.02 -32.63 74.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.46 68.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.7 -49.34 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.23 -36.45 79.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 9.0 mm -73.2 -34.18 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.07 -47.3 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 389' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.4 t -75.38 -37.32 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.03 -54.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.58 97.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.45 72.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 393' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -65.11 -54.93 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 394' ' ' THR . . . . . 0.577 HG21 HD21 ' A' ' 395' ' ' LEU . 61.7 m -55.33 -40.99 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 395' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.33 -44.18 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -62.42 -43.63 98.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.876 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.572 0.701 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -27.77 26.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.17 149.04 46.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.082 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -155.75 169.25 24.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -87.97 165.93 14.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.903 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -164.23 158.72 19.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.917 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.9 pp -125.61 142.45 51.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.934 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 12.0 p -153.82 150.74 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.54 114.01 5.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.723 ' HB3' ' CD ' ' B' ' 368' ' ' GLU . . . -160.52 165.17 31.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.78 121.92 46.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -155.34 164.56 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 56.86 35.04 25.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.09 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -58.12 -88.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.458 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.8 m -109.35 10.43 25.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 90.1 t -89.4 -65.4 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.087 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.487 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.6 t80 -68.43 -28.67 67.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.491 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.44 -29.55 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.079 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.2 -28.21 63.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.35 -25.3 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.849 0.357 . . . . 0.0 111.124 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt -65.48 -36.46 83.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.85 -31.36 7.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -68.42 -53.76 21.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.13 -53.64 17.43 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.518 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 9.8 t -65.64 -53.37 39.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.858 0.361 . . . . 0.0 111.119 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.11 -46.49 56.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.55 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.3 -32.74 74.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.886 0.374 . . . . 0.0 110.873 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.48 68.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.95 -49.26 73.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.23 -36.25 79.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.15 -34.43 44.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.147 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 26.4 mt -62.93 -47.2 84.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.1 t -75.42 -37.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.72 -54.18 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.71 -43.49 97.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.127 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.96 -50.44 72.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.072 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.4 t -65.32 -54.99 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.176 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.498 HG21 HD21 ' B' ' 395' ' ' LEU . 21.3 m -55.11 -41.1 71.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.101 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.533 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.27 -46.41 60.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.33 -44.4 95.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -66.97 -23.15 65.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.678 ' HG ' HD13 ' B' ' 398' ' ' LEU . 7.6 tt -52.54 -67.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 3.1 tt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.585 0.707 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 160.89 48.02 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.668 2.245 . . . . 0.0 112.374 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -98.72 136.45 38.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.103 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.82 131.18 35.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -57.1 112.85 1.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.861 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.37 127.7 54.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -65.2 160.7 20.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 32.8 m -126.36 158.26 36.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -133.33 131.76 40.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -102.5 151.92 21.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -101.57 120.13 39.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . 0.723 ' CD ' ' HB3' ' A' ' 366' ' ' ALA . 6.6 tp10 -145.16 129.43 17.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 53.06 30.78 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -103.16 -70.81 0.85 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.7 p -98.0 3.41 49.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 0.0 110.842 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 90.7 t -90.06 -65.29 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.492 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.7 t80 -68.21 -28.89 67.64 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.907 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.484 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.24 -30.22 16.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.076 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.42 -28.26 61.86 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.473 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.5 -25.33 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.659 HD23 HD23 ' A' ' 377' ' ' LEU . 22.0 mt -65.76 -36.43 83.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.9 p -48.74 -31.56 7.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -68.26 -53.74 22.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.923 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.21 -53.77 16.55 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.441 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 9.6 t -65.4 -53.33 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.2 -46.55 56.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.3 t80 -66.22 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.903 0.382 . . . . 0.0 110.904 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -51.45 68.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.94 -49.23 73.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.26 -36.26 79.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.14 -34.57 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.75 -47.21 84.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.931 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.3 t -75.39 -37.68 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.7 t -69.6 -54.2 20.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.149 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.69 -43.48 97.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.29 72.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -65.48 -55.06 21.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.533 HG21 HD21 ' A' ' 395' ' ' LEU . 31.7 m -55.07 -41.03 71.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.498 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.33 -46.93 59.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.0 m -59.79 -44.55 93.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -66.74 -22.95 66.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.839 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.678 HD13 ' HG ' ' A' ' 398' ' ' LEU . 15.6 tp -78.47 -28.18 46.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 16.6 tpp85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.868 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.657 0.741 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 131.51 21.34 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.688 2.259 . . . . 0.0 112.325 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -81.66 131.8 35.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.078 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -107.48 116.86 32.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.915 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -126.43 161.51 27.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -115.05 118.77 34.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.854 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.83 174.67 9.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 107.25 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.116 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -168.32 170.24 10.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.31 127.7 18.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.06 -62.08 1.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -141.54 113.15 7.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -173.19 151.42 2.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 161.55 -82.62 0.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 24.6 p -104.64 3.47 31.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.878 0.371 . . . . 0.0 110.85 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.2 t -90.01 -65.31 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.16 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.62 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.1 t80 -68.55 -27.19 65.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.941 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.31 13.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.124 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.82 -28.03 65.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.444 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 373' ' ' TYR . 4.8 mt -82.54 -25.91 8.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.85 0.357 . . . . 0.0 111.099 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' B' ' 377' ' ' LEU . 25.5 mt -63.31 -36.41 83.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.4 p -48.75 -31.9 7.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.832 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.4 -53.79 21.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.71 17.92 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.471 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 11.0 t -65.23 -53.01 45.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.862 0.363 . . . . 0.0 111.117 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.3 55.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.524 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.51 -32.81 74.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.896 0.379 . . . . 0.0 110.877 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -51.29 69.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.942 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.1 -49.16 73.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.34 -36.07 79.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.57 45.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.0 mt -63.04 -47.02 84.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.33 -37.61 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.148 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.05 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.154 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.7 96.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.078 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.01 -50.45 72.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.108 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.1 t -65.23 -54.9 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.499 HG21 HD21 ' B' ' 395' ' ' LEU . 14.2 m -55.27 -40.92 71.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.51 HD21 HG21 ' B' ' 394' ' ' THR . 33.1 mt -71.33 -45.23 63.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.6 m -61.52 -44.18 97.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.89 -22.31 65.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.631 ' HG ' HD13 ' B' ' 398' ' ' LEU . 8.1 tt -51.84 -67.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.897 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.613 0.72 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 179.7 3.52 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.69 2.26 . . . . 0.0 112.326 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -112.91 122.67 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.118 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -79.06 134.99 36.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.861 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -151.49 148.86 28.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -101.14 124.98 47.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 7.2 tp -147.19 132.85 18.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.06 135.29 43.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -62.93 165.73 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.51 171.66 17.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.118 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 61.66 31.43 18.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.852 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -83.03 162.55 21.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 52.2 50.86 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.076 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -134.95 -51.36 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.473 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 16.9 m -103.17 2.53 34.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.968 0.413 . . . . 0.0 110.885 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.14 -65.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.123 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.583 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -69.32 -31.15 69.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.954 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.502 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -55.29 -25.86 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.67 70.61 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.77 -25.29 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 0.0 111.092 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.692 HD23 HD23 ' A' ' 377' ' ' LEU . 20.9 mt -65.81 -35.69 81.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 89.5 p -48.93 -32.11 8.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.4 -53.88 20.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.918 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.79 -53.22 20.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.529 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.52 -53.14 42.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.897 0.379 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -45.98 56.21 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.49 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.94 -32.73 74.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.908 0.385 . . . . 0.0 110.868 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.2 -51.47 68.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.82 -49.08 74.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.58 -36.11 79.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.29 -34.48 44.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.112 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.8 mt -62.93 -47.22 84.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.563 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.3 t -75.37 -37.26 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 9.8 t -70.19 -54.1 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.78 96.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.07 -50.42 72.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.563 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.9 t -65.37 -54.82 24.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.51 HG21 HD21 ' A' ' 395' ' ' LEU . 18.6 m -55.3 -40.97 71.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.165 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.499 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.31 -45.58 62.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -61.21 -44.44 97.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -66.72 -23.09 66.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.631 HD13 ' HG ' ' A' ' 398' ' ' LEU . 11.5 tp -77.04 -33.38 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.907 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.592 0.711 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.76 167.9 23.09 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.658 2.239 . . . . 0.0 112.386 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -164.87 154.76 13.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -163.42 168.42 20.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -126.07 154.75 42.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.74 177.99 8.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 47.1 mt -149.74 157.83 43.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -134.43 151.81 32.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.13 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -110.01 125.85 53.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -169.38 173.54 6.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.1 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -103.98 122.12 44.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -161.47 178.49 9.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' B' ' 369' ' ' ALA . . . -65.18 92.97 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.045 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -143.54 -66.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.512 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.12 1.1 42.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 37.7 t -89.27 -65.01 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.121 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.32 -30.54 70.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.79 -22.9 67.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.069 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.01 -25.44 70.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.47 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 111.106 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' B' ' 377' ' ' LEU . 22.5 mt -65.02 -36.16 83.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 81.9 p -48.9 -33.52 10.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.3 -53.39 30.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.955 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.22 -52.73 25.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -63.64 -52.49 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.886 0.374 . . . . 0.0 111.141 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.19 53.11 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.512 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.628 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.4 t80 -65.69 -32.62 74.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.92 0.391 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.43 68.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.14 74.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -61.71 -36.17 80.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.628 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.17 -34.45 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.12 -47.08 84.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.34 -37.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.146 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.89 -54.1 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.5 97.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.129 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.35 73.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -65.33 -54.84 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.605 HG21 HD21 ' B' ' 395' ' ' LEU . 85.2 m -55.33 -41.03 71.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.563 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.27 -46.19 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.9 m -60.55 -44.54 96.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -66.99 -22.96 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.906 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.638 ' CD2' HD13 ' B' ' 398' ' ' LEU . 1.5 tt -52.06 -45.52 64.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 23.8 tpt85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.65 0.738 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -27.14 27.09 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.693 2.262 . . . . 0.0 112.385 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -111.63 170.81 7.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -108.42 159.27 16.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.24 131.35 37.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -107.13 130.38 54.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.842 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . 0.53 HD13 ' N ' ' B' ' 364' ' ' VAL . 0.4 OUTLIER -74.8 127.36 32.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.898 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . 0.53 ' N ' HD13 ' B' ' 363' ' ' LEU . 15.9 m -137.18 136.35 47.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -90.24 -60.42 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.842 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -127.11 123.69 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.091 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -145.83 123.77 12.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -172.62 160.61 4.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.864 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 369' ' ' ALA . . . -52.55 102.35 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.101 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -153.72 -69.76 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 17.7 p -101.68 2.25 38.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.863 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 30.5 t -89.92 -65.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -67.2 -30.72 70.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.955 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.67 -22.7 67.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.113 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.21 -25.39 71.07 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.478 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.21 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.361 . . . . 0.0 111.15 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.82 HD23 HD23 ' A' ' 377' ' ' LEU . 22.5 mt -65.17 -36.19 83.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.7 p -48.93 -33.4 10.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.54 -53.53 27.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.948 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.2 -52.68 26.0 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -63.88 -52.22 59.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -47.28 53.41 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.447 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.1 t80 -65.72 -32.6 74.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 0.0 110.884 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.41 69.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.85 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.47 -49.16 74.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.958 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.71 -36.13 80.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.19 -34.67 45.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.142 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.97 -47.04 84.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.4 t -75.29 -37.85 39.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.161 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.62 -54.25 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.101 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.4 -43.63 96.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.081 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.41 72.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.05 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.4 t -65.35 -55.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.15 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.563 HG21 HD21 ' A' ' 395' ' ' LEU . 26.1 m -55.02 -41.01 70.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.175 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.605 HD21 HG21 ' A' ' 394' ' ' THR . 33.2 mt -71.29 -46.7 60.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.1 m -60.06 -44.52 94.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 38.0 mmt-85 -66.88 -23.03 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.638 HD13 ' CD2' ' A' ' 398' ' ' LEU . 15.9 tp -77.98 -34.85 50.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 9.8 tp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.58 0.705 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 176.05 7.27 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.683 2.255 . . . . 0.0 112.36 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.16 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.077 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -138.26 128.75 26.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -137.99 155.54 48.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.67 171.54 14.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 364' ' ' VAL . 2.1 tt -167.65 152.5 6.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.602 ' N ' HD23 ' A' ' 363' ' ' LEU . 31.4 m -131.46 133.78 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.113 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -167.63 168.91 12.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -65.45 126.34 27.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.131 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -149.56 -179.24 6.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -56.86 175.61 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.37 56.41 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.091 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -87.74 -82.68 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.499 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.6 p -84.82 3.06 39.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.857 0.361 . . . . 0.0 110.882 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 43.0 t -87.68 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.71 -30.8 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.911 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.81 -24.19 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.111 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.64 -25.58 69.03 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.447 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.32 -23.29 9.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' B' ' 377' ' ' LEU . 22.9 mt -65.08 -36.65 84.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.904 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.0 p -49.12 -33.29 11.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.849 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -67.43 -53.51 28.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.25 -52.74 25.43 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.85 -52.51 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.816 0.341 . . . . 0.0 111.125 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.28 53.68 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -65.58 -32.6 74.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 110.864 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.39 68.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.892 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.42 -49.14 74.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.06 80.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.19 -34.37 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.105 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -63.29 -47.17 83.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.26 -37.14 38.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.34 -54.2 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.74 96.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.64 -50.94 72.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 389' ' ' VAL . 94.1 t -62.74 -54.8 29.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.096 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.45 HG21 HD21 ' B' ' 395' ' ' LEU . 26.6 m -56.36 -46.63 79.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.434 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -64.09 -36.0 82.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.929 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -70.81 -44.81 65.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.868 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -86.22 5.46 34.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.764 ' HG ' HD13 ' B' ' 398' ' ' LEU . 1.1 tt -80.68 -38.7 28.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.23 0.062 0 CA-C-O 121.598 0.713 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 129.53 17.76 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.706 2.271 . . . . 0.0 112.336 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -71.03 162.67 29.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -95.28 146.84 24.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -71.05 107.75 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -148.3 151.68 35.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.885 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 8.3 tt -68.55 114.28 6.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.8 138.86 47.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.09 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -95.12 123.66 38.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.55 134.13 14.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -121.26 139.23 53.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -61.05 -57.52 12.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -56.81 103.54 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -164.29 -71.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.465 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 26.2 p -105.41 3.74 29.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.946 0.403 . . . . 0.0 110.867 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 40.0 t -90.13 -65.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.11 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.53 -31.16 70.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.923 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.43 -23.29 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.08 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.79 -24.88 70.17 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.46 -22.45 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 111.106 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.809 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.11 -36.75 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.3 p -49.28 -33.03 12.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.94 -53.27 27.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.941 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.39 -52.78 24.65 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.465 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.24 -52.61 53.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 0.0 111.154 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.71 -47.08 53.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.459 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.625 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.03 -32.57 74.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.895 0.379 . . . . 0.0 110.85 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.41 68.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.61 -49.16 74.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.66 -36.08 79.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.625 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.57 45.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.176 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.06 -47.13 84.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.2 t -75.36 -37.37 38.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.18 -54.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.136 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.39 97.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.1 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.6 72.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.106 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 94.5 t -64.69 -54.58 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.139 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.434 HG21 HD21 ' A' ' 395' ' ' LEU . 19.9 m -55.85 -41.08 73.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.45 HD21 HG21 ' A' ' 394' ' ' THR . 32.8 mt -71.1 -42.35 69.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -64.32 -43.7 93.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.907 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -66.81 -23.1 66.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.764 HD13 ' HG ' ' A' ' 398' ' ' LEU . 19.9 tp -73.96 -25.43 59.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 19.8 mmt-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.163 0 CA-C-O 121.588 0.709 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 178.32 4.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.696 2.264 . . . . 0.0 112.353 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -114.32 177.96 4.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -114.85 176.7 4.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.939 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -77.25 178.0 7.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.903 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.72 153.94 23.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.6 tp -142.59 136.37 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.7 142.17 35.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.144 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.2 mp0 -58.09 125.03 21.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' B' ' 367' ' ' ASP . . . -156.85 165.68 35.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -124.82 98.26 5.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.855 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -143.1 147.92 35.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 57.91 65.23 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -77.32 -87.43 0.38 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.524 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -107.18 10.12 30.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 0.0 110.839 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 93.8 t -89.64 -65.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.112 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.593 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.0 t80 -68.34 -27.45 66.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -51.02 -30.06 14.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.109 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.71 -28.21 62.59 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.512 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 373' ' ' TYR . 4.8 mt -82.44 -25.91 8.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.838 0.352 . . . . 0.0 111.106 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 24.1 mt -65.77 -35.38 80.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.4 p -48.99 -32.09 8.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.819 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.12 -54.01 21.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.37 19.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.453 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.23 -53.15 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 0.0 111.125 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.54 55.7 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.485 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -66.3 -32.68 74.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.914 0.388 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.41 69.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -64.01 -49.07 73.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.918 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.5 -36.12 79.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.07 -34.52 45.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.01 84.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.9 t -75.33 -37.54 38.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.111 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.07 -54.07 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.53 97.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.55 72.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.144 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.8 t -64.96 -54.71 26.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.137 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.513 HG21 HD21 ' B' ' 395' ' ' LEU . 87.0 m -55.54 -41.02 72.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.18 -43.79 66.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.84 -44.0 97.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -66.76 -21.7 66.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 398' ' ' LEU . 3.2 tt -51.65 -49.85 61.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.866 179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 121.622 0.725 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 -28.68 25.14 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.665 2.243 . . . . 0.0 112.4 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -146.03 141.55 27.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.041 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -134.61 141.55 46.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -72.76 108.94 6.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -115.0 136.52 53.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.889 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 6.6 mp -114.91 158.81 21.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 11.0 p -156.94 133.84 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.137 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -61.46 170.82 1.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -101.89 98.74 8.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . 0.427 ' HA ' ' HB1' ' A' ' 366' ' ' ALA . 1.5 m-20 -78.5 136.88 37.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -152.62 115.94 4.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -101.89 37.88 1.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -87.0 -76.79 1.26 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.494 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 19.0 m -96.59 3.49 52.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.88 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 59.5 t -90.09 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.14 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -68.54 -30.95 69.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -53.24 -28.36 26.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.107 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.42 -28.73 65.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.543 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' B' ' 373' ' ' TYR . 4.8 mt -82.84 -26.67 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.095 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.79 -35.52 80.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.963 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.9 p -48.89 -32.29 8.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -68.2 -53.92 21.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.32 19.51 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.492 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.19 -53.02 45.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -46.49 55.93 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.5 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -66.44 -32.56 74.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.9 0.381 . . . . 0.0 110.908 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.41 -51.47 68.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.52 -49.2 74.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.64 -35.97 79.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.31 -34.27 43.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.152 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -63.26 -47.23 83.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.915 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.22 -37.17 38.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.35 -54.1 20.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.22 96.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.124 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.77 72.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.111 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 389' ' ' VAL . 95.2 t -63.58 -54.92 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.114 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 86.5 m -55.76 -46.18 77.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 394' ' ' THR . 32.9 mt -64.32 -34.7 78.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -72.27 -44.57 62.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -87.49 7.29 30.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . . . . . . . . . 1.2 tt -77.29 -33.65 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.886 179.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.61 0.719 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 153.2 69.23 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.71 2.273 . . . . 0.0 112.36 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.77 156.97 30.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -118.81 164.61 15.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -151.13 157.09 42.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -115.43 155.39 27.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.29 142.77 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 40.9 t -144.34 145.72 21.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -72.95 138.07 45.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.48 ' HB3' ' CD ' ' B' ' 368' ' ' GLU . . . -162.88 176.35 10.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -83.69 105.54 14.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -163.07 173.91 12.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.926 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.75 40.63 7.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.067 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -84.29 -81.18 1.04 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.488 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -110.18 7.21 23.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 110.836 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 46.4 t -90.0 -65.21 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.151 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.555 ' CE2' HD11 ' B' ' 377' ' ' LEU . 2.4 t80 -67.21 -31.91 72.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.956 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -53.52 -30.58 42.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -57.17 -28.13 58.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.3 -26.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.84 0.353 . . . . 0.0 111.093 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' B' ' 377' ' ' LEU . 25.1 mt -65.55 -37.27 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 90.9 p -49.48 -31.88 10.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -68.44 -53.88 20.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.93 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.83 -53.27 20.36 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 8.3 t -65.48 -53.14 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.862 0.363 . . . . 0.0 111.163 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.23 55.56 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.46 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.71 -32.71 74.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.887 0.375 . . . . 0.0 110.898 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.24 -51.5 68.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.5 mt -63.4 -49.35 74.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.55 -36.18 79.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.858 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.631 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.8 mm -73.17 -35.19 46.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.177 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.8 mt -62.2 -47.15 85.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.26 -39.25 42.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.133 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -68.05 -54.11 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.33 -41.04 96.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.27 73.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.128 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.6 t -64.91 -55.13 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.099 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 5.8 m -55.4 -41.16 72.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.16 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.3 mt -71.21 -44.5 65.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -62.03 -43.87 97.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.62 -22.54 66.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.845 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.878 HD22 HD13 ' B' ' 398' ' ' LEU . 7.2 tp -84.76 -71.18 0.53 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.882 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.828 179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.589 0.709 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -15.54 36.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.669 2.246 . . . . 0.0 112.31 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . 63.85 35.33 11.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.118 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -112.27 160.72 17.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.66 144.06 31.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -149.34 144.41 26.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.2 pp -140.03 136.91 34.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 42.9 t -107.54 120.38 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.124 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -52.07 109.08 0.34 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.28 168.68 14.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -116.74 171.98 7.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . 0.48 ' CD ' ' HB3' ' A' ' 366' ' ' ALA . 19.4 mp0 -136.29 171.9 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 59.62 35.59 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -76.76 -82.32 0.54 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.544 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 8.9 m -107.86 5.94 26.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.936 0.398 . . . . 0.0 110.866 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.93 -65.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.171 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.559 ' CE2' HD11 ' A' ' 377' ' ' LEU . 3.1 t80 -67.72 -31.73 71.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -54.95 -29.88 57.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.048 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -57.68 -28.22 59.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.42 -27.13 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.9 0.381 . . . . 0.0 111.137 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.719 HD23 HD23 ' A' ' 377' ' ' LEU . 24.6 mt -65.52 -37.07 85.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 96.5 p -49.34 -32.04 10.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -68.41 -53.89 20.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.86 -53.23 20.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.529 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 8.0 t -65.53 -53.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 0.0 111.137 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.04 -46.11 56.19 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -66.77 -32.6 74.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.884 0.374 . . . . 0.0 110.843 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.41 68.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.33 -49.21 74.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.82 -36.14 80.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.865 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.17 -34.58 45.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.137 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.87 -47.48 83.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.927 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.1 t -75.03 -37.84 41.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.5 -53.96 22.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.31 90.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.125 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.81 72.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 88.3 t -61.16 -54.45 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 26.4 m -57.92 -48.5 79.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.155 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -62.72 -38.34 90.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.889 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.6 m -68.87 -44.66 72.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.901 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -84.84 4.0 35.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.878 HD13 HD22 ' A' ' 398' ' ' LEU . 7.9 tp -84.44 -40.3 17.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 56.6 mmt-85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.625 0.726 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -175.2 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.688 2.259 . . . . 0.0 112.352 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -164.52 154.26 13.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.076 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -152.0 176.92 11.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -105.19 177.99 4.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -90.71 -67.49 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 83.6 mt -148.09 133.44 18.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.882 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 12.6 p -115.31 -27.58 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -77.07 170.12 17.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -78.7 177.75 8.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.082 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -150.05 170.51 18.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.866 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -68.93 -20.09 64.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' B' ' 369' ' ' ALA . . . -92.47 42.79 1.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.075 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -80.02 -84.24 0.66 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 13.0 p -85.4 1.4 48.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.941 0.4 . . . . 0.0 110.895 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.4 -64.06 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.421 ' HB2' ' HB1' ' A' ' 369' ' ' ALA . 2.2 t80 -67.1 -30.47 70.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.932 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.7 -23.62 66.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.086 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.83 70.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.483 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.29 -22.57 9.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 0.0 111.17 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' B' ' 377' ' ' LEU . 23.8 mt -65.18 -36.34 83.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 79.1 p -49.1 -33.03 10.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.91 -53.33 27.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.902 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.41 -52.87 24.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.464 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.4 -52.56 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 111.129 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.72 -47.1 53.51 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.461 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.638 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.3 t80 -66.06 -32.55 74.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.834 0.35 . . . . 0.0 110.843 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.5 68.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.32 -49.14 75.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.95 -36.08 80.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.846 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.638 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.76 45.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.99 -47.02 84.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.5 t -75.25 -38.17 40.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.5 t -69.43 -54.23 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.0 96.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -51.01 71.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.13 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -63.63 -54.82 27.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.133 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 86.5 m -56.13 -41.03 74.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.124 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.0 mt -71.27 -35.85 71.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.934 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.71 -41.53 71.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.64 -23.18 66.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.744 HD13 ' CD1' ' B' ' 398' ' ' LEU . 7.7 tp -67.09 -36.92 83.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.5 tpt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 7.9 mp . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.649 0.737 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 127.29 14.36 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.365 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -127.6 170.83 12.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.121 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -119.27 144.34 46.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -148.05 136.97 21.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -83.99 133.57 34.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 5.3 mp -64.4 128.37 35.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 11.1 p -75.34 -26.76 18.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -81.02 -63.4 1.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.934 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -140.21 116.46 10.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -110.24 -26.17 9.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -125.99 172.52 9.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.593 ' CB ' ' HB3' ' A' ' 369' ' ' ALA . . . -51.7 104.75 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -154.57 -72.78 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.518 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 29.4 p -103.96 5.35 35.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 110.829 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 29.3 t -90.02 -65.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.98 -30.76 69.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.31 -23.9 67.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.89 -25.88 69.63 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.489 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.43 -22.92 9.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.866 0.365 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.79 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.29 -36.33 83.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.906 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 92.4 p -49.12 -33.04 11.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.851 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.95 -53.67 24.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.47 -52.98 23.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.443 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.2 t -64.3 -52.69 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.917 0.389 . . . . 0.0 111.123 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.88 54.14 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.51 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -65.96 -32.56 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.867 0.365 . . . . 0.0 110.892 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.53 -51.46 68.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.89 -49.29 75.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -62.03 -36.04 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.2 mm -73.05 -34.73 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -63.0 -47.25 83.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.622 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.6 t -75.03 -38.07 42.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.55 -53.99 21.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.17 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.13 -40.19 92.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.076 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.94 -51.03 71.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.622 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.5 t -61.59 -54.65 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.122 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 28.5 m -57.34 -46.83 82.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.176 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -64.3 -34.76 78.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.922 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.12 -44.77 62.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.9 mpt_? -87.74 7.69 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.866 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.744 ' CD1' HD13 ' A' ' 398' ' ' LEU . 7.2 tp -76.96 -38.61 52.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 7.0 mmt85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.636 0.732 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 173.05 11.59 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.695 2.263 . . . . 0.0 112.321 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -168.19 155.21 7.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -168.5 177.87 5.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -157.5 162.53 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -153.34 172.47 17.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 39.5 tp -156.17 137.18 13.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -156.3 151.74 9.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.13 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -76.92 132.22 38.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -170.41 168.34 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -58.43 136.11 57.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -155.36 158.95 39.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.678 ' HB1' ' HB ' ' A' ' 372' ' ' VAL . . . -51.68 103.07 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.053 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 374' ' ' ALA . . . -96.43 -51.03 1.76 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.54 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 28.1 p -98.63 0.17 44.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.678 ' HB ' ' HB1' ' A' ' 369' ' ' ALA . 89.0 t -90.12 -65.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.617 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.3 t80 -68.56 -26.7 65.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.956 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.13 -29.5 13.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.103 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.34 -28.63 64.84 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.468 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -83.05 -26.71 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt -61.6 -35.72 78.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 83.3 p -48.5 -31.97 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -68.29 -53.62 23.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.978 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.67 17.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.472 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.45 -53.21 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 111.139 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.23 55.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.633 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.7 t80 -66.7 -32.64 74.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.376 . . . . 0.0 110.881 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.35 69.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.83 -49.2 73.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.47 -36.09 79.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.633 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.32 -34.49 43.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.123 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.1 mt -62.93 -47.11 84.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.931 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.6 t -75.38 -37.66 38.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -69.79 -54.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.129 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.55 -43.23 97.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.84 71.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.4 t -64.39 -54.92 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.512 HG21 HD21 ' B' ' 395' ' ' LEU . 60.4 m -55.59 -40.78 72.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 394' ' ' THR . 32.5 mt -71.41 -40.58 70.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.0 m -64.73 -54.19 35.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.839 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -66.87 -13.57 61.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.755 HD13 HD12 ' B' ' 398' ' ' LEU . 24.0 tp -80.04 -72.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.155 0 CA-C-O 121.617 0.722 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.23 35.36 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.726 2.284 . . . . 0.0 112.323 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -97.72 113.39 25.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -96.58 138.75 33.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -63.39 137.24 58.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.903 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -116.45 -26.05 7.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 10.6 mt -52.02 -45.79 64.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.07 142.02 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.36 151.63 26.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -92.22 145.06 24.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.07 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.79 -31.16 5.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.857 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -131.92 149.76 52.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.63 -66.41 0.39 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 89.21 -71.37 2.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.472 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 1.9 m -133.12 17.34 4.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.897 0.379 . . . . 0.0 110.832 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 94.4 t -89.94 -65.58 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.604 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -68.68 -27.11 65.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.588 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.43 -29.3 15.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.081 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.6 -28.57 65.43 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.465 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.81 -26.21 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 111.133 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.67 HD23 HD23 ' A' ' 377' ' ' LEU . 21.5 mt -62.37 -35.73 80.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.933 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 80.2 p -48.62 -31.79 7.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -68.35 -53.61 22.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.97 -53.67 17.89 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.505 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.44 -53.25 41.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.903 0.382 . . . . 0.0 111.124 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.03 -46.06 56.13 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.618 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.75 -32.73 74.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.395 . . . . 0.0 110.894 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.34 69.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.917 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.82 -49.32 73.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.28 -36.31 79.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.618 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.8 mm -73.12 -34.38 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 26.9 mt -63.02 -47.13 84.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.58 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.0 t -75.46 -37.3 37.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.133 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.0 t -70.12 -54.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.13 98.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.28 -50.87 71.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.58 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.0 t -64.15 -54.57 29.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.157 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.501 HG21 HD21 ' A' ' 395' ' ' LEU . 87.1 m -56.1 -40.72 74.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.199 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.512 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.43 -36.7 71.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -70.05 -41.98 73.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.831 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -66.72 -22.68 66.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.755 HD12 HD13 ' A' ' 398' ' ' LEU . 9.6 tt -51.73 -51.35 56.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 116.76 4.71 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.684 2.256 . . . . 0.0 112.39 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -141.92 140.03 32.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -167.81 158.74 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.11 179.04 4.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' B' ' 366' ' ' ALA . 2.8 pm0 -126.49 136.68 52.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.875 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.467 ' HB2' HG21 ' B' ' 364' ' ' VAL . 38.1 mt -96.84 178.49 5.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 364' ' ' VAL . 19.1 m -87.02 123.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.126 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 54.1 mm-40 -154.99 163.17 40.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -92.18 110.86 22.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.079 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -173.09 177.09 2.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 369' ' ' ALA . 6.9 pt-20 -159.82 165.39 32.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.547 ' HB1' ' HB ' ' A' ' 372' ' ' VAL . . . -67.91 136.65 54.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -115.3 -34.77 1.41 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.7 m -118.87 -0.43 11.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.891 0.377 . . . . 0.0 110.851 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.547 ' HB ' ' HB1' ' A' ' 369' ' ' ALA . 21.3 t -90.2 -65.5 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.56 -29.32 65.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.6 60.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.106 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.31 69.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.467 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.29 -22.63 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 111.117 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt -65.68 -34.32 77.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.944 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.8 p -48.85 -33.22 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -67.53 -53.84 25.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.24 -52.93 24.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.3 t -63.66 -51.65 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 111.164 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.9 52.41 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.532 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -65.18 -32.58 74.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.37 . . . . 0.0 110.894 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.23 -51.56 68.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.09 -49.3 75.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.82 -35.96 79.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.28 -34.77 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.124 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.6 mt -62.96 -46.89 85.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -38.22 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 t -69.44 -54.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.136 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.14 97.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.97 -50.46 72.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.09 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.4 t -65.0 -55.06 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.139 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.544 HG21 HD21 ' B' ' 395' ' ' LEU . 61.5 m -55.31 -40.92 71.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.142 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.555 HD21 HG21 ' B' ' 394' ' ' THR . 33.3 mt -71.27 -44.45 65.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.2 m -62.14 -43.68 98.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.64 -23.03 66.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.889 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 1.098 HD13 HD13 ' B' ' 398' ' ' LEU . 8.1 tp -76.63 -35.19 58.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.926 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.919 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 8.2 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.639 0.733 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 125.7 12.45 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.719 2.28 . . . . 0.0 112.337 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -167.12 160.82 14.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -86.2 114.97 23.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -135.96 162.84 31.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.919 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -119.68 178.23 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.7 tt -61.04 112.59 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . 0.467 HG21 ' HB2' ' A' ' 363' ' ' LEU . 26.8 m -129.4 142.56 43.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.129 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -125.74 116.24 21.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 362' ' ' GLU . . . -130.31 130.66 44.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -164.21 124.95 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -161.34 104.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.847 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.599 ' HB1' ' H ' ' B' ' 373' ' ' TYR . . . -57.45 -63.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 86.23 -87.66 1.56 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.504 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 38.9 p -108.26 7.16 27.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 110.878 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . 0.439 ' HB ' ' HB1' ' B' ' 369' ' ' ALA . 21.7 t -89.34 -65.47 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.174 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.599 ' H ' ' HB1' ' B' ' 369' ' ' ALA . 2.0 t80 -70.73 -29.77 66.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.949 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.25 -22.68 63.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.081 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.95 -25.95 71.05 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.484 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.41 -21.88 9.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.828 0.347 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.87 HD23 HD23 ' A' ' 377' ' ' LEU . 23.2 mt -65.68 -34.36 78.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.2 p -48.75 -33.38 10.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.823 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -67.54 -53.79 25.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.21 -52.88 24.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.4 t -63.53 -51.7 67.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.886 0.374 . . . . 0.0 111.137 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.86 -47.75 52.74 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.514 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.2 t80 -65.24 -32.64 74.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 110.892 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.69 67.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.853 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -62.81 -49.24 75.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.95 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.01 -35.94 80.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.852 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.32 -34.74 44.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.158 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 29.1 mt -62.99 -46.91 85.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.593 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.29 -38.27 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.118 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.33 -54.06 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.66 -43.12 98.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.48 72.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.09 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.593 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.6 t -64.99 -55.19 21.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.17 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 395' ' ' LEU . 40.4 m -55.11 -40.95 71.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.544 HD21 HG21 ' A' ' 394' ' ' THR . 33.0 mt -71.34 -45.06 63.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -61.48 -43.68 98.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -66.86 -22.98 65.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 1.098 HD13 HD13 ' A' ' 398' ' ' LEU . 8.0 tp -77.19 -39.16 49.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.929 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 15.5 mmm-85 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.617 0.722 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 173.46 10.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -139.62 164.38 30.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.095 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -102.43 177.09 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.923 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -159.62 169.89 22.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . 0.61 ' O ' HD22 ' A' ' 363' ' ' LEU . 71.7 mm-40 -98.37 145.03 27.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.61 HD22 ' O ' ' A' ' 362' ' ' GLU . 4.3 mm? -127.73 168.22 15.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 26.2 t -95.84 147.36 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.77 155.06 39.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.905 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -85.97 -50.52 7.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.089 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -60.1 172.47 0.79 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.95 157.73 21.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.567 ' HB1' ' H ' ' A' ' 373' ' ' TYR . . . -51.64 -62.12 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.137 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 85.92 -85.0 1.56 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.484 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.0 m -114.16 9.91 17.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.864 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' A' ' 369' ' ' ALA . 25.4 t -90.04 -65.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.114 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.567 ' H ' ' HB1' ' A' ' 369' ' ' ALA . 2.2 t80 -69.47 -30.72 68.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -57.58 -25.82 60.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.101 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.61 -28.42 69.75 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.448 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.5 -24.16 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 0.0 111.135 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' B' ' 377' ' ' LEU . 23.6 mt -64.73 -35.91 82.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 76.0 p -48.97 -32.2 8.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -68.24 -53.84 21.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.935 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.78 -53.31 20.33 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.502 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.14 -53.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.371 . . . . 0.0 111.118 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -46.43 55.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.488 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -66.49 -32.67 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.887 0.375 . . . . 0.0 110.853 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.37 -51.46 68.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.62 -49.18 74.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.57 -36.21 79.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.12 -34.33 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.125 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.3 mt -63.18 -47.39 82.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.614 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.5 t -75.14 -37.45 40.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.98 -54.12 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.18 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.05 -40.89 95.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.076 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.74 -50.94 72.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.092 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 389' ' ' VAL . 99.3 t -62.27 -54.73 30.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.417 HG21 HD21 ' B' ' 395' ' ' LEU . 65.8 m -56.71 -46.95 80.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.41 HD21 HG21 ' B' ' 394' ' ' THR . 34.2 mt -63.92 -35.73 81.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.914 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.4 m -71.12 -45.14 64.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -86.24 6.16 30.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.754 HD13 HD12 ' B' ' 398' ' ' LEU . 8.2 tp -80.44 -34.29 36.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.945 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.124 0 CA-C-O 121.648 0.737 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -44.93 1.8 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.67 2.247 . . . . 0.0 112.351 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -86.03 136.86 33.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.094 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -95.5 145.46 25.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -146.52 141.6 27.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.877 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.14 168.38 9.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.18 139.64 53.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 22.8 m -86.9 -25.45 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.141 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -70.94 151.56 44.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -97.41 160.1 14.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -78.5 112.81 15.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -154.85 135.29 13.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' B' ' 372' ' ' VAL . . . -60.39 121.64 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.088 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -108.19 -53.44 0.65 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.478 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 8.4 m -93.27 1.88 56.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.894 0.378 . . . . 0.0 110.832 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . 0.789 ' HB ' ' HB1' ' B' ' 369' ' ' ALA . 95.5 t -90.12 -65.65 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.682 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.0 t80 -68.62 -25.42 64.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.931 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' B' ' 370' ' ' GLY . . . -51.01 -29.55 12.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.084 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.78 -28.21 65.34 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.533 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . 0.548 HD12 ' CE1' ' B' ' 373' ' ' TYR . 4.8 mt -82.62 -26.74 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.104 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.724 HD23 HD23 ' A' ' 377' ' ' LEU . 23.5 mt -62.56 -35.41 79.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 87.8 p -48.91 -32.3 8.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.815 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.34 -53.93 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.04 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.457 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.3 -53.09 44.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.825 0.345 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.32 55.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.46 -32.82 74.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.878 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.39 69.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.71 -49.26 73.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.46 -36.11 79.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.53 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.92 -47.12 84.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.936 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.595 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.5 t -75.39 -37.78 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.103 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -69.63 -54.1 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.141 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.57 98.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.075 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.7 72.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.9 t -64.13 -54.54 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.41 HG21 HD21 ' A' ' 395' ' ' LEU . 32.9 m -56.28 -40.99 75.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.166 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.417 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.19 -39.28 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.2 m -67.45 -42.81 82.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.79 -21.64 66.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.754 HD12 HD13 ' A' ' 398' ' ' LEU . 10.1 tt -51.34 -68.45 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.944 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.867 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 121.691 0.758 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 111.96 2.95 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.679 2.253 . . . . 0.0 112.341 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -137.34 105.3 5.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -135.58 143.37 45.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -138.02 139.32 39.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -58.6 178.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 8.5 tp -140.34 125.11 18.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.952 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -141.74 151.6 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.132 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -75.86 111.21 10.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -165.23 162.32 19.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.11 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -92.03 106.86 18.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -157.44 179.53 9.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -75.47 166.81 23.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 126.78 54.75 0.14 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.493 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.2 p 51.62 27.93 4.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.0 110.874 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.07 -48.2 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.156 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.63 -30.36 66.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.403 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -62.87 -22.19 66.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -66.64 -23.4 72.21 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.474 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.36 -21.19 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 111.139 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' B' ' 377' ' ' LEU . 19.4 mt -65.1 -35.9 82.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.96 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 59.1 p -48.88 -33.38 10.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -66.93 -53.3 33.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.59 -52.64 24.53 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.6 t -63.42 -53.1 49.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.895 0.379 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.54 -47.99 50.3 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.483 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.636 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.0 t80 -65.07 -32.82 74.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 110.903 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.14 -51.44 69.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.842 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.56 -49.03 75.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.66 -36.16 80.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.636 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.02 -34.43 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.125 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.16 -47.14 83.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.7 t -75.22 -37.52 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.123 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -70.01 -54.09 20.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.5 -43.99 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.86 -50.48 72.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.6 t -65.34 -54.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.167 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.558 HG21 HD21 ' B' ' 395' ' ' LEU . 25.6 m -55.21 -40.96 71.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.528 HD21 HG21 ' B' ' 394' ' ' THR . 33.4 mt -71.31 -46.0 61.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.904 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.69 -44.38 96.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.96 -23.08 65.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.894 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.673 HD13 ' CD2' ' B' ' 398' ' ' LEU . 14.8 tp -77.1 -27.53 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.93 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 21.7 tpt85 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.808 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.618 0.723 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 134.43 28.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.668 2.246 . . . . 0.0 112.358 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -137.57 166.04 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.068 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -94.37 107.04 19.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -149.62 143.25 25.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -109.19 127.35 54.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 7.5 tp -142.19 108.58 5.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 34.2 m -149.11 133.84 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -157.14 146.87 20.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -113.4 167.53 10.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.113 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -145.09 112.68 6.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.85 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -121.66 104.73 9.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.887 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.56 103.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.064 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -133.29 -48.28 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.516 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 2.8 m -126.42 7.73 7.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 0.0 110.874 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.0 -65.14 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.13 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -70.26 -30.34 67.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.932 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.05 -23.05 66.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -66.57 -21.91 71.14 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.469 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.36 -21.31 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.126 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.75 HD23 HD23 ' A' ' 377' ' ' LEU . 19.2 mt -65.19 -35.66 81.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 90.7 p -48.97 -33.48 11.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -66.91 -53.24 33.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.942 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.52 -52.77 24.15 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.446 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.34 -53.0 51.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.65 52.09 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.445 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.624 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.1 t80 -65.49 -32.74 74.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.898 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.15 -51.39 69.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.873 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.71 -48.97 74.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.67 -36.13 79.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.624 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.05 -34.3 45.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.22 -47.26 83.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.572 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.7 t -75.22 -37.43 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.97 -54.11 20.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.125 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.89 96.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.116 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.91 -50.34 72.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.572 HG23 ' O ' ' B' ' 389' ' ' VAL . 97.4 t -65.39 -54.92 23.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 395' ' ' LEU . 23.5 m -55.2 -40.9 71.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.17 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.558 HD21 HG21 ' A' ' 394' ' ' THR . 32.7 mt -71.42 -46.12 60.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.7 m -60.62 -44.47 96.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -66.99 -23.08 65.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.673 ' CD2' HD13 ' A' ' 398' ' ' LEU . 1.5 tt -51.86 -42.36 62.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.576 0.703 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 78.79 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -63.66 158.72 20.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.07 174.78 5.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -111.47 144.04 41.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -117.51 130.25 56.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.87 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 6.6 mt -102.38 164.24 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.972 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 7.3 m -151.53 145.99 16.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -100.09 128.06 46.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -115.46 175.59 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.085 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -75.26 105.14 6.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . 0.715 ' O ' HG23 ' A' ' 372' ' ' VAL . 16.1 tt0 -154.78 157.69 38.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -53.65 -27.1 25.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -64.94 -17.67 63.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.487 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.6 m -122.95 -3.45 8.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.909 0.385 . . . . 0.0 110.815 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 368' ' ' GLU . 93.6 t -90.26 -65.05 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -66.3 -30.56 71.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.53 -23.32 66.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.082 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.57 -25.32 70.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.532 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.47 -22.39 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt -65.26 -35.39 80.87 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 78.9 p -48.85 -33.48 10.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -67.46 -53.41 29.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.942 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.16 -52.71 25.98 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.496 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -63.56 -52.18 60.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.86 0.362 . . . . 0.0 111.133 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.75 -47.72 52.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.464 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.2 t80 -65.25 -32.59 74.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.864 0.364 . . . . 0.0 110.842 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.31 -51.47 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.858 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.21 -49.27 74.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.03 79.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.73 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.92 -47.09 84.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.4 t -75.27 -38.23 40.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.133 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.28 -54.18 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.155 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.0 97.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.94 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.094 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 389' ' ' VAL . 87.0 t -63.57 -54.82 27.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 29.2 m -56.19 -41.07 74.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.6 mt -71.32 -36.36 71.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.95 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -70.22 -41.56 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -66.66 -23.11 66.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.735 HD13 ' CD1' ' B' ' 398' ' ' LEU . 7.6 tp -67.87 -35.51 78.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.621 0.724 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 97.73 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.664 2.242 . . . . 0.0 112.361 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.94 112.61 13.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.081 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -69.06 122.71 19.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -138.58 117.09 12.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -61.65 169.13 2.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 14.9 mt -88.83 106.9 18.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 13.0 p -138.53 138.31 42.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.098 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -57.13 133.03 54.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -120.1 141.71 49.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.116 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -136.19 107.18 6.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -58.33 -42.22 86.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -165.33 166.39 18.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 139.89 -90.53 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.474 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 29.4 p -106.39 0.23 24.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.893 0.377 . . . . 0.0 110.823 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 60.5 t -90.24 -65.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -63.71 -30.16 71.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.9 -23.66 66.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.12 -25.49 69.62 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.473 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.35 -22.78 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 111.132 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.831 HD23 HD23 ' A' ' 377' ' ' LEU . 22.2 mt -65.32 -35.5 81.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.937 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -48.81 -33.47 10.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.48 -53.48 28.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.24 -52.85 24.89 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.456 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.51 -52.14 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.189 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.76 -47.63 52.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.504 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.33 -32.53 74.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 110.901 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.46 -51.51 68.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.09 -49.23 75.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.918 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.83 -36.09 80.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.4 mm -73.2 -34.63 45.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -62.94 -47.36 83.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.625 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.2 t -74.98 -38.1 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.143 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.45 -54.03 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.03 92.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.114 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.05 71.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.625 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.6 t -61.6 -54.74 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 32.5 m -57.17 -46.78 82.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.1 mt -64.35 -34.56 78.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -72.21 -45.09 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -87.3 7.4 28.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.735 ' CD1' HD13 ' A' ' 398' ' ' LEU . 7.8 tp -76.59 -34.97 58.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.868 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.639 0.733 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 171.54 14.28 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.692 2.261 . . . . 0.0 112.323 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -143.85 160.71 40.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.07 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.85 174.58 14.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -100.58 162.9 12.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.7 158.73 18.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 3.5 pp -158.46 162.76 37.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 11.6 m -119.05 145.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -102.4 -37.72 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -54.65 166.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.57 113.06 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -164.6 161.79 21.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -66.21 -179.87 0.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 127.4 -100.74 0.55 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.447 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.5 p -97.99 3.83 49.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 110.889 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 24.7 t -90.03 -65.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.83 -31.02 68.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -61.77 -23.73 66.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.094 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.53 -25.05 69.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.437 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.25 -22.85 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.88 0.371 . . . . 0.0 111.124 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' B' ' 377' ' ' LEU . 22.8 mt -65.02 -36.67 85.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 77.5 p -48.94 -33.28 10.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -67.64 -53.46 27.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.38 -52.83 24.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.3 t -64.09 -52.45 56.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 111.107 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.15 53.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.635 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -65.86 -32.49 74.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.848 0.356 . . . . 0.0 110.841 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.5 68.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.31 -49.22 74.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.86 -36.07 80.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.857 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.635 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.16 -34.48 44.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.12 -47.24 83.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' A' ' 393' ' ' VAL . 48.5 t -75.16 -37.49 40.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.0 t -70.15 -54.03 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.122 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.63 -42.31 96.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.111 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.63 72.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.9 t -63.69 -55.03 24.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.079 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.59 HG21 HD21 ' B' ' 395' ' ' LEU . 94.4 m -55.73 -46.24 77.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.163 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.541 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -64.09 -36.06 82.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.898 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.1 m -70.83 -44.69 65.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -86.41 5.82 33.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.953 HD12 HD12 ' B' ' 398' ' ' LEU . 1.1 tt -80.83 -35.97 32.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.604 0.716 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 136.09 32.11 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.738 2.292 . . . . 0.0 112.299 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -62.71 105.9 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.058 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -131.92 137.52 48.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -138.78 120.08 14.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -146.95 104.67 3.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 8.1 tp -130.04 123.14 29.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 29.0 m -68.36 142.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.29 111.97 4.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -138.04 106.15 5.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -81.9 -49.55 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 52.5 38.69 26.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -106.08 27.09 8.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.23 66.95 1.76 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.25 28.75 4.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.865 0.364 . . . . 0.0 110.867 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 84.5 t -88.22 -46.79 15.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.127 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -70.24 -30.68 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.57 66.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.106 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -65.21 -25.8 71.26 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.24 -22.36 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.867 0.365 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.797 HD23 HD23 ' A' ' 377' ' ' LEU . 23.8 mt -65.06 -36.37 84.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.931 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.0 p -49.01 -33.18 10.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -67.82 -53.37 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.44 -53.02 23.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.5 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.414 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -64.28 -52.61 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.142 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -46.97 54.07 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.474 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.622 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.8 t80 -65.98 -32.6 74.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.879 0.371 . . . . 0.0 110.919 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.48 68.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.851 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.58 -49.05 74.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.8 -36.03 79.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.622 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.3 mm -73.09 -34.71 46.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.101 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.5 mt -63.06 -46.99 84.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.576 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.27 -37.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -70.03 -54.13 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.73 96.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.106 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.18 -50.43 72.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.0 t -65.22 -54.89 23.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.541 HG21 HD21 ' A' ' 395' ' ' LEU . 87.7 m -55.32 -40.96 71.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.129 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.59 HD21 HG21 ' A' ' 394' ' ' THR . 32.4 mt -71.26 -45.84 62.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.2 m -60.93 -44.75 96.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.895 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -66.88 -22.99 65.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.953 HD12 HD12 ' A' ' 398' ' ' LEU . 7.0 tt -52.04 -60.34 3.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.878 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.956 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.58 0.705 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 113.85 3.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.47 133.76 42.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.095 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -140.04 176.45 8.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -142.28 144.3 33.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -151.83 163.17 39.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.15 149.1 52.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.06 149.96 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.153 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -83.94 126.99 33.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -170.71 171.0 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -55.68 171.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -172.65 168.6 5.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.4 ' H ' ' HB1' ' B' ' 369' ' ' ALA . . . -52.17 -76.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 89.95 -88.68 1.48 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.481 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 37.4 p -108.78 11.88 26.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 0.0 110.792 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.18 -65.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.663 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.0 t80 -68.97 -24.94 64.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.25 -28.76 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.2 -28.56 66.93 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.491 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.532 HD12 ' CE1' ' A' ' 373' ' ' TYR . 5.1 mt -83.0 -27.19 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 111.125 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' B' ' 377' ' ' LEU . 18.8 mt -59.84 -33.83 72.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 99.8 p -48.6 -32.25 7.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.871 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -67.99 -53.75 23.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.92 -53.1 20.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.513 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.92 -53.07 45.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.94 -46.74 55.15 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.498 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.626 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.1 t80 -66.11 -32.6 74.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.889 0.376 . . . . 0.0 110.9 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.45 -51.39 68.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.78 -49.12 74.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.1 79.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.16 -34.7 45.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -62.93 -47.05 84.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 393' ' ' VAL . 47.8 t -75.31 -37.78 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.137 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.67 -54.23 20.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.159 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.41 -43.64 96.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.45 72.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.087 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -65.14 -54.63 27.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.592 HG21 HD21 ' B' ' 395' ' ' LEU . 50.3 m -55.7 -40.49 72.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.571 HD21 HG21 ' B' ' 394' ' ' THR . 32.1 mt -71.32 -37.97 71.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.4 m -68.93 -41.83 77.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -67.07 -22.99 65.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.493 HD12 HD13 ' B' ' 398' ' ' LEU . 10.3 tt -51.68 -52.61 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.96 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 25.9 mmm-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.615 0.721 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.37 16.77 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.728 2.285 . . . . 0.0 112.315 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . 59.94 37.21 21.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.091 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -116.02 147.48 41.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -136.85 143.11 42.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.86 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -118.41 135.67 54.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . 0.64 HD23 ' N ' ' B' ' 364' ' ' VAL . 3.3 tt -123.79 144.18 49.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . 0.64 ' N ' HD23 ' B' ' 363' ' ' LEU . 60.4 t -124.54 130.52 73.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.125 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -71.06 146.32 49.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.2 136.05 29.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.132 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -90.33 146.82 23.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -106.74 112.02 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.4 ' HB1' ' H ' ' A' ' 369' ' ' ALA . . . -124.38 8.33 8.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -120.89 -20.7 3.37 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.524 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 4.2 m -108.2 -4.42 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 0.0 110.868 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.2 -65.71 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.121 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.653 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.0 t80 -68.8 -24.4 64.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.616 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -50.88 -29.31 11.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.136 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.68 -28.75 65.87 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.505 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . 0.547 HD12 ' CE1' ' B' ' 373' ' ' TYR . 5.1 mt -83.19 -27.44 7.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.113 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.729 HD23 HD23 ' A' ' 377' ' ' LEU . 20.2 mt -59.58 -33.61 71.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.6 p -48.6 -32.22 7.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -68.09 -53.84 22.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.952 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.91 -53.27 20.01 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.489 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.01 -53.02 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.927 0.394 . . . . 0.0 111.158 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.95 -46.65 55.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.498 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.23 -32.66 74.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 110.856 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.38 68.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.79 -49.09 74.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.05 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.21 -34.42 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.14 -47.07 84.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.569 ' O ' HG23 ' B' ' 393' ' ' VAL . 42.6 t -75.39 -37.29 37.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.145 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.23 -54.16 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.54 -43.58 97.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.102 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.33 -50.5 72.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.569 HG23 ' O ' ' B' ' 389' ' ' VAL . 93.3 t -64.81 -54.51 29.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.571 HG21 HD21 ' A' ' 395' ' ' LEU . 89.3 m -55.95 -40.72 73.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.13 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.592 HD21 HG21 ' A' ' 394' ' ' THR . 32.0 mt -71.33 -40.3 70.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.6 m -66.49 -42.76 86.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 20.2 mmt180 -66.91 -22.11 65.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 398' ' ' LEU . 37.8 tp -51.32 -32.5 25.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.952 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 20.2 mt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.647 0.737 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 170.08 17.39 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.733 2.289 . . . . 0.0 112.313 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -107.26 178.55 4.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.098 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -132.91 107.8 8.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -90.61 150.73 21.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -127.48 130.22 48.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -148.46 144.81 27.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 17.9 m -151.32 174.85 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.147 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -78.28 -25.98 46.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . 63.55 48.03 3.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.12 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -65.58 113.79 4.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 58.3 29.07 17.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -115.27 32.06 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.105 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 374' ' ' ALA . . . -131.33 -43.85 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.46 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 6.9 p -88.0 0.18 56.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.923 0.392 . . . . 0.0 110.853 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 95.4 t -90.22 -65.45 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.681 ' CE1' HD11 ' B' ' 377' ' ' LEU . 1.9 t80 -68.23 -25.07 65.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.891 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 370' ' ' GLY . . . -50.68 -30.71 14.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.099 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -58.42 -28.3 61.92 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.481 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.604 HD12 ' CE1' ' A' ' 373' ' ' TYR . 5.1 mt -82.61 -26.39 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.091 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' B' ' 377' ' ' LEU . 23.0 mt -63.73 -34.46 77.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.81 -32.42 8.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -68.23 -53.94 21.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.935 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.91 -53.36 19.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.95 -52.94 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.891 0.377 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.93 -46.85 55.04 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.543 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.632 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.8 t80 -66.08 -32.63 74.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.857 0.361 . . . . 0.0 110.888 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.46 68.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.0 mt -63.76 -49.07 74.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.965 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.54 -36.08 79.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.632 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.18 -34.42 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.146 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.24 -47.2 83.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.62 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.5 t -75.12 -37.46 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -70.04 -53.98 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.115 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.19 -40.19 93.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.1 71.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 389' ' ' VAL . 98.3 t -61.19 -54.7 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 16.9 m -57.43 -48.42 79.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.405 HD21 HG21 ' B' ' 394' ' ' THR . 34.4 mt -62.53 -37.23 85.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.927 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 15.6 m -70.08 -44.32 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.73 3.79 35.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.762 HD12 HD13 ' B' ' 398' ' ' LEU . 4.4 tp -71.09 -39.44 72.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.947 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.857 179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.563 0.697 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 78.76 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.696 2.264 . . . . 0.0 112.332 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -134.48 160.58 37.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.109 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -84.02 148.65 26.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -149.67 169.38 21.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.899 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -153.89 124.63 7.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 5.3 tp -93.61 151.02 19.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.957 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . 0.599 HG22 ' H ' ' B' ' 366' ' ' ALA . 7.2 p -149.95 126.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.168 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -113.46 27.84 9.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . 0.599 ' H ' HG22 ' B' ' 364' ' ' VAL . . . -79.48 -27.47 41.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.099 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.08 -58.17 7.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 51.72 51.51 16.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . 54.09 57.67 5.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -99.79 -82.29 1.66 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.7 m -86.99 2.67 48.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.902 0.382 . . . . 0.0 110.878 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 67.1 t -90.0 -65.07 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.16 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.529 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -68.48 -30.93 69.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.503 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -54.53 -28.29 44.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.29 -28.45 64.43 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.85 -24.56 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.849 0.357 . . . . 0.0 111.138 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.741 HD23 HD23 ' A' ' 377' ' ' LEU . 22.1 mt -65.78 -35.02 79.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 78.4 p -48.78 -32.57 8.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.839 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -68.04 -53.77 23.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.76 -53.19 21.04 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.503 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.3 t -64.82 -53.04 46.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.899 0.381 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.85 -46.63 54.75 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.533 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -66.12 -32.79 74.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.921 0.391 . . . . 0.0 110.9 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -51.45 68.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.61 -49.07 74.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.64 -36.3 80.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.05 -34.54 45.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.108 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.05 -47.19 84.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.585 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.4 t -75.24 -37.66 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.9 t -69.88 -54.2 20.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.6 -42.84 97.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.13 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.43 -50.88 71.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.135 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.585 HG23 ' O ' ' B' ' 389' ' ' VAL . 98.1 t -63.87 -54.46 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 395' ' ' LEU . 60.3 m -56.38 -40.8 75.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.31 -34.4 70.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.88 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.2 m -72.53 -41.54 65.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -66.95 -23.06 65.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.762 HD13 HD12 ' A' ' 398' ' ' LEU . 15.5 tp -61.95 -36.47 81.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.914 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.602 0.715 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 120.91 7.63 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.694 2.263 . . . . 0.0 112.341 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -78.13 151.55 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -135.53 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -167.57 157.1 10.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -146.85 163.58 35.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.26 168.88 18.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.866 HG21 HG21 ' B' ' 372' ' ' VAL . 29.1 t -137.87 139.72 42.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.116 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.16 153.18 40.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -103.99 30.71 4.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -80.87 -53.18 6.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 171.64 5.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.873 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 52.53 52.2 14.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -82.23 -86.31 0.74 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.47 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 19.8 p -102.49 5.94 39.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.964 0.411 . . . . 0.0 110.846 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.93 -65.24 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.171 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.569 ' CE2' HD11 ' B' ' 377' ' ' LEU . 2.4 t80 -69.06 -31.29 69.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.965 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.489 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -56.71 -26.57 57.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.97 -28.29 68.47 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.529 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.64 -24.46 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 111.114 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' B' ' 377' ' ' LEU . 22.3 mt -65.63 -36.64 84.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 87.4 p -49.12 -31.97 9.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -68.35 -53.78 21.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.929 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.97 -53.36 19.37 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.486 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 7.6 t -65.56 -53.35 40.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 111.112 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.15 -46.0 56.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.509 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.1 t80 -66.85 -32.67 74.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.55 68.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.52 -49.22 74.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.47 -36.29 80.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.912 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.7 mm -73.2 -34.85 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.146 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.46 -47.27 84.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.914 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.9 t -75.34 -38.06 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.1 t -69.3 -54.39 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.52 97.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.089 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.08 -50.44 72.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.092 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 389' ' ' VAL . 89.2 t -64.59 -55.0 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.16 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 26.7 m -55.72 -40.49 72.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 31.9 mt -71.14 -34.02 70.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.93 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.5 m -73.51 -39.39 64.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 17.0 mmt85 -66.69 -23.47 66.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.867 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.975 HD22 HD12 ' B' ' 398' ' ' LEU . 1.0 OUTLIER -103.69 -13.67 16.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.862 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . 0.411 HD23 ' HD2' ' B' ' 358' ' ' PRO . 1.6 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.644 0.735 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . 0.411 ' HD2' HD23 ' B' ' 357' ' ' LEU . 54.0 Cg_endo -69.74 148.77 65.92 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.668 2.245 . . . . 0.0 112.349 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -80.77 162.71 23.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -107.27 178.07 4.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -110.17 128.88 55.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -60.52 -64.32 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 31.2 mt -102.39 175.69 5.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 33.4 m -91.39 -25.89 5.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -147.32 139.42 24.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.878 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -147.9 141.96 25.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.092 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -96.76 106.42 18.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.838 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -81.92 -26.48 34.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -155.99 105.95 2.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -167.96 -73.37 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.489 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.5 p -99.29 3.23 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.846 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . 0.866 HG21 HG21 ' A' ' 364' ' ' VAL . 98.3 t -90.08 -65.32 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.116 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.575 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -68.46 -27.97 66.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.424 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.37 -29.43 15.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.068 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.4 -28.22 64.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.501 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.46 -24.96 8.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.905 0.383 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.68 HD23 HD23 ' A' ' 377' ' ' LEU . 25.0 mt -65.31 -36.89 85.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -48.73 -31.75 7.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.864 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -68.33 -53.77 21.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -69.06 -53.67 17.54 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.479 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.31 -53.21 42.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.898 0.38 . . . . 0.0 111.125 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.41 56.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.5 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.616 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -66.39 -32.71 74.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.25 -51.51 68.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.75 -49.13 74.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.52 -36.2 79.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.616 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.15 -34.52 45.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.116 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.87 -47.51 83.04 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.899 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.632 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.05 -37.64 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.71 -54.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.41 90.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.166 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.36 -51.18 71.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.632 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -60.95 -54.42 35.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 40.3 m -57.82 -47.14 83.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.155 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -64.33 -34.42 78.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.7 m -72.38 -45.53 59.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -85.16 4.34 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.975 HD12 HD22 ' A' ' 398' ' ' LEU . 1.2 tt -76.16 -36.81 58.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 179.963 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.648 0.737 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 130.1 18.75 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.685 2.257 . . . . 0.0 112.381 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -101.57 148.02 25.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -77.92 147.35 35.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -120.14 171.16 8.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -127.92 150.92 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.939 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 9.9 tp -84.85 133.42 34.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.904 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.567 HG22 ' H ' ' A' ' 366' ' ' ALA . 7.5 p -152.96 125.67 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -114.17 33.63 5.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.567 ' H ' HG22 ' A' ' 364' ' ' VAL . . . -111.76 -48.43 3.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.075 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -115.01 176.04 5.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 61.5 40.35 13.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.933 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 63.7 58.17 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -93.36 -65.12 1.06 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.459 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 26.7 p -105.71 6.65 32.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.825 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.63 -65.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.407 ' CE2' HD11 ' B' ' 377' ' ' LEU . 2.2 t80 -69.08 -30.86 69.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.92 -24.24 65.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.082 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.86 -25.54 69.29 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.493 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.38 -23.04 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.833 0.349 . . . . 0.0 111.099 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' B' ' 377' ' ' LEU . 24.9 mt -65.22 -36.58 84.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.0 p -49.15 -32.87 10.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.844 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.93 -53.56 25.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.48 -53.05 22.81 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.522 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -64.33 -52.84 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.905 0.383 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.78 -46.87 54.18 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.6 t80 -66.0 -32.48 73.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.915 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.49 -51.4 68.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.45 -49.15 74.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.72 -36.23 80.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.82 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.15 -34.35 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.15 -47.48 82.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.623 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -74.95 -37.57 41.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.182 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.89 -54.07 20.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.92 92.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.07 71.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 389' ' ' VAL . 96.4 t -61.24 -54.58 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.129 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 7.1 m -57.55 -47.63 81.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.151 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -63.7 -35.41 80.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.34 -45.13 63.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -86.72 6.85 29.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.732 HD12 HD13 ' B' ' 398' ' ' LEU . 0.9 OUTLIER -80.0 -36.94 35.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.982 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.585 0.707 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 152.27 69.61 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.663 2.242 . . . . 0.0 112.398 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -59.38 140.75 55.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -77.36 155.3 32.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -153.38 165.34 36.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -119.22 104.09 10.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.2 107.23 4.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.927 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.65 -35.94 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.166 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 52.59 47.55 24.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.01 155.29 18.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -86.39 150.28 24.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -150.46 163.71 37.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -69.17 165.32 20.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.137 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 136.34 -96.76 0.26 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.52 3.79 52.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.894 0.378 . . . . 0.0 110.821 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 44.5 t -90.06 -65.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.103 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -69.0 -30.86 69.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.969 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.65 -24.63 65.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.59 -25.44 68.83 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.488 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.5 mt -82.26 -23.44 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.802 HD23 HD23 ' A' ' 377' ' ' LEU . 24.2 mt -65.07 -36.64 84.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.915 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 77.6 p -49.03 -32.91 10.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -68.01 -53.64 24.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.9 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.53 -53.04 22.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.501 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.4 t -64.37 -52.74 51.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 111.11 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -46.82 54.44 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -66.13 -32.55 74.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.915 0.388 . . . . 0.0 110.909 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.51 68.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.857 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.44 -49.12 74.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.8 -36.14 80.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.21 -34.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.142 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.23 -47.36 82.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.619 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.8 t -75.07 -37.45 40.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.155 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.97 -54.1 20.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.83 91.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.071 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.51 -51.08 71.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.067 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.619 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -60.66 -54.41 35.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 47.0 m -58.13 -47.7 82.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.115 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.5 mt -63.67 -34.97 79.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.2 m -72.11 -45.11 61.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.878 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -86.93 7.49 27.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.897 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.732 HD13 HD12 ' A' ' 398' ' ' LEU . 7.0 tp -78.37 -36.8 45.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.62 0.724 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 161.11 47.21 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.656 2.238 . . . . 0.0 112.359 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -159.05 163.77 36.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.122 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.93 177.92 0.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.839 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -132.88 139.29 47.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.935 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -110.76 138.36 47.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.841 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 364' ' ' VAL . 1.8 tt -132.95 141.03 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.926 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . 0.485 ' N ' HD23 ' A' ' 363' ' ' LEU . 10.8 p -115.53 151.67 17.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -138.7 147.68 43.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -62.72 176.85 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.95 115.01 8.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -153.1 175.23 13.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -64.29 113.84 3.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -171.53 -71.56 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.523 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 24.8 p -104.91 5.44 32.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.39 . . . . 0.0 110.845 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 45.7 t -89.98 -65.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.124 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -69.54 -31.09 69.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.88 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.102 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.14 -25.2 69.42 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.474 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.42 -23.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.884 0.373 . . . . 0.0 111.1 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' B' ' 377' ' ' LEU . 22.6 mt -64.81 -36.74 85.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.7 p -49.19 -33.37 12.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.52 -53.38 29.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.46 -52.99 23.2 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.464 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.7 t -63.67 -52.86 52.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.66 -47.37 52.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.485 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -65.53 -32.62 74.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.887 0.375 . . . . 0.0 110.832 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.42 -51.49 68.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.54 -49.0 75.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.929 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.79 -36.3 80.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.831 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.13 -34.69 45.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.115 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.5 mt -62.84 -47.08 84.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.1 t -75.38 -37.85 39.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.173 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -69.55 -54.24 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.114 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.88 97.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.074 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.16 70.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.122 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.0 t -62.94 -54.83 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.148 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 35.9 m -56.4 -41.13 75.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.164 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.3 -33.8 70.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.907 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.5 m -71.88 -55.98 6.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -66.61 -14.0 61.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.564 HD13 ' CD2' ' B' ' 398' ' ' LEU . 5.1 tp -67.16 -63.78 0.99 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . 0.461 HD23 ' HD2' ' B' ' 358' ' ' PRO . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.618 0.723 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . 0.461 ' HD2' HD23 ' B' ' 357' ' ' LEU . 53.9 Cg_endo -69.69 132.21 22.96 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.729 2.286 . . . . 0.0 112.342 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -85.25 158.72 20.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.063 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -91.34 170.33 10.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -65.78 -49.24 69.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.66 177.22 3.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.866 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 46.4 mt -77.27 -46.45 23.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 18.7 m -149.9 160.9 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -164.21 156.05 16.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -169.72 145.79 3.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.093 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -102.2 120.0 39.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -146.86 179.72 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -104.0 34.16 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.084 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -77.39 -74.47 0.99 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 25.4 p -104.24 4.42 33.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.878 0.371 . . . . 0.0 110.851 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 41.9 t -89.93 -65.23 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.129 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -68.99 -31.26 69.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.922 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -63.4 -23.78 67.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.079 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -64.27 -25.03 69.49 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.54 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.6 mt -82.41 -22.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 0.0 111.145 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.798 HD23 HD23 ' A' ' 377' ' ' LEU . 22.6 mt -65.11 -36.58 84.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 93.5 p -48.96 -33.29 10.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -67.65 -53.29 29.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.46 -52.9 23.66 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.48 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.5 t -63.87 -52.9 51.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.16 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.7 -47.25 53.06 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.529 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.0 t80 -65.54 -32.63 74.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -51.45 68.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.876 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.6 -49.07 74.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.16 80.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.7 mm -73.3 -34.68 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.128 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.79 -47.07 85.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.599 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.4 t -75.38 -38.08 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.114 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.3 -54.17 21.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.31 98.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.118 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.21 -50.5 72.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.599 HG23 ' O ' ' B' ' 389' ' ' VAL . 87.5 t -64.44 -54.92 24.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 18.5 m -55.75 -40.89 73.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.153 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.3 -42.26 68.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -63.33 -54.18 41.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -66.71 -13.68 61.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.564 ' CD2' HD13 ' A' ' 398' ' ' LEU . 2.8 tt -55.8 -51.73 66.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.877 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.636 0.731 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 132.7 23.97 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.716 2.278 . . . . 0.0 112.381 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -70.1 144.28 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -138.5 159.3 42.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -150.37 149.58 30.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -140.57 172.57 12.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.852 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 12.4 mt -137.3 114.15 10.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 32.4 m -143.74 164.07 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.143 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -64.63 130.44 43.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -167.61 -177.4 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.086 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -161.28 109.95 1.56 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -147.89 111.23 4.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.933 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -159.3 87.03 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.085 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -127.32 -84.27 0.47 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.454 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -92.48 4.23 53.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.919 0.39 . . . . 0.0 110.87 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 32.5 t -90.18 -65.46 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.125 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.72 -28.77 66.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -57.14 -26.62 60.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.085 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.88 -25.94 64.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.473 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.44 -24.58 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.884 0.374 . . . . 0.0 111.158 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' B' ' 377' ' ' LEU . 20.7 mt -65.66 -33.58 76.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 86.4 p -48.38 -33.8 9.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -66.96 -53.81 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.9 -52.72 27.08 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.9 t -62.72 -51.37 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.909 0.385 . . . . 0.0 111.163 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -48.54 50.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.458 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.629 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 21.3 t80 -64.44 -32.61 74.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.879 0.371 . . . . 0.0 110.849 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.33 -51.54 68.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.33 -49.22 74.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.68 -36.08 79.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.629 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.4 mm -73.24 -34.31 43.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.2 mt -63.25 -47.1 83.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.7 t -75.34 -37.43 38.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.1 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -70.07 -54.12 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.23 97.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.099 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.44 -50.58 72.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.66 -54.52 29.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.578 HG21 HD21 ' B' ' 395' ' ' LEU . 26.1 m -55.92 -41.01 73.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.6 HD21 HG21 ' B' ' 394' ' ' THR . 32.8 mt -71.16 -41.31 70.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.7 m -65.44 -43.38 90.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.864 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -67.05 -23.2 65.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.872 HD12 HD13 ' B' ' 398' ' ' LEU . 1.6 tt -72.42 -30.06 64.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.862 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.663 0.744 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 129.44 17.53 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.686 2.257 . . . . 0.0 112.325 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -102.8 114.86 29.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.098 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -149.8 167.36 26.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -119.38 113.1 20.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.857 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -136.77 132.54 34.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.57 146.73 28.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.25 146.92 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.152 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -80.82 -46.76 14.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -61.17 160.51 10.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.072 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -102.23 161.01 14.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -155.41 150.92 27.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -167.58 101.92 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.54 69.99 1.98 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.425 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.26 28.62 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.904 0.383 . . . . 0.0 110.856 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.85 -65.27 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.146 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -69.82 -28.75 65.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.84 -26.37 61.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.122 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.13 -25.81 64.98 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.459 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.42 -24.4 8.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.852 0.358 . . . . 0.0 111.123 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.858 HD23 HD23 ' A' ' 377' ' ' LEU . 20.6 mt -65.54 -33.56 76.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 84.0 p -48.4 -33.9 9.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -66.88 -53.74 29.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.874 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.419 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.79 -52.67 27.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.476 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.0 t -62.59 -51.36 73.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 0.0 111.126 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.83 -48.3 51.29 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.505 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.614 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.7 t80 -64.54 -32.6 74.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.883 0.373 . . . . 0.0 110.847 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -51.64 67.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.838 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.2 -49.16 75.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.78 -36.11 80.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.614 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.26 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.29 -47.05 83.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.37 -37.36 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.18 -54.06 20.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.151 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.53 -43.7 96.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.51 72.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.9 t -64.98 -54.72 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.6 HG21 HD21 ' A' ' 395' ' ' LEU . 91.4 m -55.54 -40.89 72.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.16 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.25 -44.08 66.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 18.8 m -62.74 -43.89 97.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.872 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.93 -23.14 65.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.918 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.872 HD13 HD12 ' A' ' 398' ' ' LEU . 16.2 tp -75.31 -36.38 61.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.908 179.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.231 0.132 0 CA-C-O 121.615 0.721 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.27 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.662 2.242 . . . . 0.0 112.317 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.71 166.01 13.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.093 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -66.42 178.13 1.32 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.96 105.38 16.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -114.91 177.07 4.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.59 121.42 5.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 29.0 m -136.05 172.43 15.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.135 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -80.04 153.75 28.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.894 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . 0.666 ' HB3' ' N ' ' B' ' 367' ' ' ASP . . . -175.84 177.81 1.61 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -129.39 41.47 3.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.43 96.54 2.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -147.18 93.19 2.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.079 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -139.44 -68.71 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.1 m -109.86 2.95 20.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.845 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.07 -65.42 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.402 ' CE1' HD12 ' A' ' 376' ' ' ILE . 1.9 t80 -70.08 -28.89 65.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.81 -25.43 55.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.2 -26.19 67.39 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.402 HD12 ' CE1' ' A' ' 373' ' ' TYR . 5.1 mt -82.34 -23.64 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt -65.86 -33.12 75.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 89.2 p -48.62 -33.54 10.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.851 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.11 -53.93 26.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.913 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.06 -52.91 25.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.496 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 377' ' ' LEU . 5.7 t -62.89 -51.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 111.125 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.92 -48.52 51.36 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.48 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -64.46 -32.58 74.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -51.6 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.11 -49.27 75.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -61.77 -36.06 79.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.24 -34.39 44.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.14 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -63.13 -47.35 83.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.968 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.635 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.9 t -75.0 -37.97 42.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.2 t -69.54 -53.96 22.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.22 -39.9 91.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.113 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.96 -51.18 71.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 389' ' ' VAL . 88.9 t -61.43 -54.94 28.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.109 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 3.5 m -57.02 -47.14 81.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.161 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 33.7 mt -63.96 -35.3 80.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.3 m -71.36 -45.18 63.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -86.56 6.46 30.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.942 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.702 ' CD1' HD13 ' B' ' 398' ' ' LEU . 13.7 tp -79.78 -35.01 39.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.887 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.8 tpp85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.935 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.624 0.726 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 107.51 1.88 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -165.57 162.78 19.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -68.74 146.69 52.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -130.85 134.9 47.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -95.87 163.41 13.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.933 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . 0.417 ' O ' HD12 ' B' ' 363' ' ' LEU . 3.2 pp -75.78 129.42 37.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 45.3 t -146.93 147.07 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.09 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -56.23 133.21 52.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -107.39 141.15 39.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.147 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . 0.666 ' N ' ' HB3' ' A' ' 366' ' ' ALA . 2.9 t0 -60.31 -172.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 26.9 mp0 -130.88 -173.88 3.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.428 ' HB1' ' HB ' ' B' ' 372' ' ' VAL . . . -51.44 -69.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.047 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 97.18 -65.34 0.93 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.527 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 2.7 m -132.07 7.45 4.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.949 0.404 . . . . 0.0 110.893 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . 0.428 ' HB ' ' HB1' ' B' ' 369' ' ' ALA . 21.5 t -90.1 -65.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.425 ' CE1' HD12 ' B' ' 376' ' ' ILE . 1.9 t80 -70.11 -28.81 65.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -56.82 -25.29 55.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.134 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.6 -25.72 67.55 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.464 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' B' ' 373' ' ' TYR . 5.0 mt -82.31 -23.43 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.119 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.888 HD23 HD23 ' A' ' 377' ' ' LEU . 21.0 mt -65.86 -33.23 75.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.927 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 70.5 p -48.58 -33.46 9.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -67.26 -54.03 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.05 -52.82 25.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.488 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.6 t -63.05 -51.33 73.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.822 0.344 . . . . 0.0 111.146 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.35 51.23 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.509 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -64.75 -32.56 74.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 0.0 110.866 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.5 68.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.25 -49.16 75.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.88 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.92 -35.96 79.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.34 -34.59 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.99 -47.07 84.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.952 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.6 ' O ' HG23 ' B' ' 393' ' ' VAL . 46.5 t -75.24 -38.18 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 t -69.4 -54.24 20.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.112 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.9 96.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.73 72.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.6 HG23 ' O ' ' B' ' 389' ' ' VAL . 86.8 t -63.65 -54.66 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.115 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 22.8 m -56.36 -41.15 75.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 33.2 mt -71.19 -36.47 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.8 m -70.08 -41.8 73.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -66.71 -22.96 66.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.702 HD13 ' CD1' ' A' ' 398' ' ' LEU . 7.5 tp -68.08 -37.63 81.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.985 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.628 0.728 . . . . 0.0 110.947 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -173.32 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 179.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -168.01 160.42 12.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.098 179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -145.48 145.74 31.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -151.69 167.59 27.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.869 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . 0.549 ' C ' HD12 ' A' ' 363' ' ' LEU . 12.6 mp0 -111.14 164.99 12.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 362' ' ' GLU . 5.4 mp -150.38 173.58 13.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.89 151.66 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -141.79 166.17 25.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -56.58 178.85 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.093 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.8 120.37 39.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.889 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -156.32 159.64 38.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . 51.93 46.58 26.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.101 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 374' ' ' ALA . . . -93.31 -39.68 5.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.501 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 16.6 p -99.3 -0.22 41.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.844 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 91.7 t -90.12 -65.43 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.56 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.2 t80 -69.06 -25.42 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.702 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.45 -28.17 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.056 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -61.98 -28.44 70.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.489 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.89 -27.54 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.834 0.349 . . . . 0.0 111.141 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 374' ' ' ALA . 19.7 mt -57.02 -35.68 69.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.4 p -48.64 -31.7 7.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -68.43 -53.58 22.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.97 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -69.07 -53.63 17.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.468 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.1 t -65.46 -53.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.901 0.381 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.26 55.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.498 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.0 t80 -66.65 -32.7 74.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 0.0 110.855 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -51.49 68.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.55 -49.27 74.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.56 -36.16 79.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.15 -34.53 45.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.91 -47.53 82.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' A' ' 393' ' ' VAL . 44.3 t -75.01 -37.77 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.128 179.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.62 -54.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.61 91.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.2 71.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 389' ' ' VAL . 84.3 t -61.19 -54.52 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.16 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 84.8 m -57.59 -47.31 82.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.14 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 34.0 mt -63.96 -34.9 79.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -71.96 -44.95 62.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.906 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -87.61 7.9 27.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.854 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.76 HD12 HD13 ' B' ' 398' ' ' LEU . 0.8 OUTLIER -78.41 -28.44 46.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 -179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.962 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 10.3 tp . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.645 0.736 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 128.25 15.77 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.688 2.259 . . . . 0.0 112.351 179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -117.84 139.63 50.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.87 107.97 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -136.2 116.49 13.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -152.66 140.37 19.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.938 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 9.3 mt -126.88 122.44 34.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 10.2 p -123.14 137.68 55.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.152 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -131.58 133.6 45.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.39 114.22 4.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.094 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -115.27 114.74 25.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.87 -28.74 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -129.68 103.46 6.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . 165.21 -35.41 0.26 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.456 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 25.4 p -103.49 1.35 32.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.902 0.382 . . . . 0.0 110.848 -179.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.22 -65.41 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.096 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.564 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.1 t80 -69.01 -25.68 64.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.921 -179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.46 -28.31 12.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.103 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.0 -28.5 70.52 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.447 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.75 -27.44 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.891 0.377 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.669 HD23 HD23 ' A' ' 377' ' ' LEU . 20.4 mt -57.48 -35.39 70.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.94 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 95.5 p -48.74 -31.67 7.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.839 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -68.48 -53.61 22.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.411 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.93 -53.68 18.0 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.514 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.51 -53.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -46.12 56.02 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.619 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.9 t80 -66.81 -32.65 74.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.884 0.373 . . . . 0.0 110.868 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.48 68.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.62 -49.11 74.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.921 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.66 -36.17 80.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.619 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.15 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.7 mt -62.9 -47.44 83.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.631 ' O ' HG23 ' B' ' 393' ' ' VAL . 47.6 t -74.97 -37.91 42.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.139 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.6 t -69.52 -54.1 21.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.27 -39.72 91.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.1 -51.23 70.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 389' ' ' VAL . 84.7 t -60.99 -54.66 32.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 24.4 m -57.55 -47.33 82.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.103 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.2 mt -64.12 -34.56 78.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 13.8 m -72.16 -45.19 61.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -87.49 7.9 27.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.76 HD13 HD12 ' A' ' 398' ' ' LEU . 7.6 tp -77.64 -37.01 50.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 179.932 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.583 0.706 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 175.55 7.94 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.68 2.253 . . . . 0.0 112.372 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -152.95 169.87 21.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -99.9 179.48 4.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -134.69 168.92 18.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -155.59 167.17 31.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.87 169.45 17.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.5 151.71 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -87.56 113.36 23.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.66 137.02 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -148.47 117.71 6.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -115.3 -25.51 7.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -57.51 98.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.116 179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.98 80.65 0.58 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.494 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 3.3 p 51.29 28.64 4.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.877 -179.669 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 89.5 t -76.84 -65.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.611 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.4 t80 -68.87 -25.7 64.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.895 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.644 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.17 -28.87 12.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.106 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.43 -28.28 67.09 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.524 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.8 -27.72 8.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 111.145 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' B' ' 377' ' ' LEU . 20.0 mt -58.79 -35.49 72.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 95.7 p -48.59 -31.81 7.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.42 -53.72 21.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.902 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.96 -53.59 18.28 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.451 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.45 -53.13 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 111.131 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.07 -46.04 56.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.512 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 19.9 t80 -66.76 -32.7 74.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.866 0.365 . . . . 0.0 110.864 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -51.43 68.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.833 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.82 -49.11 74.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.886 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.61 -36.08 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.634 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.11 -34.63 45.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.165 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 27.6 mt -62.96 -47.11 84.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.579 ' O ' HG23 ' A' ' 393' ' ' VAL . 42.3 t -75.28 -37.49 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.09 -54.24 19.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.43 -43.39 96.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.22 -50.69 72.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 389' ' ' VAL . 95.6 t -64.63 -54.43 30.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.152 179.981 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.437 HG21 HD21 ' B' ' 395' ' ' LEU . 29.5 m -56.05 -40.82 74.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.128 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.486 HD21 HG21 ' B' ' 394' ' ' THR . 32.6 mt -71.26 -40.55 70.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.931 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 17.8 m -66.13 -43.32 87.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.857 179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -66.92 -23.13 65.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.871 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.817 HD13 ' HG ' ' B' ' 398' ' ' LEU . 18.1 tp -71.83 -26.05 62.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 179.948 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.605 0.717 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 166.23 28.25 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.677 2.252 . . . . 0.0 112.385 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -112.78 118.57 35.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -54.43 126.76 24.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -164.85 156.62 15.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -71.29 -67.08 0.54 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 31.2 mt -148.7 161.29 42.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 59.9 t -148.38 111.93 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -157.82 127.61 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -81.96 -66.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -132.81 153.89 50.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -175.15 155.01 1.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.901 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -52.14 102.88 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.092 179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -169.77 -72.1 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.529 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 5.1 p -96.56 1.88 51.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.39 . . . . 0.0 110.858 -179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 91.0 t -90.11 -65.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.634 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.3 t80 -68.76 -26.35 65.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.949 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.622 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -51.43 -28.77 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.104 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.19 -28.5 66.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.475 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.9 mt -82.84 -27.55 8.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.891 0.377 . . . . 0.0 111.135 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.684 HD23 HD23 ' A' ' 377' ' ' LEU . 20.7 mt -59.53 -35.32 73.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 98.6 p -48.6 -31.86 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -68.37 -53.68 22.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.99 -53.7 17.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 10.7 t -65.27 -53.14 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 111.151 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.02 -46.32 55.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.473 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.617 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 19.8 t80 -66.53 -32.66 74.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.893 0.378 . . . . 0.0 110.909 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.52 68.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.1 mt -63.59 -49.19 74.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -61.62 -35.99 79.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.617 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.25 -34.64 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.9 mt -62.87 -47.24 84.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.596 ' O ' HG23 ' B' ' 393' ' ' VAL . 48.2 t -75.24 -37.52 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.5 t -69.99 -54.11 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.125 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.65 96.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.089 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -58.34 -50.8 72.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.596 HG23 ' O ' ' B' ' 389' ' ' VAL . 99.4 t -63.32 -54.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.112 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 395' ' ' LEU . 36.8 m -56.13 -45.97 79.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.437 HD21 HG21 ' A' ' 394' ' ' THR . 33.4 mt -64.65 -34.55 78.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.39 -44.72 62.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.939 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -87.18 6.91 30.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.886 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.817 ' HG ' HD13 ' A' ' 398' ' ' LEU . 0.9 OUTLIER -76.66 -34.96 58.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 -179.996 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.847 179.946 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 61.2 mt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.603 0.716 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 165.27 31.48 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.735 2.29 . . . . 0.0 112.365 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -157.81 168.52 26.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.075 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -83.38 178.15 8.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -156.31 139.64 15.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.889 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -99.73 153.01 19.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.856 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 10.2 mt -144.95 141.81 29.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 26.7 m -57.88 -178.52 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.119 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -108.43 112.64 25.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.47 107.8 2.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -130.09 110.73 11.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -84.66 -59.43 2.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . . . . . . . . . . . -51.79 103.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.099 179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -109.0 -54.8 0.58 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.513 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 4.2 m -115.34 13.91 16.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.952 0.406 . . . . 0.0 110.888 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 86.2 t -90.0 -65.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.633 ' CE1' HD11 ' B' ' 377' ' ' LEU . 2.2 t80 -69.09 -24.77 64.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.928 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . 0.658 ' HA ' HD12 ' A' ' 377' ' ' LEU . . . -51.36 -28.67 13.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.116 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.55 -28.55 67.81 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . 0.478 HD12 ' CE1' ' A' ' 373' ' ' TYR . 4.9 mt -82.95 -27.41 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 0.0 111.094 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' B' ' 377' ' ' LEU . 19.7 mt -59.11 -34.62 72.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.941 179.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 96.0 p -48.45 -31.92 7.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 -179.927 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -68.44 -53.63 22.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.74 -53.72 18.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 10.6 t -65.23 -52.83 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.884 0.373 . . . . 0.0 111.132 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.05 -45.83 56.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.524 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.7 t80 -67.02 -32.64 73.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.892 0.377 . . . . 0.0 110.911 -179.915 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.48 68.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.896 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 6.9 mt -63.66 -49.29 73.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.957 179.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.39 -36.01 79.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.63 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.5 mm -73.22 -34.52 44.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.138 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.0 mt -63.07 -47.07 84.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 393' ' ' VAL . 43.5 t -75.33 -37.34 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.17 -54.38 19.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.05 -45.05 94.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.088 179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.43 -50.39 71.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 389' ' ' VAL . 91.2 t -66.09 -55.01 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.632 HG21 HD21 ' B' ' 395' ' ' LEU . 85.6 m -54.73 -40.15 68.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.171 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.591 HD21 HG21 ' B' ' 394' ' ' THR . 31.3 mt -71.06 -34.09 70.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 18.3 m -73.55 -39.16 64.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -67.0 -23.45 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 398' ' ' LEU . 1.1 pp -104.4 -11.44 17.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 179.961 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 20.3 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.593 0.711 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 135.58 30.8 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.679 2.253 . . . . 0.0 112.375 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -94.4 162.12 13.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.083 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -148.31 132.24 17.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.906 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -142.89 131.63 22.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.895 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -146.4 129.32 16.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 3.3 pp -163.65 155.89 17.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 14.7 p -113.3 148.43 16.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.155 179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.45 153.88 50.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.61 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.116 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.68 -65.61 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -155.26 115.17 3.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -121.33 12.13 10.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' B' ' 374' ' ' ALA . . . -122.68 -27.87 1.52 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.47 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.9 p -96.25 -0.66 49.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 0.0 110.873 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 91.2 t -90.16 -65.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.11 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . 0.644 ' CE1' HD11 ' A' ' 377' ' ' LEU . 2.2 t80 -68.56 -24.91 64.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' B' ' 377' ' ' LEU . . . -50.85 -29.57 12.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -59.45 -28.62 65.11 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.47 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . 0.47 HD12 ' CE1' ' B' ' 373' ' ' TYR . 5.0 mt -83.14 -27.35 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.709 HD23 HD23 ' A' ' 377' ' ' LEU . 19.7 mt -60.11 -34.06 72.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.894 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 99.3 p -48.67 -32.19 7.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -68.24 -53.79 22.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.955 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.408 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.81 -53.39 19.87 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.452 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.36 -53.08 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 111.151 -179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.95 56.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.515 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.615 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.4 t80 -66.9 -32.74 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 110.895 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.29 -51.45 68.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.68 -49.13 74.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -61.53 -36.14 79.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.897 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.615 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.5 mm -73.17 -34.44 44.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.104 -179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 27.4 mt -63.11 -46.99 84.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 393' ' ' VAL . 43.6 t -75.5 -37.27 37.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.103 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.7 t -70.28 -54.15 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.138 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.26 -45.28 93.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.13 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -56.27 -50.33 71.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.115 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 389' ' ' VAL . 92.0 t -66.34 -55.03 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.157 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.591 HG21 HD21 ' A' ' 395' ' ' LEU . 61.4 m -54.63 -39.92 68.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.088 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.796 ' HA ' HD23 ' B' ' 398' ' ' LEU . 31.1 mt -71.26 -34.64 70.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 19.7 m -73.31 -38.24 65.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.895 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -67.58 -23.37 65.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 -179.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.796 HD23 ' HA ' ' B' ' 395' ' ' LEU . 0.4 OUTLIER -74.39 -25.28 59.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.959 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.08 0 CA-C-O 121.602 0.715 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 169.09 19.72 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.673 2.249 . . . . 0.0 112.343 179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -147.68 155.25 41.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.99 177.68 5.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -152.25 169.02 23.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -81.67 172.63 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 -179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.636 HD22 ' OE2' ' B' ' 368' ' ' GLU . 7.0 mt -112.05 174.55 5.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 19.7 m -104.4 176.2 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.143 179.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -112.45 111.51 22.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -156.65 175.19 14.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.116 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.21 102.4 7.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.871 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -147.83 153.75 39.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 373' ' ' TYR . . . 59.09 40.86 21.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.02 -80.85 0.52 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.526 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 88.7 p -84.87 3.3 38.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.943 0.401 . . . . 0.0 110.864 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 62.1 t -90.04 -65.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.591 ' HB2' ' HB1' ' A' ' 369' ' ' ALA . 2.0 t80 -68.9 -29.93 68.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -58.14 -27.67 63.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.063 179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.18 -25.39 62.26 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.463 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.45 -25.07 8.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.865 0.364 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' B' ' 377' ' ' LEU . 21.2 mt -65.53 -34.2 77.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.963 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 92.1 p -48.6 -33.87 10.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.849 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -66.93 -53.47 31.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.938 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -67.87 -52.6 27.87 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.491 179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -62.85 -51.39 72.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.849 0.357 . . . . 0.0 111.12 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.84 -48.4 51.12 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.466 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.5 t80 -64.51 -32.63 74.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.931 0.396 . . . . 0.0 110.853 -179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.3 -51.67 67.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.1 -49.31 74.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.921 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -61.69 -36.11 79.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 8.6 mm -73.31 -34.59 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 28.1 mt -62.88 -47.16 84.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 393' ' ' VAL . 46.1 t -75.3 -38.1 40.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.34 -54.22 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.04 97.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.46 -50.66 72.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.077 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 389' ' ' VAL . 86.8 t -64.03 -54.74 27.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . . . . . . . . . 42.2 m -56.16 -41.01 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . . . . . . . . . 32.8 mt -71.21 -38.97 72.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 16.4 m -67.59 -42.41 82.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -66.53 -23.03 66.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.89 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.724 HD13 ' CD1' ' B' ' 398' ' ' LEU . 6.5 tp -71.38 -62.69 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 -179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.836 179.97 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 3.2 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.633 0.73 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -32.94 17.49 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 0.0 112.354 179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -121.38 156.59 32.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -162.74 170.78 17.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.895 -179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.49 162.58 39.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -148.61 141.9 25.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 4.2 pp -159.39 166.94 30.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 7.9 m -152.3 126.77 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.156 179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -146.83 141.04 26.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -142.94 157.26 44.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.81 179.08 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . 0.636 ' OE2' HD22 ' A' ' 363' ' ' LEU . 41.4 tt0 -85.05 98.05 10.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . . . . . . . . . . . -142.76 118.07 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.122 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . 157.34 -58.1 0.36 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.527 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 3.1 m -99.24 2.65 45.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.938 0.399 . . . . 0.0 110.869 -179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.15 -65.22 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.93 -30.15 68.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.93 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -57.71 -27.65 63.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -60.51 -24.92 62.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 4.8 mt -82.36 -25.03 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.876 0.37 . . . . 0.0 111.113 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.837 HD23 HD23 ' A' ' 377' ' ' LEU . 19.9 mt -65.35 -34.36 78.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.92 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 83.4 p -48.57 -33.81 10.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -67.0 -53.48 30.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.413 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -67.87 -52.65 27.62 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.511 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.474 HG23 ' O ' ' B' ' 377' ' ' LEU . 5.9 t -62.89 -51.62 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -48.2 51.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.487 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 21.0 t80 -64.73 -32.47 74.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 0.0 110.902 -179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.47 -51.57 68.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.4 mt -63.13 -49.21 75.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -61.74 -36.38 80.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 8.6 mm -73.08 -34.42 45.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.136 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 28.3 mt -62.97 -47.48 83.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.904 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.63 ' O ' HG23 ' B' ' 393' ' ' VAL . 45.5 t -75.03 -37.84 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 11.1 t -69.61 -53.97 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.72 91.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -59.11 -51.2 71.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.068 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 389' ' ' VAL . 85.8 t -61.25 -54.66 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . . . . . . . . . 39.3 m -57.4 -47.1 82.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . . . . . . . . . 34.7 mt -64.26 -35.77 81.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.87 -45.09 65.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -86.11 5.42 33.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.724 ' CD1' HD13 ' A' ' 398' ' ' LEU . 6.8 tp -80.26 -36.83 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.561 0.696 . . . . 0.0 110.945 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 358' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 158.6 56.38 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.671 2.247 . . . . 0.0 112.376 179.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -154.4 140.21 18.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 360' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -154.55 166.15 34.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -149.08 172.1 15.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 362' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -146.42 172.34 13.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.872 -179.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.31 170.68 20.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 364' ' ' VAL . . . . . . . . . . . . . 35.0 m -115.05 176.22 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.18 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -125.48 175.1 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.887 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -132.72 175.62 9.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.129 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -144.51 176.0 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 368' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 57.25 -171.34 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 369' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' B' ' 369' ' ' ALA . . . 62.94 53.55 2.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -97.43 -75.28 1.23 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.441 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 371' ' ' SER . . . . . . . . . . . . . 84.8 p -90.07 2.08 55.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 372' ' ' VAL . . . . . . . . . . . . . 45.8 t -90.02 -63.83 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.104 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -68.46 -29.98 68.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.925 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 374' ' ' ALA . . . . . . . . . . . . . . . -59.74 -25.63 65.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 375' ' ' GLY . . . . . . . . . . . . . . . -62.63 -24.61 66.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 376' ' ' ILE . . . . . . . . . . . . . 4.7 mt -82.55 -23.7 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 111.112 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' B' ' 377' ' ' LEU . 22.2 mt -65.39 -34.75 79.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.939 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 94.3 p -48.78 -33.68 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 379' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -67.28 -53.53 29.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' B' ' 380' ' ' GLY . . . -68.04 -52.82 25.9 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 377' ' ' LEU . 6.1 t -63.18 -51.83 66.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.836 0.35 . . . . 0.0 111.161 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.77 -47.96 51.74 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.49 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 383' ' ' PHE . . . . . 0.627 ' CZ ' HD11 ' A' ' 387' ' ' ILE . 20.3 t80 -64.88 -32.65 74.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 0.0 110.866 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.4 69.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.881 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.75 -49.28 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.856 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 386' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.34 -36.3 79.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 387' ' ' ILE . . . . . 0.627 HD11 ' CZ ' ' A' ' 383' ' ' PHE . 9.1 mm -73.33 -34.35 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 25.4 mt -62.81 -47.29 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 389' ' ' VAL . . . . . 0.589 ' O ' HG23 ' A' ' 393' ' ' VAL . 45.5 t -75.43 -37.77 38.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.136 179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -69.35 -53.93 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.139 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.27 98.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.117 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.34 -48.33 79.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 393' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 389' ' ' VAL . 93.3 t -66.6 -55.09 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.091 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 394' ' ' THR . . . . . 0.566 HG21 HD21 ' B' ' 395' ' ' LEU . 35.6 m -55.71 -41.12 73.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 395' ' ' LEU . . . . . 0.577 HD21 HG21 ' B' ' 394' ' ' THR . 35.5 mt -71.4 -51.74 22.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 396' ' ' CYS . . . . . . . . . . . . . 21.1 m -57.01 -38.17 72.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -89.22 -2.81 58.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 398' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' B' ' 398' ' ' LEU . 0.3 OUTLIER -64.97 -25.37 67.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.881 -179.997 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 399' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.832 179.97 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 357' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.549 0.69 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 358' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 115.37 4.05 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.682 2.255 . . . . 0.0 112.406 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 359' ' ' ALA . . . . . . . . . . . . . . . -132.39 165.23 24.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.092 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 360' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -155.15 133.8 11.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.875 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 361' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -136.36 167.36 21.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 362' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -147.77 156.83 43.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.914 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 363' ' ' LEU . . . . . . . . . . . . . 13.4 tp -88.63 130.24 35.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 364' ' ' VAL . . . . . . . . . . . . . 39.5 t -146.28 123.68 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 365' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -122.25 137.66 54.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 366' ' ' ALA . . . . . . . . . . . . . . . -126.08 110.62 13.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.133 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 367' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -149.57 116.89 6.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.39 175.98 2.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 369' ' ' ALA . . . . . 0.888 ' HB3' ' HB3' ' A' ' 369' ' ' ALA . . . -52.25 107.47 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 370' ' ' GLY . . . . . . . . . . . . . . . -125.39 -47.82 0.21 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 371' ' ' SER . . . . . . . . . . . . . 14.7 m -109.26 2.6 20.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.861 0.363 . . . . 0.0 110.889 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 372' ' ' VAL . . . . . . . . . . . . . 22.6 t -90.2 -65.38 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.174 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 373' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -70.03 -30.25 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 374' ' ' ALA . . . . . . . . . . . . . . . -60.61 -24.37 65.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 375' ' ' GLY . . . . . . . . . . . . . . . -63.31 -25.6 68.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 376' ' ' ILE . . . . . . . . . . . . . 5.0 mt -82.52 -23.23 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 111.131 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.843 HD23 HD23 ' A' ' 377' ' ' LEU . 21.9 mt -65.34 -35.2 80.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 378' ' ' SER . . . . . . . . . . . . . 94.4 p -48.6 -33.68 10.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.903 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 379' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -67.36 -53.56 28.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 380' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 380' ' ' GLY . . . -68.01 -52.96 25.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.499 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 381' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 377' ' ' LEU . 6.1 t -63.22 -51.75 67.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.387 . . . . 0.0 111.119 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 382' ' ' GLY . . . . . . . . . . . . . . . -51.82 -47.83 52.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.492 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . 0.613 ' CZ ' HD11 ' B' ' 387' ' ' ILE . 20.6 t80 -65.02 -32.63 74.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.901 0.381 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 384' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.33 -51.46 68.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.845 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 385' ' ' LEU . . . . . . . . . . . . . 7.6 mt -63.7 -49.34 73.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 386' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.23 -36.45 79.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.839 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 387' ' ' ILE . . . . . 0.613 HD11 ' CZ ' ' B' ' 383' ' ' PHE . 9.0 mm -73.2 -34.18 43.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 388' ' ' LEU . . . . . . . . . . . . . 25.2 mt -63.07 -47.3 83.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 389' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 393' ' ' VAL . 44.4 t -75.38 -37.32 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.116 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 390' ' ' VAL . . . . . . . . . . . . . 10.4 t -70.03 -54.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.133 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 391' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.58 97.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 392' ' ' ALA . . . . . . . . . . . . . . . -57.13 -50.45 72.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.115 179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 393' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 389' ' ' VAL . 96.7 t -65.11 -54.93 23.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 394' ' ' THR . . . . . 0.577 HG21 HD21 ' A' ' 395' ' ' LEU . 61.7 m -55.33 -40.99 71.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 395' ' ' LEU . . . . . 0.566 HD21 HG21 ' A' ' 394' ' ' THR . 32.6 mt -71.33 -44.18 65.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 396' ' ' CYS . . . . . . . . . . . . . 17.9 m -62.42 -43.63 98.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 397' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 -66.73 -22.92 66.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 -179.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 398' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 398' ' ' LEU . 1.7 tt -76.4 -36.27 58.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 399' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.881 179.915 . . . . . . . . 0 0 . 1 stop_ save_